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Bacteria have developed a plethora of strategies to cope with constantly changing 
environmental conditions, including post-transcriptional regulatory mechanisms. With this regard, 
regulation of gene expression can be achieved by either the rapid removal or stabilization of RNA 
molecules by ribonucleases (RNases). RNases properties and functions have been mainly studied 
in the two model organisms Escherichia coli and Bacillus subtilis and their investigation often relied on 
the characterization of a limited number of substrates. Although these studies are highly 
informative, they do not provide a global picture of all the RNase targets in the bacterial cell. In 
addition, studies in non-model microorganisms – including pathogens – have revealed that distinct 
RNase orthologs exhibit species-specific effects on gene expression, bacterial physiology and 
strategies of target recognition, indicating that our understanding of the RNA degradation 
machinery is not yet complete.  
The aim of this thesis was to investigate the features and functions of endoRNase Y from 
the strict human pathogen Streptococcus pyogenes, whose RNA degradation machinery is poorly 
studied. To gain insight into the role and specificity of this RNase, we identified RNase Y cleavage 
positions (i.e. targetome) genome-wide by RNA sequencing. Next, to investigate the RNA 
degradation pathway depending on RNase Y, we compared the RNase Y targetome with the ones 
of the three 3′-to-5′ exoribonuclease (exoRNases) present in this bacterium, namely PNPase, YhaM 
and RNase R. Finally, to dissect the requirements for RNase Y processing in vivo and to decipher 
the role of RNase Y in virulence gene regulation, we studied the impact of RNase Y on speB mRNA, 
that encodes a major virulence factor.  
This study reveals that RNase Y preferentially cleaves transcripts downstream of a 
guanosine and for the first time we were able to show that the presence of a guanosine residue is 
essential for the processing of speB mRNA, in vivo. Although RNase Y cleaves the speB mRNA, our 
data underpin a model in which RNase Y-mediated regulation of speB expression occurs at the 
transcriptional level. Using the targetome comparative approach, we demonstrated that RNase Y 
initiates RNA decay in S. pyogenes and that the transcript 3′ ends produced by this RNase are usually 
further trimmed by the 3′-to-5′ exoRNases. In particular, RNase Y acts mainly in concert with 
PNPase in RNA decay, through the generation and subsequent degradation of decay intermediate 
fragments.  
The comprehensive analysis of RNase Y processing positions gives insights into the 
specific features of RNase Y in S. pyogenes, highlighting the importance of expanding the 
investigation of RNase Y orthologs to poorly characterized organisms. Overall, these findings 




Bakterien haben eine Vielzahl von Strategien entwickelt, um sich an ständig wechselnde 
Umweltbedingungen anzupassen, dazu gehören unter anderem post-transkriptionelle 
regulatorische Mechanismen. Genexpression kann entweder durch einen zügigen Abbau oder die 
Stabilisierung von RNA durch Ribonukleasen (RNasen) reguliert werden. Eigenschaften und 
Funktion von RNasen wurden bisher hauptsächlich in Escherichia coli und Bacillus subtilis untersucht, 
wobei diese Charakterisierung oft auf einer limitierten Anzahl von Substraten beruht. Obwohl diese 
Studien informativ sind, können sie kein umfassendes Bild aller RNase-Substrate in Bakterien 
widerspiegeln. Weiterhin haben Untersuchungen in Nicht-Modell Organismen, inklusive 
Pathogenen gezeigt, dass bestimmte orthologe RNasen spezies-spezifische Einflüsse auf 
Genexpression, bakterielle Physiologie und Strategien der Substraterkennung haben. Dies 
unterstreicht die Tatsache, dass unser Verständnis des RNA Abbaus bei weitem nicht vollständig 
ist. 
Ziel dieser Arbeit ist es die Eigenschaften und Funktionen der endoRNase Y des 
Humanpathogen Bakteriums Streptococcus pyogenes zu untersuchen. Um einen Überblick über die 
Rolle und Spezifität dieser RNase zu gewinnen, wurden deren genomweiten Schnittpositionen 
(“targetome”) mit Hilfe von RNA-Sequenzierung identifiziert. Dieses Ergebnis wurde mit dem 
“targetome” der drei 3′-nach-5′ Exoribonukleasen (exoRNasen) PNPase, YhaM und RNaseR 
verglichen, um den RNA-Abbauweg von RNase Y zu untersuchen. Anforderungen für RNase Y 
Aktivität in vivo und deren Rolle in der Regulation von Virulenz-Genen wurde anhand des 
Einflusses von RNAse Y auf die speB mRNA, welche einen wichtigen Virluenz-Faktor codiert, 
untersucht. Wir konnten in dieser Arbeit zeigen, dass RNase Y RNA-Substrate präferentiell nach 
einem Guanosin schneidet und dass dieses Nukleosid essentiell für die Prozessierung der speB 
mRNA in vivo ist. Obwohl RNase Y die speB mRNA schneidet, unterstützen die Daten ein Modell 
nach dem RNase Y die Expression von speB auf der Ebene der Transkription reguliert. Mit Hilfe 
des “targetome” Vergleichs konnten wir zeigen, dass RNase Y den RNA Abbau in S. pyogenes 
initiiert und dass die dabei produzierten 3′ Enden der RNA weiter von 3′-nach-5′ exoRNasen 
getrimmt werden. Der RNA Abbau erfolgt dabei vor allem durch die Generierung und den 
darauffolgenden Abbau von intermediären Fragmenten durch das Zusammenspiel von RNase Y 
mit PNPase.  
Die umfassende Analyse der RNase Y Prozessierungsstellen gewährt Einblicke in 
spezifische Eigenschaften von RNase Y in S. pyogenes. Dies betont die Wichtigkeit der 
Untersuchung weiterer RNase Y Orthologe in weniger charakterisierten Bakterien. 
Zusammenfassend erweitern diese Erkenntnisse unser Verständnis der Funktionalität von 
RNase Y und des RNA Abbaus in Gram-positiven Bakterien. 









1.1 Post-transcriptional regulation of gene expression in bacteria 
acteria need to constantly cope with changing environmental conditions in order to 
successfully acquire nutrients and proliferate. Such a complex adaptation is achieved by 
precisely adjusting gene expression according to the external stimuli and environmental cues. For 
a long time, bacterial gene expression regulation was thought to occur entirely at the transcriptional 
level, through the regulated activity of transcriptional factors. In 1961, Jacob and Monod in the 
description of the “operon model”, formulated the hypothesis that the repressor molecule, 
responsible for inhibiting the operon expression, was a ribonucleic acid (RNA) molecule acting 
either at the deoxyribonucleic acid (DNA) or at the messenger RNA (mRNA) level1. In the latter 
case, the operon negative regulation would occur post-transcriptionally1. While, this mechanism of 
gene expression regulation was initially neglected with the discovery of the first protein acting as 
transcriptional repressors (i.e. Lac and Lambda repressors)2,3, research over the past few decades 
has revealed that bacterial gene expression is far more complex than what was thought and does 
not uniquely depend on transcriptional factors. It is now, indeed, well established that bacteria also 
extensively control the expression of genes at the post-transcriptional level through an intricate 
network of regulatory small RNAs (sRNAs), RNA binding proteins and ribonucleases (RNases). 
 
 
1.1.1 Regulatory RNAs 
RNA molecules are typically divided into: (i) mRNAs involved in transferring the genomic 
information from DNA to proteins, (ii) ribosomal RNAs (rRNAs) representing the major 
structural component of ribosomes, (iii) transfer RNAs (tRNAs) responsible for decoding the 
mRNAs into proteins and (iv) sRNAs, which exert regulatory roles and usually do not encode 
B 
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proteins. The first RNA described to function as regulatory molecule was an antisense RNA 
(asRNA), encoded within the Escherichia coli plasmid ColE1 and named RNAI4. RNAI inhibits the 
plasmid replication by binding to RNAII, which hybridizes to the DNA template and serves as a 
primer for the DNA polymerase5. 
sRNAs play a key role in the control of gene expression at the post-transcriptional level 
and are involved in a variety of physiological processes in bacteria, such as virulence, stress 
responses and community behavior6. sRNAs can be divided in different categories depending on 
their mode of action and on the nature of their targets: (i) asRNAs that are cis-encoded on the 
opposite DNA strand compared to the target RNA, (ii) riboswitches that are encoded within the 
5′ untranslated region (5′ UTR) of the target RNA that they regulate in cis, (iii) trans-acting sRNAs 
encoded on a different locus than the target mRNA, (iv) sRNAs interacting with proteins instead 
of RNA molecules and (v) clustered regularly interspaced palindromic repeats (CRISPR) associated 
sRNAs, which interact with DNA molecules6,7. 
 
asRNAs 
asRNAs control gene expression by base-paring the target RNAs. Since asRNAs are 
encoded in cis on the opposite DNA strand compared to their target RNAs, the two RNAs share 
perfect sequence complementarity. At first, asRNAs were mainly thought to be encoded in mobile 
genetic elements (e.g. plasmids, transposons and bacteriophages) where they are involved in the 
control of plasmid replication or bacteriophage development8,9.  
Plasmids often encode toxin-antitoxin (TA) systems consisting of stable toxin and an 
unstable antitoxin, which neutralizes the toxin activity. These systems ensure plasmid stability by 
post-segregational killing since the more stable toxin will kill the cells that have lost the plasmid. In 
type I TA systems, the antitoxin is an asRNA that base-pairs with the mRNA encoding the toxin 
and inhibits its expression10,11. The best characterized type I TA system is the host killing 
(hok)/suppression of killing (sok) system encoded in the E. coli plasmid R112. The antitoxin RNA 
Sok interacts with the Shine-Dalgarno (SD) sequence of the open reading frame (ORF) located 
just upstream of the toxin gene hok and indirectly inhibits hok mRNA translation. The duplex 
formed by the two RNAs is then recognized and subsequently cleaved by the double-stranded 
RNA (dsRNA) specific endoribonuclease (endoRNase) III (RNase III)13,14. 
With the development of highly sensitive technologies to study bacterial transcriptomes, a 
large amount of asRNA was also identified to originate from antisense transcription of bacterial 
genomes15–18. asRNAs, usually between 100 and 300 nucleotides (nt) long, can be classified based 
on whether they derive from antisense transcription of 5′ UTRs, 3′ UTRs or from ORFs19. Longer 
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asRNAs have been also reported, for example in Listeria monocytogenes, where some asRNAs were 
detected that span over several ORFs20.  
Different mechanisms are exploited by asRNAs to control gene expression at the level of 
transcription, RNA stability and translation. In the first scenario, asRNAs can affect transcription 
by directly interfering with the transcription machinery of the sense strand or by transcription 
attenuation, which affects the formation of a termination structure downstream of the asRNA-
RNA duplex21. At the post-transcriptional level, the asRNA binding to the target mRNA leads to 
occlusion of the ribosome binding site (RBS) and to subsequent inhibition of the translation 
initiation. asRNA-target mRNA interaction can also induce processing by RNases. For instance, 
the asRNA GadY, base-pairs with the gadXW bicistronic mRNA and induces cleavage by 
RNase III, which processes the duplex RNA, causing gadW mRNA stabilization22–24.  
Long asRNAs (lasRNAs) encoded in the antisense DNA strand were shown not only to 
act as mRNAs (encoding for proteins), but also to exert regulatory functions by inhibiting the 
expression of the genes expressed in the sense DNA strand21. The outcome of this genomic 
arrangement is that the lasRNA negatively regulates the sense ORFs while ensuring the expression 
of the antisense (i.e. divergently transcribed) ORFs. This distinctive locus arrangement was named 
“excludon”, as it exclusively allows the expression of one of the two transcriptional units21. 
Recently, the concept of not-contiguous operon, consisting of genes co-transcribed from the sense 
DNA strand and interspaced by a gene divergently transcribed, was proposed in 
Staphylococcus aureus25. This organization would allow the coordinated regulation of genes encoded 
in the same operon, by RNase III mediated-processing of the overlapping region, which in turns 
affects mRNA translation and/or stability25.  
 
Trans-acting sRNAs 
trans-acting sRNAs are encoded at a distal site in the genome compared to the target 
mRNA. Hence, there is not perfect sequence complementarity between the sRNAs and the mRNA 
target. While originally trans-acting sRNAs that harbor their own promoter and terminator were 
only identified within intergenic regions26,27, it is now clear that these sRNAs can also originate 
from 5′ and 3′ UTRs of mRNAs28–30. In addition, fragments derived from degradation of mRNAs 
and tRNAs can also act as regulatory RNAs31,32.  
trans-acting sRNAs mainly regulate the target mRNA by sequestering the RBS and thereby 
blocking the 30S ribosome recruitment. The subsequent lack of ribosomes on the mRNA exposes 
the mRNA to the activity of RNases, which therefore degrade the targeted mRNA6,33. Alternatively, 
trans-acting sRNAs can positively regulate gene expression by promoting the mRNA translation. 
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In this case, binding of the sRNA to the target mRNA triggers a structural change that is 
responsible for the liberation of the sequestrated RBS, which otherwise is inaccessible to the 
ribosome34. 
trans-acting sRNAs do not only act at the mRNA 5′ UTRs, but can also target the mRNA 
internally, i.e. in the coding DNA sequence (CDS). MicC, the first sRNA identified to interact with 
the target mRNA in the CDS, was shown to induce the degradation of the ompD mRNA by 
recruiting an endoRNase (RNase E) and promoting degradation initiation of the target in 
Salmonella typhimurium35,36. sRNAs can also prevent mRNA degradation and therefore causing 
mRNA stabilization. For example, in Bacillus subtilis the RoxS sRNA interacts with the 5′ end region 
of yflS mRNA thereby blocking the activity of RNase J1, an exoribonuclease (exoRNase) that 
degrades RNA molecules from the 5′ extremity37. The interplay between sRNAs and RNases will 
be further discussed in section 1.1.6.  
Finally, sRNAs can also act in trans by interacting with others sRNAs and therefore 
indirectly regulating RNA targets. For instance, the SroC sRNA, consisting of an RNA fragment 
produced during RNA degradation of the gltIJKL mRNA (coding for an amino acid transporter) 
functions as a sponge of the GcvB sRNA38. Interestingly, it has also been shown that RNA 




RNA-dependent regulation at the post-transcriptional level also relies on riboswitches that 
consist of RNA structures found in the 5′ UTR of mRNAs. These elements are able to sense 
different type of metabolites (e.g. vitamins cofactor, amino acids) or environmental conditions (e.g. 
temperature)40–42. As they regulate the expression of their own mRNA, riboswitches are defined as 
cis-acting regulatory elements. The binding of a specific metabolite or the sensing of a certain 
stimulus induces a conformational change that modulates the expression of the downstream 
located CDS. Riboswitches affect gene expression through different mechanisms, including 
inhibition or activation of the mRNA translation and transcriptional termination or 
antitermination.  
A different type of 5′ regulatory element largely used by Gram-positive bacteria is the so-
called T-box, which senses non-aminoacylated tRNAs43,44. The interaction with the uncharged 
tRNAs leads to the formation of an antitermination structure, which promotes transcription of the 
downstream ORF encoding a specific aminoacyl-tRNA synthetase.  
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Interestingly, some riboswitches can also function as trans-acting regulators, as shown in 
L. monocytogenes28. The premature terminated transcript of the S-adenosyl-L-methionine riboswitch 
binds to the 5′ UTR of prfA mRNA, encoding the major virulence transcriptional regulator, and 
blocks its translation28. 
 
sRNA sequestering proteins 
Some others sRNAs act in trans by interacting with proteins in order to sequester them or 
inhibit their function. This distinct group of sRNAs includes the CsrB sRNA that binds the carbon 
storage regulator CsrA, consisting of a protein that negatively regulates several target mRNAs 
through translation inhibition45.  
Another member of this class is the 6S sRNA, which was shown to associate with the RNA 
polymerase (RNAP) complex and modulate its activity46–48. Bacterial RNAP consists of a 
multicomplex, which includes the factors involved in transcription and the sigma specificity factor 
(σ) responsible for the recognition of the promoter regions. Bacteria display a housekeeping σ 
factor, known as σ70 or σA, which is required in all growth stages and also different alternative σ 
factors, which are activated under specific environmental conditions49. During stationary phase of 
growth, the 6S sRNA interacts with the RNAP complex through the σ70 factor, mimicking the 
interaction of RNAP with the promoter regions, and therefore prevents the RNAP binding to the 
DNA. The outcome is the repression of genes harboring a σ70-dependent promoter47,48,50. 
sRNAs interacting with proteins are also largely used in type III TA systems, as exemplified 
by the toxI/toxN locus of Erwinia carotovora51. The RNA antitoxin (ToxI) is produced as a precursor 
long RNA, which comprises an array of repeat sequences. This precursor undergoes maturation 
though the processing by the endoRNase toxin (ToxN), resulting in the production of ToxI 




Lastly, the sRNAs involved in the bacterial adaptive clustered regularly interspaced short 
palindromic repeats (CRISPR) – CRISPR associated proteins (CRISPR-Cas) system constitute 
another class of sRNAs. CRISPR-Cas systems confer protection against invading foreign nucleic 
acids, including plasmids and phages. This adaptive defense mechanism relies on the integration of 
DNA fragments, deriving from foreign nucleic acids, into the genomic CRISPR array locus, 
allowing to keep memory of the infections52. During a second foreign nucleic acid invasion, the 
CRISPR RNAs (crRNAs) are produced, from endoribonucleolytic processing of the transcribed 
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CRISPR array (pre-crRNA). The defense mechanism relies on the recognition of the invading 
DNAs by the crRNAs, which act in trans by base-pairing the target DNAs. The crRNAs guide the 
Cas effector protein(s) to the extrachromosomal DNAs, leading to their subsequent degradation52.  
The crRNAs are generated as a precursor RNA molecule (pre-crRNA) that undergoes a 
maturation process in order to generate the active crRNAs. In the type II CRISPR-Cas system, the 
crRNAs biogenesis requires the activity of the trans-acting crRNA (tracrRNA), a sRNA that 
functions in trans through base-pairing the pre-crRNAs and promoting the pre-crRNAs processing 
by RNase III53,54.  
CRISPR-Cas can also be involved in the regulation of endogenous gene expression55–58. 
Recently, it has been shown in Francisella novicida that the expression of two bacterial lipoproteins 
depends on a complex formed by tracrRNA, another small CRISPR-Cas associated RNA (named 
scaRNA) and the Cas9 nuclease59. In this complex, the scaRNA guides Cas9 to interact in proximity 
of the promoter region of the target genes, promoting transcription inhibition59. 
 
1.1.2 RNA binding proteins 
RNA binding proteins can exert structural roles in large complexes (e.g. ribosomes) or can 
function as regulatory factors involved in transcription, translation and RNA degradation60. 
 
RNA chaperones 
Hfq is an RNA chaperone crucial in the sRNA-mediated regulation, especially in 
enterobacteria, and it was initially identified as a host factor for the replication of the Qβ phage in 
E. coli. In enterobacteria, Hfq assists trans-acting sRNAs in the recognition and regulation of the 
target mRNAs. Hfq binds both the trans-acting sRNA and the target mRNA, promoting the base-
pairing and thereby facilitating the formation of the sRNA-mRNA complex6,61. Whereas the 
interaction with the trans-acting sRNA occurs though an uracil (U)-rich region at the sRNA 3′ end62, 
the binding to the mRNA is mediated by an adenosine (A)-rich region at the 5′ end region of the 
target mRNA63,64. The complex of Hfq-sRNA is able to recruit RNase E, which is responsible for 
the degradation of the target mRNA35,65,66. However, it is still unclear whether RNase E recruitment 
is uniquely mediated by the sRNA or by Hfq60. 
Hfq likely plays a different role in Gram-positive bacteria. It was shown indeed to not be 
required for the sRNA-mediated regulation of gene expression in S. aureus and B. subtilis and it is 
completely absent in other bacteria like Streptococcus pyogenes67–69. The only sRNA identified in Gram-
positives that requires Hfq to base-pair its target mRNA is LhrA from L. monocytogenes70. Based on 
the Hfq-limited function in Gram-positive bacteria and the fact that some sRNAs in enterobacteria 
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are Hfq-independent, it is likely that other RNA binding proteins can replace Hfq function. In 
B. subtilis, the Fur-regulated basic protein B (FbpB) was shown to participate in the sRNA FsrA-
mediated regulation of gene expression. It was proposed that FbpB may act as an RNA chaperone, 
however the FbpB ability to bind RNA has not been proven yet71. The RNA-binding proteins 
RocC from Legionella pneumophila72 and ProQ from Salmonella enterica73 were recently identified to be 
involved in sRNA stabilization and to enhance the sRNA-mRNA duplex formation72,74. Oppositely 
to Hfq, which recognizes sequence motifs, both ProQ and RocC recognize stem-loop structures, 
such as terminator stem-loops75,76. 
 
RNA helicases 
Bacterial helicases are also key modulators of gene expression at the post-transcriptional 
level as they affect mRNA degradation and translation77,78. Helicases are divided in 6 superfamilies 
and most of the bacterial helicases belong to the superfamily 2 and to the DEAD-box class. The 
transcription termination factor Rho represents an exception, as it belongs to the superfamily 5 of 
helicases77,79.  
The Rho protein consists of a hexameric RNA-dependent ATPase which slides, in 5′-to-3′ 
direction, along a nascent RNA molecule and promotes transcription termination by unwinding of 
the RNA-DNA duplex79. Upon Rho-mediated transcription termination in E. coli, the 3′ end region 
of the transcripts is processed by RNases, in order to produce the mature transcript 3′ ends80. 
The DEAD-box class of helicases plays a key role in RNA degradation by unfolding RNA 
secondary structures and therefore generating single-stranded RNA (ssRNA), which can be 
targeted by ssRNA-specific RNases. In E. coli, the RhlB helicase is found associated to the 
degradosome, which is a multi-enzymatic complex involved in RNA degradation (see section 
1.1.5)81,82. Other members of the DEAD-box class, such as CsdA, are involved in the regulation of 
the translation process. In E. coli, CsdA was shown to stimulate protein synthesis by unfolding 
RNA structures, which negatively affect the translation process83.  
Gram-positive bacteria harbour a different set of helicases. In B. subtilis, four DEAD-box 
RNA helicases were identified: CshA, CshB, YmfL and DeaD84. Deletion of the genes encoding 
CshA, CshB or YmfL resulted in impaired growth at low temperatures85–87. The DEAD-box 
helicase CshA, similarly to RhlB, is highly involved in RNA degradation by generating ssRNA 
regions more susceptible to the exoRNases unable to degrade structured RNAs. As described for 
RlhB, CshA was shown to interact with RNases and likely be part of a degradosome-like complex 
in Gram-positive bacteria88 (see section 1.1.5). Of note, in S. aureus, CshA promotes the degradation 
of the agr mRNA, encoding the multiple factors of the agr quorum sensing system, including the 
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AgrA transcriptional regulator89. AgrA not only regulates the transcription of the agr operon itself, 
but also the expression of the sRNA RNAIII, a key regulator of virulence90. Overall, CshA-
mediated repression of agrA expression results in downregulation of RNAIII, which in turn leads 
to increase in biofilm formation and reduction of haemolysin secretion in S. aureus89. 
 
1.1.3 Ribonucleases 
RNases are enzymes that catalyze the scission of a phosphodiester bond in an RNA 
molecule. The RNA susceptibility to the RNase activity depends on several factors including 
intrinsic RNA properties (e.g. RNA secondary structures), the rate of translation, and as already 
discussed, RNA binding proteins and sRNAs91,92. First, RNA molecules arising from transcription 
harbor a 5′ triphosphorylated (5′ PPP) end, which exerts a protective role against degradation as 
restrains the activity of several endo or exoRNases. The 5′ PPP can be converted to 5′ 
monophosphorylated (5′ P) by a pyrophosphohydrolase enzyme (RppH) that eventually triggers 
transcript degradation93,94. Second, newly synthesized transcripts can be modified at the 5′ end with 
the addition of a nicotinamide-adenine dinucleotide cap, which prevents transcript degradation95,96. 
RNA structures at the 5′ end of transcripts have been shown to impede the targeting by RNases97,98. 
At the 3′ ends, the transcripts are also protected from exoRNase degradation by transcriptional 
terminator structures99. In addition, RNase target recognition and processing are often inhibited by 
ribosomes, which mask the RNase cleavage site on the RNA molecules and therefore promote 
RNA stabilization100–102. Lastly, RNA cellular localization also plays a role in determining the rate 
of degradation, as was described in E. coli. In this bacterium, the mRNAs encoding inner-
membrane proteins are enriched at the membrane and they display a higher turnover compared to 
the mRNAs encoding cytoplasmic and outer-membrane proteins not localized at the membrane103. 
 RNases can be classified based on their capability to cleave an RNA molecule internally 
(endoRNases) or from the extremities (exoRNases). EndoRNases can cleave specifically ssRNA 
or dsRNAs. exoRNases are further classified based on the directionality of the RNA degradation, 
which can occur starting from the RNA 5′ end (5′-to-3′ exoRNases) or from the RNA 3′ end (3′-
to-5′ exoRNases). When the cleavage of the RNA backbone occurs through a H2O-mediated 
nucleophilic attack and causes the release of a nucleoside monophosphate, the RNase is defined as 
hydrolytic. Conversely, RNases that use inorganic phosphate to cleave the phosphodiester bond 
and liberate nucleoside diphosphate are classified as phosphorolytic enzymes104. 
 




RNA degradation (or RNA decay) allows bacteria to rapidly and constantly adjust the levels 
of RNAs in order to produce the correct amount of proteins needed, adapt to changing 
environmental conditions and recycle nucleotides. Bacteria displays a rapid mRNA turnover with 
a half-life of approximately 6.8 minutes in E. coli 15 or less than 7, 5 and 2 minutes in B. subtilis 98, 
S. aureus 105 and S. pyogenes 106, respectively. Conversely, stable RNAs including rRNAs and tRNAs, 
which represent the majority of the intracellular RNAs, are usually not degraded at standard growth 
conditions; while they undergo degradation during certain environmental stresses (e.g. starvation 
and stationary growth phase)107. RNA degradation mechanisms have been mainly investigated in 
the two model organisms E. coli and B. subtilis, which harbor different sets of RNases108,109. Two 
pathways, which differ on the initiation step, have been described and named “5′ end-dependent 
pathway” and “direct entry pathway” (Figure 1). 
5′ end-dependent pathway. In both E. coli and B. subtilis, the 5′ end-dependent pathway 
relies on the enzymatic conversion of the transcript 5′ PPP to 5′ P, which renders the RNA 
molecule susceptible to RNA degradation93,110–112. In E. coli, RNase E, which is the major 
endoRNase in Gram-negative bacteria, preferentially targets 5′ P transcript and, after sensing the 
5′ P group at the RNA terminus, catalyzes multiple processing events in the targeted RNA113,114 
(Figure 1). Further, cleavage sites within the ssRNA regions are found by linearly scanning the 
target from the 5′ P to the 3′ end115. RNase E is an essential enzyme and plays a crucial role in RNA 
degradation, but does not have a homolog in Gram-positive bacteria, with the exception of some 
species such as Streptomyces coelicolor (class of Actinomycetales), Bacillus halodurans (class of Bacilli) 
and Clostridium acetobutylicum (class of Clostridia)84,116. Therefore, other RNases are involved in the 
initiation of RNA degradation, including the 5′-to-3′ exoRNase J1 that is able to degrade transcripts 
with a 5′-to-3′ directionality84,117. Upon removal of the 5′ PPP group, RNase J1 recognizes the 5′ P 
group and initiates the degradation of the transcript94,118. Alternatively, RNase Y, which also prefers 
5′ P RNAs119, can internally cleave the target RNA and initiate degradation108.  
Direct entry pathway. RNA degradation can also be initiated directly through an internal 
cleavage by RNase E and RNase Y in E. coli and B. subtilis, respectively108,120. In this case, the activity 
of the endoRNases is independent from the chemical nature of the transcript 5′ end (Figure 1). 
Indeed, it has been shown that the recognition of the 5′ P is not required for the processing of 
several RNase E targets93,121. This RNA decay pathway has also been identified in Gram-positive 
bacteria, where RNase Y cleaves the body of the target RNAs102,122. 
 
   
 
   
    
Introduction 10 
 
Figure 1. RNA degradation pathways in Gram-positive and Gram-negative bacteria. 
Schematic representation of the E. coli (left) and B. subtilis (right) mechanisms of RNA degradation. In the 
5′ end-dependent pathway, the 5′ triphosphate group (5′ PPP) is converted to 5′ monophosphate (5′ P) by a 
pyrophosphohydrolase (RppH, pink scissors). In E. coli, this event triggers the activity of endoRNase E 
(blue scissors) that catalyzes multiple processing events. In B. subtilis the 5′ P RNA is targeted either by 
endoRNase Y (purple scissors) or by RNase J1 (orange “pacman” symbol), which degrades the RNA from 
the RNA 5′ to the 3′ end. In the direct entry pathway, RNase E and RNase Y independently from the 
phosphorylation state of the transcript 5′ end, cleave internally the RNA target. In E. coli, the degradation 
of the decay intermediate fragments generated by endoRNases are then degraded by 3′-to-5′ exoRNases 
RNase II, PNPase and RNase R (green “pacman” symbol), which generate nanoRNAs further degraded by 
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the oligoRNase Orn (brown “pacman” symbol). In some cases, a poly(A) polymerase (PAP) (blue circle) 
catalyzes the addition of a poly(A) tail at the RNA 3′ end, which is followed by 3′-to-5′ exoRNase 
degradation. In B. subtilis, 3′-to-5′ exoRNases (mainly PNPase) and RNase J1 degrade the decay intermediate 
fragments. The nanoRNAs are degraded by NrnA, NrnB or YhaM (pink “pacman” symbol). 
 
RNA degradation termination. Initiation of RNA degradation by endoRNases leads to 
the production of decay intermediate fragments that are consequently and rapidly degraded by 
exoRNases120,123 (Figure 1). In E. coli, the 3′-to-5′ exoRNases, mainly RNase II and PNPase, are 
involved in degradation of the decay intermediate fragments generated by endoRNases124–126. These 
exoRNases do not complete the degradation of the fragment up to the fragment 5′ end, but they 
produce 2-5 nt-long oligoribonucleotides (named nanoRNAs)127. These short RNA products are 
then subsequently degraded by an essential 3′-to-5′ oligoRNase (Orn), which generates 
mononucleotides128,129 (Figure 1). The RNA fragments containing a stem-loop terminator structure 
at the 3′ end are usually degraded by RNase R, which displays an intrinsic helicase activity130 or by 
PNPase acting in concert with RNA helicases131,132. Alternatively, the repetitive addition of a 
poly(A) tail at the RNA 3′ end, by a poly(A) polymerase (PAP), renders the fragments more 
susceptible to 3′-to-5′ exoRNase degradation133,134 (Figure 1). Indeed, these enzymes require a 
ssRNA overhang at the 3′ end of the substrate to bind the RNAs and perform degradation135,136. 
B. subtilis does not have an RNase II ortholog and RNA degradation is mainly performed 
by PNPase and to a lesser extent by RNase R91,104,123. B. subtilis, as opposed to E. coli harbors a 5′-
to-3′ exoRNase (RNase J1), which is involved in degradation of decay intermediate fragments. In 
particular, fragments containing the transcription terminator structure were shown to be efficiently 
degraded by this 5′-to-3′ exoRNase137. RNAs with a poly(A) tail at the 3′ end were also identified in 
B. subtilis, however the impact of the poly(A) on the RNA stability is unclear138. Finally, two 
nanoRNases (nanoRNase A and nanoRNase B) are able to degrade the nanoRNAs produced by 
exoRNases to mononucleotides. In addition, the 3′-to-5′ exoRNase YhaM also possibly plays a role 
as nanoRNase in B. subtilis139. 
 
RNA maturation  
RNases were considered to act only as degradative enzymes, but it was later found that they 
play a crucial role also in RNA maturation i.e. processing event that results in the production of a 
functional RNA molecule. Some RNAs, are at first produced as precursor transcript that undergoes 
to RNase processing responsible for the generation of a functional RNA molecule. For example, 
rRNAs (16S, 23S and 5S) and some tRNAs are cotranscribed and multiple endoribonucleolytic 
processing and trimming events are required to generate the individual rRNA molecules140,141. For 
instance, in both E. coli and B. subtilis, the 16S rRNA is released from the precursor transcript by 
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RNase III processing142–144. The mature tRNA 5′ end is generated in both model organisms by 
RNase P145,146, which is a ribonucleoprotein complex composed of an RNA molecule exerting the 
catalytic activity and a protein subunit147. The RNA component of RNase P also requires a 
maturation event in order to be active, and this is achieved by RNase E148 and RNase Y149 
processing in E. coli and B. subtilis, respectively. 
 In bacteria, the production of the correct amount of proteins encoded by genes expressed 
from an operon, is often achieved by endoRNase-mediated processing within the polycistronic 
transcript. This maturation event allows differential stability of the processed mRNAs and thus to 
uncouple the expression of the different genes from the same operon150–153.  
In some cases, sRNAs also require a maturation step in order to be functionally active. For 
instance, the mature 6S sRNA, able to modulate the RNAP activity, is generated from a longer 
RNA precursor processed by RNase E154,155. This endoRNase was also shown to be highly involved 
in the generation of functionally active sRNAs from processing of mRNA 3′ UTRs29,30. RNase Y 
also takes part in sRNA maturation, for example the RNase Y processing of the sRNA RoxS results 
in a truncated sRNA variant, which interacts with an increased number of target mRNAs than the 
precursor sRNA156. Finally, as already mention in section 1.1.1, the activation of CRISPR RNAs 
from the CRISPR-Cas systems relies on a processing event, which is performed by RNase III53. 
 
1.1.4 Ribonucleases involved in RNA metabolism in Gram-positive bacteria  
Gram-positive bacteria harbor a different set of RNases compared to Gram-negative, with 
RNase Y being the major endoRNase initiating RNA degradation in B. subtilis and most of 
Firmicutes84,109. Although RNases are quite conserved in different Gram-positive bacteria, they 
often display different characteristics and functions among the various bacterial species. The main 
RNases involved in RNA metabolism and the regulation of gene expression in Gram-positive 
bacteria are discussed in detail below. 
 
RNase Y 
General characteristics. RNase Y is a ssRNA specific endoRNase, which harbors 
different domains: (i) a trans-membrane domain at the N-terminal region responsible for the 
RNase Y localization at the membrane (similar to what was described for RNase E), (ii) a 
disordered domain overlapping with a predicted coiled-coil region able to interact with other 
proteins, (iii) a ribonucleoprotein K homology (KH) domain involved in RNA binding, (iv) a 
histidine and aspartate (HD) containing domain responsible for the catalytic activity and (v) a C-
terminal domain whose function is currently unknown157. RNase Y is considered to act as the 
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RNase E functional equivalent in the majority of Gram-positive bacteria, in which RNase E is not 
present. Interestingly, RNase Y can be found in Helicobacter pylori, a Gram-negative bacterium, and 
in the class of Clostridia, in which also RNase E is present84,158. 
RNase Y proteins form a dimeric structure157,159. RNase Y is also able to interact with other 
proteins involved in RNA decay and the role of RNase Y as a central enzyme of a degradosome-
like complex in Gram-positive bacteria will be discussed in section 1.1.5.  
Deletion of the RNase Y trans-membrane domain is lethal in B. subtilis157 and it has a severe 
effect on S. aureus growth160. Surprisingly, in S. aureus the number of RNase Y targets did not vary 
when the trans-membrane domain was removed160, similarly to what was observed in S. pyogenes161. 
Therefore, the physiological function for RNase Y membrane localization is unclear. 
Effects of gene deletion. Depletion of rny (encoding RNase Y) expression has severe 
consequences on B. subtilis growth, cell morphology and sporulation162,163. While the three 
independent transcriptomic studies performed in B. subtilis revealed that depletion of RNase Y 
affects the expression of 20% to 30% of the transcriptome, they observed few common 
differentially expressed genes157,164,165. In Clostridium perfringens, the RNase Y knockout strain (∆rny) 
could not be generated and the depletion of the enzyme severely affects the growth and the 
expression of up to 400 genes166. Oppositely, deletion of RNase Y in S. aureus does not have major 
effects on the bacterial growth and transcript abundance167. In S. pyogenes, two transcriptomic 
studies demonstrated that RNase Y participates in RNA degradation. In the first study, rny deletion 
caused only a small delay in growth and affected the expression of approximately 30% of the 
transcripts at stationary phase of growth168. The second showed that 98% of transcripts were 
stabilized in the ∆rny strain106. As RNase Y is highly conserved protein, the reason why RNase Y 
exerts such a different impact in these Gram-positive bacteria remains unclear. The main sequence 
variability among RNase Y orthologs is found in the N-terminal region of the protein, between the 
transmembrane domain and the disordered domain, and it might be responsible for the different 
RNase Y ortholog activity and specificity84. 
Progressing determinants. The study of RNase Y activity on the S-adenosylmethionine 
riboswitch revealed that this endoRNase preferably cleaves 5′ P RNA in A/U rich regions119, as 
was reported for RNase E. Only two RNA sequencing-based studies were performed to annotate 
RNase Y processing sites in S. aureus and B. subtilis and in both approximately one hundred cleavage 
sites were mapped153,160. RNase Y was shown to preferentially cleave after a guanosine (G) residue 
in A/U ssRNA regions in S. aureus160. The role of this nucleotide is unclear, as it is not required for 
the saePQRS transcript processing by RNase Y, which instead depends on the presence of a stem-
loop structure located 6 nt downstream of the RNase Y processing site169. In B. subtilis, the mapping 
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of the RNA 5′ ends generated by RNase Y did not reveal any sequence or structural preference153. 
In this study, RNase Y was shown to form a complex with three other proteins (YlbF, YmcA and 
YaaT), which affect RNase Y specificity153. This complex was previously shown to be involved in 
the regulation of biofilm formation, competence and sporulation in B. subtilis170–173. The complex 
mediates the destabilization of the transcript encoding the master regulator of biofilm formation 
(SinR), by promoting RNase Y cleavage173,153. Recently, it has been shown that the YlbF, YmcA 
and YaaT complex consists of an heterotrimer harboring a double iron-sulfur cluster, which is 
ligated by cysteines174. These residues were demonstrated to be necessary for the maturation 
processing of the cggR-gapA operon by RNase Y174. 
Functions. RNase Y is involved in uncoupling the expression of genes that are encoded 
within the same polycistronic transcript159,175, in the maturation of the RNA component of 
RNase P106,149, in the decay of premature terminated transcripts derived from regulatory 5′ UTRs 
(e.g. riboswitches and T-boxes)119,153,160 and in modulating the abundance of regulatory 
sRNAs106,160,166,167. Interestingly, RNase Y is required for the virulence of S. aureus176,177, S. pyogenes168 
and C. perfringens166. For instance, RNase Y is responsible for stabilizing a transcript encoding the 
two-component system SaeRS, which regulates the expression of numerous virulence genes in 
S. aureus167,169. Attenuated virulence was observed for the ∆rny strain in both silkworm and murine 
S. aureus infection models176. In C. perfringens, RNase Y controls the expression of the κ-toxin 
collagenase by acting in concert with a sRNA166. In S. pyogenes, RNase Y affects the expression of 
virulence genes during stationary phase of growth in accordance to the nutrient availability (e.g. 
carbon and peptides)168 and it is required for the thermoregulation of capsule production178. An 
impaired subcutaneous infection was observed after injection of the ∆rny strain in mice, indicating 
that RNase Y is required for S. pyogenes pathogenesis168.  
 
RNase III 
General characteristics. RNase III is a double-stranded (dsRNA) specific 
endoribonuclease, which cleaves the phosphodiester bond between two nucleotides leaving a 3′ 
hydroxyl (OH) and 5′ P termini and 2 nucleotide (nt) 3′ overhang179,180. RNase III functions as a 
homodimer and the catalytic site of each subunit is responsible for cleaving independently one of 
the RNA strands, generating a double strand break179,180. However, RNase III can also nick RNA, 
meaning cleaving only one RNA strand of the duplex180–182. The gene encoding for the bacterial 
RNase III (rnc) is not essential, with the exception of rnc from B. subtilis. In this bacterium, 
RNase III is required to repress the production of toxins encoded in prophage regions, as it cleaves 
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the RNA duplex formed by the toxin mRNAs and its respective RNA antitoxin164. An RNase III 
deletion strain could be constructed only after the deletion of these prophage regions84,164.  
Functions and effects of gene deletion. RNase III plays a crucial role in rRNA 
maturation by producing the precursor transcript of the 16S and 23S rRNAs141. It is also involved 
in the regulation of gene expression, often in concert with regulatory sRNAs84,92. Deletion of rnc in 
B. subtilis affects the expression of 12% of the transcripts, similar to what was previously observed 
in E. coli164,183. Mapping of the RNase III cleavage sites by RNA sequencing137 and co-
immunoprecipitation of RNase III followed by RNA sequencing184 revealed that RNase III, apart 
from rRNA, targets also mRNAs and several intergenic regions in B. subtilis and S. aureus, 
respectively. In addition, in S. aureus the amount of antisense transcription was increased in the ∆rnc 
strain compared to the WT strain, indicating an important role for RNase III in antisense RNA 
regulation16,184. Dissimilarly, in B. subtilis and S. pyogenes the effect of RNase III on antisense RNA 
processing and clearance seemed to be minor137,185.  
In S. pyogenes, RNase III is involved in the activation of the crRNAs from the type II 
CRISPR-Cas system (see section 1.1.1). The tracrRNA harbors a complementary region to the pre-
crRNA and the duplex formed by the two RNAs is recognized and cleaved by RNase III. This 
processing event results in the maturation of the crRNA, which in complex with tracrRNA, guides 
the nuclease Cas9 to the invading nucleic acids53,54. Genome wide mapping of the RNase III 
cleavage sites in S. pyogenes revealed that this enzyme preferentially cleaves in UTRs rather than in 
CDSs185, as was also demonstrated in S. aureus184. For instance, the processing of RNase III in the 
UTR between secY (encoding Sec translocase) and adk (encoding adenylate kinase) uncouples the 
expression of the two genes185. In this bacterium RNase III displays a broad nicking activity in vivo, 
whose role in transcript regulation is not known yet. Overall, at standard growth conditions, 
deletion of rnc has little impact on gene expression and antisense transcription. Overall, RNase III 
is mainly involved in RNA maturation pathways (e.g. rRNA maturation) in S. pyogenes185. 
 
RNases J1 and J2 
General characteristics. In eukaryotes, RNA degradation by exoRNases occur in both 3′-
to-5′ and 5′-to-3′ directions. The search in E. coli for an exoRNase capable of degrading RNA from 
5′ to 3′ transcript ends was not successful. In 2007 a 5′-to-3′ exoRNase, named RNase J1, was 
instead identified in B. subtilis and it was shown to be involved in the 16S rRNA maturation117. 
More recently, a 5′-to-3′ exoRNase was also identified in E. coli (RNase AM), however its activity 
was only validated in vitro on RNA oligonucleotides186. 
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While Gram-positive bacteria with low guanosine and cytosine content (low-GC) display 
two RNase J orthologs (RNase J1 and J2), the high-GC Gram-positive bacteria encodes only for 
one ortholog (RNase J1). These enzymes are mostly present in Gram-positive bacteria, with the 
exception of H. pylori, a Gram-negative bacterium that harbors a homolog of RNase J1 (RNase J) 
is expressed84,162.  
RNase J1 operates as a processive enzyme (i.e. removes one nucleotide at the time), but can 
also act as distributive enzyme when the target is shorter than 5 nt187. Transcripts with a 5′ P or a 
5′ OH are the preferred substrates of RNase J1, as the enzyme cannot bind to 5′ PPP RNAs117,188. 
RNase J1 is unable to degrade the transcripts whose 5′ end regions are involved in the interaction 
with another RNA molecule37. Although RNase J1 activity is impaired by RNA secondary 
structures, this enzyme is involved in the degradation of terminator step-loops during RNA 
decay189. RNase J1 was also shown to act as an endoRNase in vitro, but this activity was never 
confirmed in vivo, where RNase J1 is believed to act mainly as a 5′-to-3′ exoRNase190. In B. subtilis 
RNase J2 exoribonucleolytic activity is much weaker when compared to the one of RNase J1 and 
the two enzymes have been shown to interact forming a heterodimer complex191,192.  It was 
proposed that RNase J2 exert more a structural role in the complex with RNase J1190. 
Functions and effects of gene deletion. Deletion of the gene encoding RNase J1 (rnjA) 
in B. subtilis has a drastic effect on growth, cell physiology and alters the expression of 
approximately 21% of the transcripts162. Coherent with the reduced exoribonucleolytic activity of 
RNase J2 (encoded by rnjB), the deletion of rnjB did not affect cell growth in this bacterium. 
Different impacts of RNases J1 and J2 on the bacterial physiology and gene expression have been 
observed in other Gram-positive bacteria than B. subtilis. For instance, in S. aureus deletion of rnjB 
causes stronger growth defects than rnjA deletion193. In Streptococcus mutants, these two RNases are 
not essential and RNase J2 acts as an endoRNase in vivo independently from RNase J1194. It was 
shown that RNase J2 cleaves the gbpC mRNA and the processing can be inhibited by the base-
pairing of gbpC mRNA with the 5′ UTR of irvA mRNA. Lastly, in S. pyogenes, both RNases are 
essential and they exert a role in the regulation of transcript stability195. 
 
PNPase  
General characteristics. PNPase (polynucleotide phosphorylase) is a phosphorolytic 3′-
to-5′ processive exoRNase that uses inorganic phosphate to degrade RNAs and thereby releasing 
nucleoside diphosphate. PNPase was also shown to catalyze the reverse reaction, meaning that it 
is able to synthesize RNA from nucleoside diphosphates without a template196,197. The major 
activity of PNPase in vivo is the degradation of RNAs more than their synthesis, but the polymerase 
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function is used to add polynucleotide tails at the RNA 3′ ends to favor RNA degradation by 3′-to-
5′ exoRNases. However, this role appears to be less important in B. subtilis than in E. coli138,198. As 
already mentioned, PNPase requires a ssRNA tail of at least 6 nt at the RNA 3′ ends to bind the 
target and perform RNA degradation199,200. PNPase displays a ring-like structure, which forms a 
channel ending with the catalytic site. The channel can accommodate only ssRNA, explaining why 
this enzyme is unable to digest secondary structures109. Therefore, PNPase often acts in concert 
with the CshA helicase and the two enzymes were shown to physically interact88. 
Functions and effects of gene deletion. In B. subtilis, PNPase functions as the major 3′-
to-5′ exoRNase involved in RNA degradation and deletion of the corresponding gene (pnpA) 
causes pleiotropic effects (e.g. increased sensitivity to antibiotics and cold, impaired 
competence)123,201–203. In S. pyogenes, PNPase was also demonstrated to act as the main 3′-to-5′ 
exoRNase in RNA decay, but the ∆pnpA strain does not exhibit major phenotypes except for 
reduced fitness at low temperatures204. In both B. subtilis and S. pyogenes, PNPase is involved in the 
degradation of  decay intermediate fragments generated by endoRNases136,204.  
In addition, PNPase was shown to participate in sRNA regulation in E. coli by sequestering 
the Hfq-dependent sRNAs thereby protecting them from degradation205. This activity has never 
been observed in Gram-positive bacteria. However, in L. monocytogenes PNPase is required for the 




General characteristics. RNase R is a hydrolytic 3′-to-5′ exoRNase that degrades RNA in 
a processive mode and also displays an RNA helicase activity that is involved in the unfolding of 
secondary structures207,208. In vitro, RNase R is able to digest long dsRNA regions, but a ssRNA tail 
at the 3′ end (optimally 10 nt-long) is necessary for the enzyme to degrade the substrates130,130,209. 
Functions and effects of gene deletion. Deletion of the gene encoding RNase R (rnr) in 
B. subtilis does not affect the bacterial growth and bulk RNA stability136. The double rnr and pnpA 
deletion strain grows slower than the single pnpA mutant, indicating that RNase R can in some 
cases compensate for the absence of PNPase. In S. pyogenes, however, rnr and pnpA could not be 
simultaneously deleted, indicating that this bacterium requires the presence of at least one of the 
two 3′-to-5′ exoRNases204. 
RNase R is involved in the maturation of stable RNAs (e.g. rRNAs) and in RNA quality 
control by degrading fragments derived from defective transcripts130,210. RNase R also participates 
in RNA decay, ensuring the degradation of structured fragments136,211. However, the overall role of 
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RNase R in RNA degradation is limited, as was shown in both B. subtilis and S. pyogenes136,204. Instead, 
RNase R exerts a more critical role under non-standard growth conditions. For instance, in E. coli 
RNase R production is triggered during environmental stresses (e.g. cold)212,213. RNase R was shown 
to be involved in the adaptation to cold shock by degrading transcripts during the acclimation 
phase and allowing translation recovery214. Coherently with the prominent role of RNase R during 
stress, RNase R production is tightly controlled. The regulation of this RNase will be further 
discussed in section 1.1.6. 
 
YhaM 
General characteristics. YhaM is a hydrolytic 3′-to-5′ exoRNase found only in Gram-
positive bacteria215. The enzyme is composed of an oligonucleotide/ oligosaccharide binding (OB) 
domain and a HD domain, which is responsible for the catalytic activity215. 
Functions. This exoRNase degrades nanoRNAs in vitro and overexpression of the gene 
encoding YhaM (yhaM) was able to partially compensate for the absence of the oligoRNase Orn in 
E. coli 139. It has been proposed that YhaM, by removing few nucleotides at the transcript 3′ ends, 
could prevent degradation of the transcripts by RNase R, which requires a sufficiently long ssRNA 
tail to degrade the substrate136. YhaM was also shown in vitro to degrade longer RNA substrates and 
to be sensitive to secondary structure215. YhaM ortholog in S. aureus (CBF1), beside displaying RNA 
degradation activity in vitro215, has the ability to bind DNA and it was shown to participate in DNA 
replication216. In B. subtilis the production of this enzyme is induced under conditions of DNA 
damage217 and it degrades DNA in the 3′-to-5′ direction in vitro215, suggesting that YhaM could play 
a role for DNA repair mechanisms. Deletion of yhaM does not affect the bacterial growth and 
global transcript levels neither in B. subtilis nor in S. pyogenes204,215. Recently, it has been shown in 
S. pyogenes that YhaM acts as an unspecific 3′-to-5′ exoRNase that removes on average 3 nt at the 
RNA 3′ ends of the majority of the transcripts in the cell. The biological consequences of such 
general trimming activity are still unclear204. Interestingly, deletion of yhaM causes growth defect at 
low temperature in S. pyogenes and the effect is even more pronounced when both yhaM and rnr are 
deleted204. These results indicate that YhaM could play an important role under specific 




3′-to-5′ exoRNases do not complete the digestion of RNAs, but usually generate short RNA 
products (nanoRNAs or oligoRNAs), which then are fully digested by nanoRNases (or 
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oligoRNases). In E coli, this function is performed by Orn, an essential oligoRNase that is not 
present in B. subtilis. Instead, this bacterium harbors two nanoRNases (NrnA and NrnB) and the 
double deletion mutant of these two genes is viable127,139,218. Moreover, simultaneous deletion of the 
genes encoding NrnA, NrnB and YhaM is not lethal indicating that in B. subtilis the degradation of 
nanoRNAs is probably performed by enzymes acting redundantly139. NrnA is a bidirectional 
exoRNase able to degrade from the 5′ extremity a 12-nt long oligoRNA and to digest the substrate 
from the 3′ extremity when the oligoRNA is not longer than 3 nt219. NrnB degrades 5-nt oligoRNAs 
in vitro with a 3′-to-5′ directionality139. Some Gram-positive bacteria, like S. aureus and S. pyogenes, 
only encode NrnA84. 
 
1.1.5 RNA degradosome and localization of RNA degradation  
In E. coli and other Gram-negative bacteria, the enzymes involved in RNA degradation are 
part of a multiprotein complex called degradosome. The central factor of this complex is RNase E, 
which is anchored at the bacterial membrane and through its C-terminal domain is able to interact 
with PNPase, RhlB and enolase (an enzyme involved in the glycolytic pathway)220,221. The 
degradosome components can change upon variations of the environmental conditions and 
stimuli. For instance, in some circumstances the Hfq-sRNA complex contacts RNase E in order 
to promote the sRNA-mediated degradation of the target mRNAs158. 
It was proposed that a degradosome-like complex is also formed in Gram-positive bacteria, 
with RNase Y replacing RNase E. However, the existence of this complex is still controversial222,223. 
In B. subtilis, RNase Y by two-hybrid assays was shown to interact with enolase and 
phosphofructokinase, RNA helicase CshA, RNase J1 and PNPase159. The interaction of RNase Y 
with enolase and CshA was also confirmed using different methods in both B. subtilis and 
S. aureus88,157,224. However, the interaction of RNase J1 and RNase Y was not observed by co-
purification experiments192,225 and RNase J1 was instead shown to interact with RNase J2 and CshA, 
which are both associated to the ribosomes191,225. In S. aureus, RNase J2 was recently shown to 
interact not only with RNase J1, but also with several other proteins including RNase Y, CshA and 
enolase. In addition, it also transiently forms complexes with DnaK, DnaJ (two proteins involved 
in protein quality control) and FtsZ (a GTPase involved in cell division)226. 
The interaction of RNase Y with PNPase, although not confirmed in S. aureus, likely occurs 
in B. subtilis. The residues involved in this interaction were identified and resembled the ones used 
by PNPase to interact with RNase E in E. coli227. However, mutations of these residues do not 
affect the expression of two known RNase Y-PNPase targets in B. subtilis227.  
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The only protein interaction of RNase Y reported in S. pyogenes is the one with enolase168, 
which was also identified in S. aureus and B. subtilis159,224. The reason why enzymes involved in the 
carbon metabolism are associated with the RNA decay machinery remains unclear. It has been 
proposed that these enzymes could play a structural role in the degradosome or could regulate the 
degradation of RNA molecules based on the metabolic state of the cell222,228. 
More recently, a localization study of the putative degradosome complex components 
revealed that while RNase Y is localized at the membrane, the putative interacting partners 
(i.e. PNPase, enolase and phosphofructokinase) were found uniformly distributed in the 
cytoplasm229. It is possible that the interactions between the components of the degradosome-like 
complex are transient and do not occur simultaneously, as the entire complex has never been 
purified in Gram-positive bacteria221–223. 
  The reason why RNase E and RNase Y are anchored at the membrane, with the 
consequence of compartmentalizing the RNA degradation at the cell periphery, is unclear. In E. coli 
it has been recently shown that the RNase E membrane localization is required for RNase E protein 
stabilization, assembling of the degradosome and protecting the newly synthesized transcripts from 
premature degradation230.  
 
1.1.6 Post-transcriptional regulation mediated by RNases 
RNases can regulate gene expression at the post-transcriptional level by targeting 
specifically an mRNA, leading to its degradation or stabilization. The targeting of a specific mRNA 
can be achieved by modifying the RNase accessibility to the mRNA, for instance trough the action 
of sRNAs. Alternatively, the activity of RNases can also be modulated by interacting proteins that 
promote the degradation or stabilization of certain mRNAs, in response to external stimuli. 
Examples of RNase activity regulation are described below in detail. 
 
RNases and sRNAs 
A plethora of sRNA-RNase mechanisms of gene expression regulation have been 
described in Gram-positive bacteria92,231 (Figure 2). sRNAs can modulate RNase activity in order 
to promote either target mRNA degradation (Figure 2A and B) or stabilization (Figure 2C and D). 
The two outcomes can be a consequence of either an indirect sRNA effect on the mRNA stability 
through the regulation of translation initiation (Figure 2A and C), or a direct role on mRNA stability 
by affecting RNase processing (Figure 2B and D). In the following paragraphs examples of sRNA 
and RNase concerted action in gene expression regulation are discussed. 
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sRNA-mediated RNA degradation by translation inhibition. In B. subtilis, the sRNA 
RoxS, which is involved in the response to oxidative stress, was shown to bind to the RBS of the 
ppnkB mRNA, encoding a nicotinamide adenine dinucleotide kinase156. This interaction negatively 
affects the mRNA translation as it blocks the access of the ribosome to the ppnkB mRNA. The 
reduced ribosome trafficking on the mRNA facilitates the processing by RNase Y156 (Figure 2A). 
In addition, the dsRNA formed by RoxS and ppnKB mRNA is cleaved by RNase III. The overall 
output of these two processing events is the rapid ppnKB mRNA degradation (Figure 2A).  
sRNA-mediated RNA degradation by RNase processing. The B. subtilis genome 
encodes several type I TA systems consisting of an mRNA (toxin) and asRNA (antitoxin) produced 
from the same locus. In the txpA/ratA system, the asRNA RatA binds the txpA toxin mRNA and 
triggers RNase III processing of the duplex region164 (Figure 2B). The products deriving from the 
RNase III cleavage are subsequently degraded by PNPase and RNase J1 leading to downregulation 
of the toxin expression164 (Figure 2B). The processing of RNase III is essential to ensure bacterial 
viability, this is the reason why rnc can be deleted in B. subtilis only in the absence of type I TA 
systems regulated by RNase III. 
sRNA-mediated RNA degradation by translation activation. The sRNA VR-RNA 
from C. perfringens, binds at the 5′ end region of the colA mRNA, coding for a collagenase involved 
in virulence166,232. Prior VR-RNA binding, the 5′ UTR of colA mRNA harbors a stem loop structure, 
which sequesters the RBS and renders the mRNA unstable (Figure 2C). The binding of VR-RNA 
induces a change in the secondary structure of the colA mRNA 5′ UTR, thereby triggering RNase Y 
cleavage and subsequent liberation of the RBS (Figure 2C)166. The processing of RNase Y is 
responsible for another structural change in the colA mRNA 5′ UTR. A stem-loop structure is 
formed after RNase Y processing of the colA mRNA 5′ UTR and it protects the colA mRNA from 
degradation (Figure 2C).  
sRNA-mediated RNA stabilization by inhibition of RNase processing. In S. pyogenes, 
the FasX sRNA binds and forms a duplex with the 5′ extremity region of ska mRNA (Figure 2D), 
coding for a streptokinase involved in S. pyogenes pathogenesis233. This interaction likely prevents 
the activity of RppH and/or RNase J1, whose activities are both inhibited by dsRNA at the 5′ end 
region of the transcripts233 (Figure 2D). Therefore, in the presence of FasX the stability of ska 
mRNA is increased because its degradation is blocked. It has been proposed that in the absence of 
FasX, the 5′ PPP of the ska mRNA is targeted by RppH, which generates a 5′ P group recognized 
by RNase J1. This model has not been experimentally confirmed, but it is known that both 
RNase Y and PNPase are not involved in the FasX-mediated regulation of ska mRNA. 
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Figure 2. Modulation of RNase activity by sRNAs. 
A. The sRNA RoxS from B. subtilis binds to the ribosome binding site (RBS) of the ppnKB mRNA and 
inhibits its translation. The dsRNA region formed by the interaction between ppnKB mRNA and RoxS 
sRNA is targeted by RNase III (blue scissors). In the absence of ribosomes on the ppnKB mRNA, the 
RNase Y (purple scissors) processing site is exposed and RNase Y can cleave the mRNA. B. In B. subtilis, 
the 3′ region of the antitoxin sRNA RatA binds the txpA mRNA, encoding a toxin. RNase III cleaves the 
dsRNA leading to txpA mRNA degradation, which is performed by PNPase (green “pacman” symbol) and 
RNase J1 (orange “pacman” symbol). C. The VR-RNA base-pairs with the 5′ end region of the colA mRNA 
in C. perfringens. The binding induces a conformational change that triggers RNase Y cleavage. The 
processing leads to an increase of the mRNA stability, because of the formation of a stem-loop structure at 
the transcript 5′ end. D. The sRNA FasX from S. pyogenes binds the 5′ end region of the ska mRNA blocking 
the mRNA degradation, likely performed by RNase J1, and leads to mRNA stabilization. 
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Regulation of RNase production and activity 
The control of RNase expression and activity have been elucidated only for a limited 
number of RNases and only in few organisms234. Below the best characterized mechanisms of 
RNase expression and activity regulation are described. 
RNase III. In several bacteria, RNase III negatively autoregulates its own expression, by 
cleaving the rnc mRNA leading to its degradation137,184,235. At post-translational level, RNase III can 
interact with different proteins that modulate its activity. For instance, in E coli during T7 
bacteriophage infection, the T7 protein kinase stimulates RNase III activity to promote the 
processing and maturation of the phage mRNAs236. In E coli, RNase III interacts with the YmdB 
stress response regulator, which inhibits the RNase III dimer formation thereby reducing 
RNase III activity under cold-shock or at stationary growth phase237. 
RNase Y. In B. subtilis, RNase Y expression is growth-phase dependent157 and in S. pyogenes  
RNase Y activity is affected by the cell nutritional conditions through an unknow mechanism168. 
In S. aureus, RNase Y cleaves the rny mRNA, likely regulating its own expression160. In addition, in 
this bacterium RNase Y interacts with flotillin (FloA), which consists of a protein-associated 
membrane involved in the formation of microdomains within membranes. In the absence of FloA, 
RNase Y dimerization and thereby activity is impaired238.  
RNases J1 and J2. In B. subtilis, RNase J1 appears to be able to autoregulate its own 
production and RNase J2 likely negatively affects the expression of RNase J1239. 
PNPase. PNPase expression and regulation are tightly regulated. PNPase can autoregulate 
its own expression by degrading the pnpA transcript after RNase III processing of the pnpA mRNA 
5′ UTR or by inhibiting pnpA mRNA translation240,241.  In E coli, pnpA expression was also shown 
to be regulated by sRNAs. The sRNA CsrA prevents RNase III processing and therefore positively 
regulates pnpA expression242. In E. coli PNPase production is also regulated by the asRNA SraG, 
which induces pnpA mRNA destabilization likely by inhibiting translation243. In addition, stress 
conditions (e.g. cold-shock)244,245 or metabolites (e.g. citrate, ppGpp and ATP) can affect pnpA 
expression246–248.  
RNase R. RNase R, similarly to PNPase, is tightly regulated and different stress conditions 
can affect the levels of this enzyme in the cell. RNase R is a highly unstable protein, but during 
cold shock or starvation the protein stability increases212,213. RNase R is post-translationally 
modified by the addition of an acetyl group, which renders the protein unstable during exponential 
growth phase249,250. At stationary phase of growth, RNase R is not acetylated and is no longer 
subject to proteolysis249,250. Binding of RNase R to the ribosomes also affects the levels of RNase 
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R; during exponential phase of growth RNase R is mainly associated to the ribosomes and the 
unbound RNase R proteins are degraded251.  
 
1.2 Methodologies to study RNases 
1.2.1 Characterization of RNase targets 
The investigation of the RNase properties and functions relies on the identification and 
characterization of their targets. RNases have been largely studied in vitro, using biochemical 
approaches on a limited number of substrates. These studies are highly valuable, but they come 
with several disadvantages: (i) difficulties in purifying the enzymes (especially membrane associated 
RNases such as RNase Y), (ii) limited number of targets tested, (iii) absence of RNase interacting 
proteins that could play a role in regulating the RNase activity and specificity, (iv) difference in the 
RNA structures formed in vitro and in vivo and (v) absence of post-translational modifications that 
could affect the RNase activity. Other techniques, based on the comparison of the RNA in vivo in 
the WT strain and in the deletion mutant of the RNase of interest (∆rnase) (e.g. Northern blot 
analysis and primer extension), although very informative are not suitable for high-throughput 
studies. More recently, transcriptomic studies based on RNA sequencing gave global insights into 
the genome-wide transcript abundance and improved the understanding of the bacterial RNase 
function. RNA sequencing is a high-throughput technique which allows the simultaneous 
identification of the RNA sequence and abundance from a specific sample. The total RNA or a 
specific fraction of RNAs is converted into a library of cDNA fragments that harbor adapter 
sequences at one or both the RNA extremities. Each cDNA is then sequenced from one extremity 
(single-end sequencing) of from both the extremities (pair-end sequencing). The sequenced 
cDNAs (i.e. reads) are then mapped to reference a genome.  
The steady state levels of total RNAs in the WT and ∆rnase strains are usually calculated to 
identify the transcripts that are differentially expressed in the absence of the RNase of 
interest16,123,252–255. A different approach is to inhibit transcription by blocking the RNA polymerase 
(using e.g. rifampicin). The RNA abundance is measured by RNA sequencing at different time 
points after the rifampicin treatment. This strategy allowed an estimation of the RNA half-life in 
different bacteria106,256,257. The limit of these approaches is the impossibility of distinguishing 
between direct targets (i.e. regulated by the RNase at post-transcriptional level) or indirect targets 
(i.e. regulated by other factors which are controlled by the RNase under study). 
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1.2.2 RNA sequencing methodologies to study bacterial RNase direct targets 
Identification of the RNAs associated to an RNase 
Several tailored RNA sequencing based methodologies have been developed in order to 
specifically identify the direct targets of an RNase. Pull-down of the RNAs associated to 
catalytically inactive RNase III followed by RNA sequencing was used to globally map the 
RNase III direct targets in S. aureus184. This technique exploits epitope-tagged inactive variants of 
RNase III yet able to bind to its substrates (Figure 3A). The target RNAs are captured in vivo, as 
they are bound to RNase III mutants unable to cleave. In the WT scenario, the fragments generated 
by RNase III processing will be displaced and degraded, or occasionally one of the generated 
products can be found associated with RNase III. In these cases, the 5′ termini of the RNA pulled-
down with the WT RNase III variant corresponded to the RNase III cleavage sites mapped in 
vitro184. RNA targets bound to the inactive RNase III variants are not necessarily direct targets of 
RNase III, as this enzyme could bind its substrates without cleaving182. For this reason, RNase III 
processing of the co-immunoprecipitated RNAs had to be confirmed by mapping the cleavage 
sites in vitro184.  
A similar strategy was applied to identify sRNA-mRNA duplexes associated with RNase E 
in E. coli and the method was named “crosslinking ligation and sequencing of hybrids” (CLASH)258 
(Figure 3B). In the CLASH approach RNAs are cross-linked to a flagged active RNase E, by in vivo 
treatment with ultraviolet radiations (UV). Subsequently, the covalently bound RNAs are trimmed 
and RNA linkers are added before the cDNA library preparation258 (Figure 3B). This approach 
allows not only to identify at the single nucleotide resolution the RNA region bound to an RNase, 
but also the RNA-RNA interactions taking place on the enzyme.   
RNase III direct targets were identified in E. coli using a different RNA sequencing-based 
methodology, which relies on the specificity of the J2 antibody able to bind dsRNAs independently 
from their sequence259 (Figure 3C). The RNAs immunoprecipitated with the J2 antibody from the 
E. coli WT and ∆rnc strains were used for the cDNA library preparation (Figure 3C). RNA duplexes 
were mainly detected in the ∆rnc strain than in the WT strain, suggesting that in E. coli RNase III 
plays a critical role in the degradation of dsRNAs259.  
 
Identification of the RNase processing positions genome-wide 
The above-mentioned studies are not suitable to determine the exact location of the 
processing events. Therefore, other RNA sequencing approaches based on the genome-wide 
mapping of the RNA ends in the WT and ∆rnase strains were employed (Figure 3D). The majority 
of these methods rely uniquely on the mapping of RNA 5′ ends and they were used to identify 
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processing sites of several endoRNases: (i) RNase III cleavage sites in both B. subtilis137 and 
E. coli260,261, (ii) RNase Y cleavage sites in S. aureus160 and B. subtilis153, (iii) RNase J1 cleavage sites in 
S. aureus193 and (iv) RNase E cleavage sites in E. coli30,121.  
 
Figure 3. Methodologies to study RNases using RNA sequencing. 
A. In S. aureus the gene encoding RNase III (rnc) was deleted and epitope-tagged WT RNase III (tag-rnc) or 
catalytically inactive RNase III (tag-rnc mutant) were expressed. The inactive RNase III variant (blue scissors 
with red star) is able to bind the RNA target but not to cleave. The RNAs bound to RNase III are co-
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immunoprecipitated with the enzyme, using an antibody recognizing the epitope and used for library 
preparation and subsequent RNA sequencing (RNAseq)184. B. E. coli expressing a tagged-RNase E (tag-rne) 
was treated with UV in order to link the RNA targets (black curved line) with the interacting sRNAs (green 
curved line) to RNase E (blue scissors). The yellow cross indicates the covalent bound between the RNA 
and the RNase after UV treatment. RNase E was pulled-down with the bound RNAs using an antibody 
recognizing the tag and the RNAs were trimmed before ligation of the RNA linkers. These RNAs were 
used to prepare cDNA libraries for RNAseq258. C. In E. coli, RNAs from the WT and RNase III deletion 
mutant (∆rnc) strains were isolated and incubated with the antibody J2, which specifically recognizes double-
stranded RNA (dsRNA) regions. Less dsRNAs are immunoprecipitated in the WT strain compared to the 
∆rnc strain259. D. Mapping of the RNA 5′ ends in the WT strain and in the strain deleted of the RNase of 
interest (∆rnase). An RNase (purple scissors) cleaves an RNA molecule producing a new 5′ RNA end, which 
harbors either a monophosphate group (5′ P) or a hydroxyl group (5′ OH). Total RNAs from the WT and 
∆rnase strains are treated with a pyrophosphohydrolase to covert the 5′ triphosphate group (5′ PPP) in 5′ P 
and with T4 polynucleotide kinase (T4 PNK) to convert the 5′ OH in 5′ P. The monophosphate group at 
the transcript 5′ ends is required during the library preparation for the adapter ligation (depicted in orange). 
The sequenced cDNAs, named reads, are mapped (total reads) as well as the reads starting at each nucleotide 
(5′ end reads). The RNA 5′ end detected in the WT strain, but not in the ∆rnase strain (purple bar) 
corresponds to the RNase cleavage position. 
 
Although these studies adopt different library preparation protocols, they all depend on the 
ligation of an adapter sequence at the RNA 5′ ends (Figure 3D). Whereas primary transcripts harbor 
a PPP group at the transcript 5′ ends, processed transcripts harbor either a P or OH group. Since 
adapter ligation at the RNA 5′ ends requires a 5′ P, total RNAs are first treated with a 
pyrophosphohydrolase (e.g. RppH or Tobacco acid pyrophosphatase), which converts the 5′ PPP 
into 5′ P thereby enabling the sequencing of the total RNA. 
To specifically sequence processed RNAs, the adapter ligation is performed using untreated 
total RNAs. In this case, the primary transcripts, whose 5′ PPP group was not converted to 5′ P, 
are not included in the library preparation (Figure 3D). After adapter ligation and eventually RNA 
fragmentation, the transcripts are retrotranscribed into cDNAs, which are subsequently amplified 
and sequenced.  
The sequenced cDNAs, named reads, are mapped to the bacterial genome of reference. 
Comparison of the coverage profile (i.e. the number of reads mapped to a certain location of the 
genome) in the WT and ∆rnase strains was used to predict the location of the RNase processing 
positions260. For instance, when the processing of an endoRNase induces stabilization of one 
cleaved product and the degradation of the other one, the coverage profile upstream and 
downstream of the processing site differs between the WT and the ∆rnase strains (Figure 3D). In 
other studies, the 5′ end coverage (i.e. the number of reads starting at a specific nucleotide) was also 
calculated. Comparison of the 5′ end reads in the WT and ∆rnase strains allowed the identification 
of an endoRNase processing sites that are defined as the RNA 5′ ends present in the WT strain, 
but not detected in the ∆rnase strain (Figure 3D). Unlike the total coverage analysis, this approach 
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pinpoints the processing positions also when the total coverage profile does not vary (i.e. both 
cleaved products are stable).   
Whereas the mapping of the RNA 5′ ends has been largely used to identify RNase cleavage 
positions, mapping of the RNA 3′ ends was exploited only to investigate RNases that specifically 
produce RNA products with a 2′, 3′ -cyclic phosphate262. In other studies, mapping of the RNA 3′ 
ends have been used to (i) detect premature terminated transcript due to riboswitches or 
attenuators263, (ii) characterize the mechanisms of transcription termination264 and (iii) investigate 
the differential RNA decay of mRNAs deriving from a polycistronic transcript265. 
 
Identification of endo and exoRNase specific cleavage positions in S. pyogenes 
The above-described methods used to identify the endoRNase processing sites rely on the 
mapping of the RNA 5′ ends. However, if after endoRNase processing, the RNA harboring the 
newly generated 5′ end is degraded by exoRNases, the processing site will not be identified. To 
overcome this problem, the Identification of Specific Cleavage Position (ISCP) method was 
developed in our laboratory to pinpoint the endoRNase processing sites by comparing in the WT 
and ∆rnase strains the abundance of both RNA 5′ and 3′ ends185 (Figure 4A). The RNAs were treated 
to allow adapter ligation at the RNA extremities and libraries containing either only primary or 
processed transcripts were generated and sequenced. The total 5′ and 3′ reads were calculated in 
both strains (schematically represented in Figure 4A). To precisely annotate an RNA end as an 
endoRNase cleavage position, the positions identified as more abundant in the WT strain than in 
the ∆rnase strain were filtered using different parameters including: (i) RNA expression threshold, 
(ii) cleavage ratio and (iii) proportion of the WT and ∆rnase cleavage ratios185. The mapping of the 
RNA 3′ ends strengthens the identification of the processing sites as it allows to detect cleavage 
positions that would have not been uncovered with the solely analysis of the RNA 5′ ends. ISCP 
was successfully applied to study RNase III in S. pyogenes. Mapping of only the RNA 5′ ends was 
successively used in E. coli to also identify the RNase III processing sites261. 
 The sequencing and mapping of the RNA 3′ ends raise the possibility to also identify the 
RNA 3′ ends produced by 3′-to-5′ exoRNases, whose processing positions were never determined 
genome-wide at the nucleotide resolution. Therefore, the ISCP method was improved and used to 
pinpoint the direct targets of the 3′-to-5′ exoRNases PNPase, RNase R and YhaM in S. pyogenes 204. 
Libraries containing both primary and processed transcripts were generated from the WT strain 
and from each of the 3′-to-5′ exoRNase deletion mutant strains (∆exornase) (schematically 
represented in Figure 4B). The abundance of the RNA 5′ and 3′ ends was calculated at each 
nucleotide genome-wide and statistical analyses were performed to define the differentially 
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expressed ends, which were then filtered with the same parameters used in the RNase III study185. 
The RNA 3′ ends corresponding to the positions where a 3′-to-5′ exoRNase starts and stops the 
degradation of an RNA molecule were identified (Figure 4B), thereby giving insight into the 3′-to-
5′ exoRNase activity in vivo, in the human pathogen S. pyogenes204. 
 
Figure 4. Analysis of RNA sequencing data to study RNases in S. pyogenes. 
A and B. Schematic representation of the strategy used in S. pyogenes to identify RNase processing sites by 
mapping the RNA ends in the WT strain and in the deletion mutant of an endoRNase (∆endornase)185 or 
exoRNase (∆exornase) strains204. A. An endoRNase (blue scissors) cleaves a primary transcript (with a 5′ 
triphosphate group, 5′ PPP) and produces new RNA 5′ and 3′ ends (indicated in blue), both harboring either 
a monophosphate (P) or a hydroxyl group (OH) group. Libraries containing either only primary or only 
processed transcripts were generated by treating the RNAs in the presence or in the absence of Tobacco 
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acid pyrophosphatase (TAP). B. A 3′-to-5′ exoRNase (green “pacman” symbol) degrades incompletely a 
transcript, producing a new RNA 3′ end with either a P or OH group. Library containing both primary and 
processed RNAs were generated by treating the RNAs with pyrophosphohydrolase (RppH). A and B. T4 
polynucleotide kinase (T4 PNK) is used to convert the OH in P. Adapters (in green and purple) are ligated 
to the RNAs with 5′ P and 3′ OH RNA ends. After the library preparation and RNA sequencing (RNAseq) 
the total, 5′ and 3′ coverages are calculated and here schematically represented. endoRNase cleavage site 
positions are identified as the RNA ends more abundant in the WT strain than in ∆endornase strain. 3′-to-5′ 
exoRNase processing positions are identified as RNA 3′ ends more abundant in the WT strain (stop 
positions) or more abundant in the ∆exornase strain (start positions). 
 
1.3 The human pathogen Streptococcus pyogenes  
S. pyogenes, also referred as group A streptococcus (GAS), is a chain forming, rod-shaped, 
Gram-positive bacterium, belonging to the Firmicutes phylum, Bacilli class and Lactobacillales 
order. One major phenotype observable while growing S. pyogenes on red blood agar plates is its 
ability to completely lyse erythrocytes and therefore to generate a halo surrounding the bacterial 
colonies. More than 200 serotypes of this bacterium have been identified via sequencing of the emm 
locus, which encodes the M protein, a major virulence factor located on the bacterial surface266,267. 
 
1.3.1 Pathogenesis  
S. pyogenes is a strict human pathogen and while it asymptomatically colonizes the 
nasopharyngeal mucosa and the skin, it is also able to cause pathologies with a wide range of 
severity. Disorders caused by S. pyogenes consist mainly in superficial infections of the skin and 
throat epithelia leading to impetigo, pharyngitis and ultimately scarlet fever as a consequence of 
pharyngeal infection268,269. S. pyogenes can also penetrate deeper into the sterile tissues, for example 
infecting the epidermis and the subcutaneous tissue causing erysipelas and cellulitis, respectively270. 
The spreading of the bacteria in the soft tissue and infection of the fascia is responsible for 
necrotizing fasciitis, resulting in a severe tissue destruction. This is the reason why S. pyogenes is 
often referred to as a “flesh-eating bacteria”. Further dispersion of the bacteria into the 
bloodstream can lead to bacteremia and subsequent streptococcal toxic shock syndrome, which 
are invasive diseases associated with high morbidity and mortality271–274. Complications due to 
S. pyogenes, after clearance of the infection, can be caused by reaction of the immune system to the 
bacterial antigens. These so-called post-infection sequelae include, for instance, the acute rheumatic 
fever and post-streptococcal glomerulonephritis268,275. 
 
1.3.2 Transmission 
As the nasopharyngeal mucosa and the skin represent the major entry route of this 
bacterium, S. pyogenes is usually transmitted through respiratory drops and skin contact of infected 
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subjects. Transmission usually occurs from a human to another, however, infections caused by 
streptococcal contaminated food have been also reported268. Outbreaks due to S. pyogenes have been 
described as well and usually they are caused by strains that underwent genomic DNA modification 
with acquisition of genes encoding virulence factors268. 
 
1.3.3 Epidemiology and treatments 
An epidemiological study in 2005 estimated that S. pyogenes was responsible for more than 
600 million cases of pharyngitis and 18 million cases of severe infection yearly271,276. Despite the 
extensive usage of β-lactams antibiotic (e.g. penicillin) for the treatment of S. pyogenes infections, 
antibiotic resistance has not been observed; therefore, penicillin remains the treatment of choice277. 
In cases of allergies to penicillin or of treatment failure, due for example to S. pyogenes persistence 
inside the infected cells, macrolides (e.g. erythromycin) are used. However, S. pyogenes resistance to 
this class of antibiotics is increasing, thus a restricting usage is recommended277,278. Currently, some 
attempts to develop a vaccine to prevent S. pyogenes infection have been unsuccessful, likely due to 
the wide strain diversity279,280.  
 
1.3.4 The repertoire of virulence factors 
An arsenal of virulence factors is produced by S. pyogenes allowing invasion and survival 
within the host, and defense mechanism against the host immune system are summarized in Figure 




Successful S. pyogenes colonization relies on the adhesion to epithelial surfaces, for instance 
at the skin or oropharynx. The attachment to the host tissues is first mediated by weak interactions 
to collagen or the cell surface through pili and lipoteichoic acid (Figure 5A). Successively, stronger 
interactions occur through adhesins, including fibronectin binding proteins and also the 
aforementioned M protein, which can interact with cell surface glycosaminoglycans conferring 
tropism for specific tissues (Figure 5A)268,281–283.  
Dissemination 
S. pyogenes produces a plethora of secreted factors to remodel the tissue and facilitate the 
spreading of the bacteria within the host. Streptokinase (Ska) and different deoxyribonucleases 
(DNases) are involved in the dissolution of fibrin clots and neutrophil extracellular traps, 
   
 
   
    
Introduction 32 
respectively (Figure 5B). In addition, extracellular matrix component and hyaluronic acid are 
degraded by the Streptococcal pyrogenic exotoxin B (SpeB) and hyaluronidases, leading to 
disruption of the connective tissue284,285 (Figure 5B).  
 
Immune evasion 
In order to survive within the host, S. pyogenes employs different strategies to antagonize 
the activity of the immune system: (i) inhibition of the complement system through the 
Streptococcal inhibitor of complement (SIC) and the ScpA peptides, (ii) degradation of 
immunoglobulins G (IgG) by SpeB and Ig degrading enzyme (IdeS) (Figure 5C). In addition, a 
hyaluronic acid capsule layer provides protection against recognition from both antibodies and 
complement system268,283 (Figure 5C). 
 
 
Figure 5. Virulence factors produced by S. pyogenes. 
Schematic representation of some of the main S. pyogenes virulence factors involved in adhesion, 
dissemination, immune evasion and toxicity. A. Pili and lipoteichoic acid (LTA) mediate weak interactions 
with the host cells, while the M protein and different types of adhesins are responsible for more stable 
interaction with the host tissue. B. Bacterial dissemination in the host is due to the activity of 
deoxyribonucleases (DNases), hyaluronidases, Streptokinase (Ska) and the Streptococcal pyrogenic exotoxin 
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B (SpeB) C. Immune evasion is accomplished through the activity of the Streptococcal inhibitor of 
complement (SIC) that blocks the membrane protein complex and through ScpA, a C5a peptidase, that 
degrades the complement-derived chemotaxin C5a. Disarming of the immune system occurs also through 
degradation of immunoglobulins (Ig) and by SpeB and Immunoglobulins degrading enzyme (IdeS). The 
capsule layer protects S. pyogenes from both Ig and complement system. D. Toxicity is due to the secretion 
SpeB, superantigens and lysis inducing proteins such as Streptolysin O (SLO) and Streptolysin S (SLS). 
 
Toxicity 
S. pyogenes produces several extracellular toxins (Figure 5D): (i) Streptolysin O (SLO) 
forming pore in the host cell membranes, (ii) Streptolysin S (SLS) inducing erythrocyte lysis, (iii) 
the SpeB protease, responsible for tissue damage and (iv) pyrogenic exotoxins (e.g. superantigens), 
which act as potent immunostimulatory molecules are responsible for severe diseases275,286,287. 
 
1.3.5 Streptococcal pyrogenic exotoxin B (SpeB) and its role in virulence 
SpeB is a cysteine protease able to degrade a wide range of proteins and it is involved in 
multiple steps of S. pyogenes infection and pathogenesis (Figure 5). The gene encoding for SpeB 
(speB) is highly conserved and found in all the group A streptococci288,289. It was initially classified 
as a superantigen, but later demonstrated not to be involved in the massive stimulation of the 
immune system (typical of superantigens), but rather to function as a virulence factor due to its 
proteolytic activity285,287. To avoid targeting of bacterial cytoplasmic proteins, SpeB is produced as 
an inactive enzyme of 40 kilodalton (kDa) named SpeB zymogen (SpeBz) that undergoes multiple 
maturation events to generate a 28 kDa catalytically active protease defined as SpeB mature protein 
(SpeBm)290. The maturation occurs through intramolecular and, more frequently, intermolecular 
autocatalytic cleavage processes resulting in the elimination of a portion of the protein (named pro-
domain), which prevents the SpeB protease activity287,291,292. In addition, reduction of a cysteine 
located in the active site is also required for SpeB activity291,293. 
 Upon secretion and activation, SpeB degrades a large variety of host proteins from 
structural tissue components (e.g. fibrinogen) to molecules involved in the immune response (e.g. 
immunoglobulins, cytokines and chemokine)294. SpeB displays pro-inflammatory properties by 
cleaving and activating the precursor of interleukin-1β (IL-1β), a potent inducer of the 
antimicrobial immune response295,296. SpeB targets also streptococcal proteins that are located on 
the bacterial surface (e.g. M protein) and secreted virulence factors (e.g. Ska and C5a peptidase, 
DNase and IdeS), thereby remodeling the bacterial secretome294. In light of the diversity within the 
SpeB targets, it is clear that SpeB activity leads to apparently contrasting outcomes acting both as 
an anti-inflammatory molecule and promoting inflammation. However, it must be pointed out that 
in order to study the impact of SpeB on virulence, the bacterial location in the host, the levels of 
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speB expression and the activity of the protein during infection have to be considered. Moreover, 
many of the SpeB targets described have been investigated in vitro and few were confirmed in vivo, 
thereby considerably limiting the translational significance of these studies294. During the course of 
infection, speB expression decreases due to spontaneous mutations in the covRS locus encoding a 
two-component system (CovRS), which is one of the major inhibitors of speB transcription297,298. 
Reduced levels of SpeB in vivo correlates with progression of the infection, as many streptococcal 
virulence factors do not undergo proteolytic degradation283,299. Under these conditions, the SpeB-
mediated activation of IL-1β is also reduced, leading to a decrease in the inflammatory response. 
It has been proposed that pathogenic bacteria evade the immune system by blocking the 
establishment of an inflammatory stage, which would impede bacterial invasion by diminishing the 
SpeB levels296. Another report showed, instead, that the levels of SpeB are not reduced in the 
majority of the strains derived from infected humans, independently of the type of diseases or 
bacterial serotype. These results indicate that a further clarification of the multiple roles of SpeB 
during an invasive disease is needed300.  
  
1.3.6 SpeB regulation 
The expression of speB is regulated by multiple factors and environmental conditions 
(mainly investigated in vitro). Different expression levels according to the particular serotype studied 
were reported290. The speB gene is transcribed from two promoters (P and P1) and a third one (P2) 
was proposed, but likely was mis-annotated161,301 (Figure 6). The expression of speB increases over 
time in cultures and it peaks during stationary phase of growth288. Environmental conditions such 
as variations in pH and salt concentration can also affect speB expression302. 
 
speB transcriptional regulation 
A plethora of transcriptional regulator have been described to affect speB expression, but 
only few were proved to directly act on the speB promoter (Table 1). 
 
speB regulators Function Activity References 
Direct transcriptional regulators 
RopB Transcription factor Activator 301,303–305 
CovRS Two-component system Repressor 233,306–309 
CcpA Transcription factor Activator 310 
Indirect regulators at transcriptional level 
LacD.1 Aldolase Repressor (via RopB) 311 
N-terminal Vfr Secreted peptide Repressor (via RopB) 312,313 
SIP Secreted peptide Activator (via RopB) 314,315 
PepO Endopeptidase Repressor (proposed via RopB) 316 
Transcriptional regulators with unknown mechanism 
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speB regulators Function Activity References 
CpsY Transcription factor Repressor 317 
CodY Transcription factor Activator 318 
MgA Transcription factor Activator 319 
LuxS Transcription factor Activator 320 
Srv Transcription factor Repressor 321 
SagP Transcription factor Activator 322 
RofA Transcription factor Repressor 323 
 
Table 1. Transcriptional regulators of speB expression.  
List of speB direct transcriptional regulators (i.e. acting at the speB promoter), indirect regulators at 
transcriptional level (i.e. factors that control speB expression through the activity of direct transcriptional 
regulators) and transcriptional regulators whose mechanism of speB expression regulation is not deciphered. 
 
One of the most studied speB transcriptional regulator is the Regulator of protease B 
(RopB), which binds inverted repeat regions upstream of the speB promoters and activates speB 
expression301,303,304 (Figure 6). The gene encoding for this regulator (ropB) is located adjacent to speB 
and the two genes are divergently transcribed and separated by a long intergenic region, which 
encodes several small ORFs, including the SpeB inducing peptide (SIP)314,315 (Figure 6). SIP consists 
of a small peptide whose expression is induced at high cell density conditions during which SIP is 
secreted and subsequently reimported into the bacteria where it binds RopB. This interaction 
enhances the ability of RopB to bind DNA and therefore it promotes speB expression activation315 
(Figure 6). It is believed that the RopB-mediated regulation of speB transcription is responsible for 
the increase of speB expression during growth. The activity of RopB is inhibited by the tagatose 1-
6 bisphospate aldolase (LacD.1)311 and the Virulence factor related (Vfr)313 (Figure 6). LacD.1 binds 
RopB, possibly in accordance to the nutritional status of the cell and consequently prevents speB 
expression activation305. Vfr harbors an amino-terminal (N-terminal) secretion signal system, which 
is cleaved, secreted and internalized312 (Figure 6). The Vfr N-terminus directly interacts with RopB 
thereby preventing RopB binding upstream of the speB promoter313. 
As mentioned above, the CovRS two-component system directly represses speB expression, 
in particular the response regulator CovR binds the speB promoter and inhibits transcription307,308. 
This system senses external signals and stimuli through the sensor kinase CovS, which in turn 
phosphorylates or dephosphorylates the transcriptional regular CovR. While phosphorylation 
enhances the CovR-mediated repression of some target genes, dephosphorylation has an opposite 
effect on another subset of genes309. It has been observed that CovS attenuates the CovR-mediated 
downregulation of speB expression, indicating that phosphorylated-CovR does not repress speB 
expression309,324 (Figure 6).  
 The last confirmed direct regulator of speB is the Catabolite control protein (CcpA), which 
activates speB expression during nutrient-limiting conditions325,326. Although direct interaction of 
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CcpA with the DNA region in proximity of speB promoter was demonstrated, the exact binding 
site has not been clarified yet325,326. 
 
 
Figure 6. Regulation of SpeB expression and activity. 
Schematic representation of some well-studied regulatory mechanisms of SpeB expression and activity. The 
speB locus is shown with the predicted promoters (P, P1 and P2) and terminators. The speB gene is 
transcribed in the same direction than SPy_2038 (encoding Spi, an inhibitor of SpeB protease activity) and 
in the opposite direction than ropB (encoding RopB). Three direct speB transcriptional regulators have been 
described: RopB, CovR and CcpA. Their positive or negative effects on speB expression are indicated. RopB-
mediated regulation of speB expression is affected by three factors: SIP, LacD.1 and Vfr. SIP. SpeB is 
produced as inactive zymogen (zSpeB), which is secreted and then activated through an autocatalytic process 
resulting in the removal of the pro-domain and generation of the mature SpeB (mSpeB). mSpeB processes 
the zSpeB producing more active SpeB proteases. Spi, mimicking the pro-domain, can block the protease 
activity intracellularly. 
 
speB post-transcriptional regulation 
 The post-transcriptional regulation of speB expression has remained unexplored. speB 
transcript abundance and production of the active SpeB were shown to be affected by the 
pleiotropic effect locus (pel), which codes for both the hemolysin SLS and a regulatory RNA 
element327,328. The mechanism of speB regulation by pel RNA is undeciphered and it is unclear 
whether it is due to direct or indirect effects. speB transcript stability was shown to increase as a 
consequence of the medium acidification during growth329. Two speB transcript isoforms were 
identified in M49 S. pyogenes strain NZ131 and RNase Y was shown to control the stability of the 
shorter speB isoform329. In addition, the abundance of speB strongly decreases in the absence of 
RNase Y, but the mechanism of RNase Y-mediated regulation of speB has not been 
characterized168,329 and it will be further investigated in this thesis (see section 3.1). 
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SpeB post-translational regulation 
 At the post-translational level, modulation of SpeB protease activity occurs at first through 
the production of the active mature SpeB (mSpeB) by removal of the pro-domain (Figure 6). Two 
peptidyl-prolyl cis-trans isomerases (RopA and PrsA) ensures the correct maturation of the inactive 
zSpeB330,331. A second control mechanism relies on the SpeB inhibitor (Spi), which mimics the SpeB 
pro-domain and therefore blocks the SpeB protease activity (Figure 6). Spi was shown not to be 
secreted. Therefore it must inhibit SpeB intracellularly to prevent cytosolic protein degradation in 
the case of premature SpeB activation332. Both genes encoding Spi and PrsA (SPy_2038 and prsA, 
respectively) are co-transcribed with speB331. 
 
1.3.7 Regulation of gene expression in S. pyogenes 
S. pyogenes tightly controls gene expression through a variety of regulatory systems; 




 The integration of external stimuli is often achieved through the activity of stand-alone 
response regulators and two-component systems. The best characterized stand-alone response 
regulators are the aforementioned RopB, Multiple gene activator (Mga) and RofA like protein 
(RALP), which can respond to quorum sensing signals and nutrient availability317. These three 
regulators are specialized in the control of a subset of virulence genes and at specific growth phases. 
For instance, MgA positively regulates genes involved in the adhesion and immune evasion during 
exponential growth phase and RopB controls the expression of secreted proteins, including 
proteases, during late growth phase333,334. Thirteen two-component systems have been identified, 
but most of them have not been characterized in detail317, with the notable exception of the CovRS 
system, a master regulator that affects the expression of 15% of S. pyogenes genome335. 
Under specific environmental conditions, bacteria often use alternative σ factors to direct 
the RNA polymerase at specific promoter regions. S. pyogenes does not extensively use alternative σ 
factors to modulate gene expression in response to environmental conditions. Instead, this is 
achieved by the network of stand-alone response regulators and two-component systems317. 
However, an alternative σ factor (σX) was identified in S. pyogenes and it was shown that this σ 
factor is poorly expressed under standard growth conditions in nutrient-rich medium336. It is known 
that σX can induce the expression of genes involved in competence acquisition337,338. 
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Post-transcriptional regulation 
 The role of few sRNAs has been characterized in S. pyogenes 68 and one of the most studied 
is the trans-acting sRNA FasX. Besides positively regulating ska mRNA, as already described233 
(Figure 2D), FasX also controls the translation of the pili operon and of prtF1-2 mRNA (encoding 
for two fibronectin-binding proteins). FasX interacts with the 5′ end region of these mRNAs and 
inhibits their translation339–341. Hence, based on the observation that FasX promotes the 
streptokinase production and inhibits the synthesis of proteins involved in the bacterial adherence 
with the host (i.e. pili and fibronectin-binding proteins), this sRNA is considered to play a role in 
the switch from bacterial adherence to dissemination during infection. 
  
Table 2. RNases present in S. pyogenes. 
The RNases identified in S. pyogenes are listed and separated based on their activity. a Schematic representation 
of an RNA molecule cleaved by an endoribonuclease (endoRNase), depicted with scissors and of an RNA 
molecule degraded by 5′-to-3′ or 3′-to-5′ exoribonuclease (5′-to-3′ or 3′-to-5′ exoRNase) depicted with orange 
and green “pacman” symbols, respectively. ssRNA: single-stranded RNA; dsRNA: double-stranded RNA. 
RNase J1 likely acts more as 5′-to-3′ exoRNase then endoRNase in vivo, RNase J2 activity is unclear. b NrnA 
(NanoRNase A) was shown to act also as a 5′-to-3′ exoRNase. Of note, S. pyogenes does not encode for 
NanoRNase B (NrnB). c Gene names are based on the NCBI and UniProt databases. Previous searches 
failed to identify YacP/RaeI endoRNase in S. pyogenes84. SpnA could be a homolog of YacP/RaeI (identity 
in BLAST: 43.84%). d The phenotypes observable when the gene encoding an RNase is deleted are reported 
for RNase Y168,329, RNase III185, Mini III (unpublished data), RNases J1 and J2195, PNPase204, YhaM204 and 
RNase R204. The minus sign indicates that the effect of the RNase deletion is not known in S. pyogenes. e The 
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RNase functions in grey are deduced from the B. subtilis homologs. YhcR was shown to be an extracellular 




Table 3. Helicases annotated in S. pyogenes. 
List of putative helicases belonging to the DEAD-box family present in S. pyogenes. a Schematic 
representation of a DEAD-box RNA helicase (composed of two domains) associated to ATP and binding 
a structured RNA. b,c The name of the gene encoding the helicase and the names of each helicase are based 
on the NCBI and UniProt databases; the minus sign indicates there is not name associated. d Homologs in 
B. subtilis are identified by BLAST search tool. e The predicted function of the S. pyogenes gene from NCBI is 
reported. 
 
A limited number of studies investigated the impact of RNases in post-transcriptional 
regulation in this bacterium and the role of helicases in RNA metabolism has not been explored 
yet. RNases and putative annotated helicases present in S. pyogenes are listed in Table 2 and Table 3, 
respectively.  The features and functions of the RNases from S. pyogenes have been already described 
in sections 1.1.3 and 1.1.4). Knowledge on RNases in S. pyogenes, prior the studies from our 
laboratory aiming at identifying RNase III, PNPase, RNase R and YhaM processing positions185,204 
(see sections 1.1.4 and 1.2.2) was restricted to a limited number of putative direct targets53,195,329,342. 
RNA stability was shown to play an important role in the regulation of gene expression in S. 
pyogenes. In this bacterium, mRNAs are grouped in two classes (I and II), based on their detection 
either during exponential or stationary phases of growth, respectively195,342,343. Class I transcripts are 
present only during exponential growth phase, since they are the preferred substrate of RNases J1 
and J2, and therefore they are processed by these RNases and rapidly degraded. On the other side, 
class II transcripts, including the ones encoding virulence factors (e.g. SLS and the DNase Sda1), 
are still detectable during stationary growth phase. This is due to the fact that the degradation 
initiation of these transcripts by RNases J1 and J2 is delayed compared to class I mRNAs. PNPase 
was shown to be involved in the degradation of transcripts from both classes, after RNases J1 and 
J2 processing342,343.   
Transcriptomic studies were performed in S. pyogenes to  investigate the impact of RNase Y 
on transcript abundance168 and stability106. The knowledge of RNase Y activity and direct targets is 
limited to few examples in S. pyogenes. It is known that RNase Y likely processes ropB mRNA that 
it controls the expression of virulence factors, including speB, but the mechanism is not 
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characterized168,329. Overall, knowledge on RNase Y direct targets and requirements for processing 
has remained limited in this bacterium compared to other Gram-positive bacteria, such as B. subtilis 
and S. aureus. Identification and characterization of the RNase Y targets in S. pyogenes will be 
therefore one of the objects of the present thesis. 
 
1.4 Aim of the thesis 
RNase Y exhibits species-specific effects on gene expression, bacterial physiology and 
different strategies of target recognition, indicating that our understanding of RNase Y function is 
not complete yet. The specific properties of RNase Y orthologs highlight the importance of 
investigating the characteristics of this endoRNase not only in well characterized model 
microorganisms, but also in other bacteria. In particular, in light of the key role of RNase Y in the 
regulation of virulence genes, the role of RNase Y in bacterial pathogens should be further 
examined. 
The aim of this thesis was to elucidate the characteristics and functions of RNase Y from 
the strict human pathogen S. pyogenes using different strategies. First, we identified the genome-
wide RNase Y direct targets in vivo (i.e. targetome), using RNA sequencing. The mapping of the 
exact RNase Y processing positions gave insights into RNase Y target determinants. Second, we 
investigated the interplay between RNase Y and the 3′-to-5′ exoRNases during RNA degradation, 
by comparing the RNase Y targetome with the 3′-to-5′ exoRNase targetomes already available. 
Third, we further examined the role of RNase Y in the regulation of the major virulence factor 
Streptococcal pyrogenic exotoxin B (SpeB).  
This study provided new and profound insights into the features of S. pyogenes RNase Y 
and expanded the current understanding of RNA degradation and dynamics in Gram-positive 
bacteria. The investigation of RNase Y-mediated regulation of speB expression may pave the way 
for further understanding of RNase Y role in virulence. 
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he methods used in the present thesis are based on published techniques that can be also 
found in previous publications from our laboratory185,204,344. The methods presented here 
were performed, if not specified, by myself (L.B.) or by myself together with Dr. Anaïs Le Rhun 
(A.L.R.) and Dr. Anne-Laure Lécrivain (A.-L.L.) and with the help of Dr. Thibaud T. Renault 
(T.T.R.) and Dr. Rina Ahmed-Begrich (R.A.-B.) for the bioinformatics and Karine Hahnke (K.H.) 
and Solange Materne (S.M.; master student in the Charpentier group supervised by L.B.) for 
technical work. 
 
2.1 Bacterial culture 
Table 4 lists all the bacterial strains used in this thesis. S. pyogenes SF370 (M1 GAS; WT strain) 
and the deletion mutant strains were cultured in THY containing: Todd Hewitt Broth (THB; 
Becton Dickinson) containing heart infusion (3.1 g/L), peptone (20 g/L), dextrose (2g/L), sodium 
chloride (NaCl, 2 g/L), sodium phosphate (Na2HPO4; 0.4 g/L) and sodium carbonate (Na2CO3; 
2.5 g/L) and supplemented with 0.2% yeast extract (Servabacter®). The above-mentioned 
components were dissolved in distillated water (dH20), the pH was adjusted at 7.0 and the medium 
was autoclaved. The growth of S. pyogenes strains was conducted in THY without shaking at 37°C 
and with 5% CO2. The growth on solid medium was conducted on TSA blood agar (TrypticaseTM 
Soy Agar, Becton Dickinson), which was supplemented with 3% defibrinated sheep blood (Oxoid).  
E. coli was grown at 37°C, shaking (180 rpm/min) and in Luria-Bertani (LB Broth Miller, Becton 
Dickinson) broth medium, consisting of tryptone (10 g/L), yeast extract (10 g/L) and sodium 
chloride (0.5g/L) dissolved in dH20. For the growth of E. coli on solid medium, LB broth medium 
with the addition of agar (15g/L; Miller) was used. For the growth of S. pyogenes, the strains were 
grown over-day (at 37°C and with 5% CO2) on a TSA blood plate streaked with the bacteria 
glycerol stocks stored at − 80°C. Subsequently the bacteria were inoculated in 10 ml (for RNA and 
protein extraction and growth curve analysis) or 2 ml (for the strains containing plasmids) of 
T 
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medium for the overnight growth. The cultures were then diluted (depending on the experiment, 
see below) and the growth was monitored by measuring the optical density at 620 nanometers 
(OD620 nm) with a microplate reader (Biotek Epoch 2). At the end of each experiment the over-day 
culture was used to streak a TSA blood plate in order to assess the presence of contaminating 
bacteria. When needed, antibiotics were added to the media at the following final concentrations: 
300 μg/ml kanamycin (CorningTM) and 3 μg/ml erythromycin (Sigma-Aldrich) for S. pyogenes; 50 
μg/ml kanamycin (CorningTM) and 300 μg/ml erythromycin (Sigma-Aldrich) for E. coli. Prior 
addition to the media the kanamycin and the erythromycin were dissolved in Milli-Q H20 and 
ethanol (EtOH), respectively and stored at − 20°C. When necessary, anhydrotetracycline 
hydrochloride (AHT) (Sigma-Aldrich) was supplemented to the medium, as previously 
described195. AHT was used at a final concentration of 0.1 ng/µL and was used to activate the 
conditional tetracycline-inducible promoter (Ptet).  
 
Strain Relevant characteristics Source 
Streptococcus pyogenes 
WT   
EC2224 SF370 (M1 serotype) ATCC 700294 
∆rny   
EC2246 ∆rny::lox72 185 
∆rnc   
EC2249 ∆rnc::lox72 185 
∆rnr   
EC2254 ∆rnr::lox72 204 
∆pnpA   
EC2297 ∆pnpA::lox72 204  
∆rny::rny   
EC2298 ∆rny::lox72∆lox72::rny-TT3-lox72 344 
∆yhaM   
EC2347 ∆yhaM::lox71- PermAM/B-ermAM/B-lox66 204 
∆rnhB   
EC2251 ∆rnhB::lox72 344 
∆mrnc   
EC2271 ∆mrnc::lox72 344 
PtetrnjA   
EC2353 PtetrnjA Laboratory collection 
∆pnpA∆rny   
EC2389 ∆pnpA::lox72Δrny::lox71- PermAM/B-ermAM/B-lox66 204 
∆rny∆rnr   
EC2310 ∆rny::lox72Δrnr::lox72 204 
∆yhaM∆rny   
EC2392 ∆yhaM::lox71-PermAM/B-ermAM/B-lox66Δrny::lox71-PermAM/B-ermAM/B-lox66 204 
∆speB   
EC2356 ∆speB::lox72 344 
Escherichia coli   
RDN204 Top10 
(Host for cloning) 
F– mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara-leu)7697 galU galK λ– rpsL(StrR) endA1 nupG Invitrogen 
 
Table 4. Strains used in the study. 
The name and genotype of the strains used in this thesis are reported. The deletion mutant strains were 
generated using the Cre-lox system345. The TT3 represents the transcriptional intrinsic terminator of the 
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bacteriophage T3346, ermAM/B denotes the erythromycin resistance cassette and PermAM/B the 
corresponding promoter. Ptet designates the tetracycline-inducible promoter, which controls the expression 
of rnjA (coding for RNase J1)195,347,348. 
 
2.1.1 S. pyogenes growth 
The growth comparison of the S. pyogenes WT and deletion mutant strains was performed 
as previously described by our laboratory185. After diluting the S. pyogenes overnight cultures to an 
OD620 nm of 0.2 in 5 ml of medium, the bacteria were centrifuged at 3200 g for 5 min at 20°C. The 
supernatant was discarded and the cell pellet was resuspended in 500 μl of medium, which was 
used to inoculate a 100 ml-flask containing 50 ml of THY supplemented with 0.2% yeast extract. 
The growth curves were performed in biological triplicates and the standard deviations are 
reported. 
 
2.1.2 Bacterial transformation 
Chemically competent E. coli cells were prepared according to a standard protocol349 and the 
cells were then transformed using heat-shock protocol with some modifications349. Chemically 
competent E. coli were mixed with plasmid DNA (100 ng or 5 μl from the ligation reaction) and 
incubated for 10 min on ice. To cause the heat-shock, the cells were then incubated at 42°C for 1 
min and subsequently on ice for 3 min. After addition of 750 μl of LB medium, the cells were 
recovered at 37°C for 1h or 1h and 30 min for plasmids with kanamycin or erythromycin resistance 
cassettes, respectively.  S. pyogenes competent cells for deletion mutant generation were prepared as 
previously described185,350. S. pyogenes WT cells were grown, over-day, until OD620 nm 0.25 in THY 
supplemented with 250 mM Sucrose (AppliChem) and 40 mM L-threonine (Sigma-Aldrich). 
Following centrifugation (3500 g for 10 min at 4°C), the cell pellets were washed twice with 5 ml 
of ice-cold 0.5 M sucrose and resuspended in 250 µL of 0.5 M sucrose and 20% glycerol. Before 
snap freezing with liquid nitrogen, the OD620 nm of the generated competence cells was measured. 
Prior transformation, the S. pyogenes competent cells were defrosted on ice and the OD620 nm was 
adjusted to 1. Subsequently the competent cells were incubated with approximately 10 μg of 
linearized plasmid for 1h on ice and electroporated in a 0.1 cm cuvette (Bio-Rad) with 1.5 kV, 400 
Ω, 25 μF pulse. After a recovery growth of 2h in THY medium, the bacteria were spread on TSA-
blood plates containing erythromycin.  
For transformation of S. pyogenes (WT or deletion mutant strains) with plasmids, the cells 
were grown over-day in THY until OD620 nm 0.3, incubated on ice for 10 min and washed twice with 
25 ml and 12 ml of ice-cold Milli-Q H20, respectively. Prior each washing step with ice-cold Milli-
Q H20, the cells were centrifuged at 3500 g for 10 min at 4°C. The cells were finally resuspended 
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in 6.25 ml of 20% glycerol and centrifuged at 3500 g for 10 min at 4°C. After resuspension in 1 ml 
of ice-cold sterile 20% glycerol, the OD620 nm was measured and the cells were snap feezed with 
liquid nitrogen. After defrosting the MQ-competent cells on ice, 500 or 800 ng plasmids were 
incubated together with OD620 nm 1 or 2 of competent cells for 1h on ice, respectively. The 
electroporation was conducted at 1.8 kV, 400 Ω, 25 μF. Following 2h of regeneration time in THY 
medium, the bacteria were grown on TSA-blood plates supplemented with kanamycin. All the 
plasmids used in the bacterial transformation in E. coli and S. pyogenes are listed in Table 5. 
 
Table 5. Plasmids used in the study. 
The name and the description of the plasmids used in this thesis are reported. a repDEG-pAMß1: origin of 
replication specific for Gram-positive bacteria353; aphIII: kanamycin resistance cassette for selection in both 
E. coli and S. pyogenes 354; ColE1: replication sequence specific for E. coli 354; lox71 and lox66: sequences 
recognized by the Cre recombinase345;  pRO1600/ColE1: combined replication sequence of pRO1600 and 
ColE1355; ermAM/B: erythromycin resistance cassette; ampR: ampicillin resistance cassette; PgyrA: constitutive 
promoter of gyrA from Streptococcus agalactiae; PspeB: promoter region of the speB gene, the region included is 
described in section 2.2.2; pLZ12Km2: vector backbone containing kanamycin resistance cassette; P23: 
lactococcal constitutive promoter P23356;  ffluc: gene encoding the firefly luciferase357. For the plasmids used 
in the speB ectopic expression experiments the positions of the guanosine (G) substituted into adenosine 
(A) or of the deleted regions (∆) are indicated relative to the speB start codon. 
 
2.2 DNA manipulation and cloning 
All the plasmids (Table 5) were purified from E. coli TOP 10 cells after an overnight growth 
in 5, 10 or 20 ml of LB medium, which contained the respective antibiotic for selection, using 
QIAprep Spin MiniPrep Kit (Qiagen) following the manufacturer’s instructions. Alternatively, the 
plasmids constructed for deletion mutant strain generation were extracted using the QIAprep Spin 
MidiPrep Kit (Qiagen), from 100 ml overnight cultures. S. pyogenes genomic DNA was extracted 
using the NucleoSpin Microbial DNA kit (Macherey-Nagel) following the protocol for Gram-
Plasmid Relevant characteristics a Source 
Plasmids used for gene deletion in S. pyogenes 
pEC707(pUC19) Fra– , Meb–, KmR , TcR, McR New England Biolabs; 351 
pEC85 repDEG-pAMß1, aphIII-Pjh1, ColE1 53 
pEC454 pUC19Ωlox71-ermAM/B-lox66 344 
pEC455 pEC85ΩPgyrA-cre  352 
pEC801 pRO1600/ColE1, ampR pSEVA141 
De Lorenzo’s lab 
pEC2145 pEC801ΩspeB::lox71-PermAM/B-ermAM/B-lox66 This study 
speB ectopic expression in S. pyogenes 
pEC2146 pEC85ΩPgyrAspeB This study 
pEC2249 pEC85ΩPgyrA-speB(G−137A) This study 
pEC2250 pEC85ΩPgyrA-speB(G−131A) This study 
pEC2263 pEC85ΩPgyrA-speB(G−137A_G−131A) This study 
pEC2264 pEC85ΩPgyrA-speB(∆−147−121) This study 
pEC2265 pEC85ΩPgyrA-speB(∆−157−111) This study 
Luminescence assay in S. pyogenes 
pEC2173 pLZ12Km2-P23R:TA:ffluc Gift from Thomas Proft (Addgene 
plasmid # 88900) 
pEC2248 pEC2173ΩPspeB This study 
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positive and Gram-negative bacteria except for the lysis step, which was performed by agitation 
for 15 min using a vortex. For the purpose of cloning the oligonucleotides used are listed in Table 6. 
Restrictions enzymes (specified below at each specific section) were used to linearize the plasmids 
and the digestion was conducted at 37°C for at least 1h following the manufacturer’s instructions. 
To avoid the relegation of the linearized plasmids, 1U of the FastAP Thermosensitive Alkaline 
Phosphatase (Thermo Scientific) was added to the reaction and incubated at 37°C for at least 10 
min. If not specified otherwise, the polymerase chain reaction (PCR) products were obtained using 
the Phusion High Fidelity Polymerase (Thermo Scientific) and the primers are listed in Table 6. 
The PCR products were purified either directly from the PCR reaction with the QIAquick PCR 
Purification Kit (Qiagen) or by gel extraction with the QIAquick Gel Extraction Kit (Qiagen) after 
gel electrophoresis and following the manufacturer’s instructions. The linearized plasmids and the 
PCR inserts were ligated using 1U of T4 DNA ligase (Thermo Scientific), following the 
manufacturer’s instructions. The sequencing of the PCR-generated DNA fragments and of the 
constructed plasmids was performed at Microsynth, Switzerland, using oligonucleotides listed in 
Table 6. 
 
Oligo Sequence 5′-3′ a F/R b Usage c Target d 
∆speB 
OLEC7565 AAAGGATCCATGTCAAAAATACGTTACGCATG F Cloning Up fragment 
(pEC2145) OLEC7566 TATAATGTATGCTATACGAACGGTATTTTTTTATACCTCTTTCAAAATAAGTTAATCTAC R LM-PCR 
OLEC7902 ATAGCATACATTATACGAACGGTAGACGGACGTAACTTCTACCATGTT F LM-PCR Dw fragment 
(pEC2145) OLEC7569 AAAGGATCCTGTTGTGTGATGATTGACAAGCTG R Cloning 
OLEC7563 TGAATGCCTAATGAATTCAACGG F PCR, SEQ Upstream speB 
OLEC7570 GTGTTTTTGGTCTCATTGTAGAAGT R PCR, SEQ Downstream speB 
pEC2146 
OLEC7968 CCTTTCTAGACTATCATTTTCAATGAAAGAAGTCACTAATAAAATGTGA F Cloning PgyrA 
(pEC455) OLEC7969 CATAGTAGGCGCCTCCTTTTAACCTTATTACATTGTACCATAATTTAGGTAAAATTGCGATGAT R LM-PCR 
OLEC7970 ATCATCGCAATTTTACCTAAATTATGGTACAATGTAATAAGGTTAAAAGGAGGCGCCTACTATG F LM-PCR speB CDS 
OLEC7971 CCCAGAATTCCTAAGGTTTGATGCCTACAACAGCAC R Cloning 
pEC2249     
OLEC8388 GTCAACTAACCGTATTATTGTCTATTACCAT F TS-PCR speB 5′ UTR  
(pEC2146) OLEC8389 GTCAACTAACCGTATTATTGTCTATTACCAT R TS-PCR 
pEC2250     
OLEC8390 GTCAACTAACCGTGTTATTATCTATTACCAT F TS-PCR speB 5′ UTR  
(pEC2146) OLEC8391 ATGGTAATAGATAATAACACGGTTAGTTGAC R TS-PCR 
pEC2263     
OLEC8392 GTCAACTAACCGTATTATTATCTATTACCAT F TS-PCR speB 5′ UTR  
(pEC2146) OLEC8393 ATGGTAATAGATAATAATACGGTTAGTTGAC R TS-PCR 
pEC2264     
OLEC8394 GTTGGGTTGTCAGTGTCATCATGGTATCAGCGACAT F TS-PCR speB 5′ UTR  
(pEC2146) OLEC8395 ATGTCGCTGATACCATGATGACACTGACAACCCAAC R TS-PCR 
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Oligo Sequence 5′-3′ a F/R b Usage c Target d 
pEC2265     
OLEC8396 GAATAATTGGGTTGGGTTAGCGACATCGTATGATAA F TS-PCR speB 5′ UTR  
(pEC2146) OLEC8397 TTATCATACGATGTCGCTAACCCAACCCAATTATTC R TS-PCR 
pEC2248     
OLEC8386 CGAGCTCATGTCAAGCCTTCCTAGTTGATGTCA F Cloning 
speB 5′ UTR 
OLEC8387 TACCCGCGGTGGCTATATCATAGCTGCTTATTTTGCT R Cloning 
 Sequencing  
OliRN228 GGAACGAAAACTCACGTTAA F SEQ 
pEC85 
OLEC787 TGTGGTTACGTGGTTTTTAAC R SEQ 
OLEC3224 TGTAAAACGACGGCCAGT F SEQ pEC707 
pEC2173 OLEC3225 CAGGAAACAGCTATGACC R SEQ 
OLEC3600 CCAGGGTTTTCCCAGTCACGAC F SEQ 
pEC801 
OLEC3590 AGCGGATAACAATTTCACACAGGA R SEQ 
OLEC1938 TCAATCGAGAATATCGTCAACTGTTTACTAAA F SEQ 
ermAM/B 
OLEC1937 TTGCTGTTTCGATTTTTATGATATGGTGC R SEQ 
OLEC5336 GGGGGATGTGCTGCAAGGCG F SEQ 
pEC802 
OLEC5337 TCCGGCTCCTATGTTGTGTGG R SEQ 
 
Table 6. Oligonucleotide primers used for cloning and sequencing. 
The name, the sequence, the directionality, the function and the respective targets of the oligonucleotides 
used in this thesis are reported. a italic: sequence annealing to the template; underlined: restriction site; b F: 
forward primer; R: reverse primer; c LM-PCR: ligation-mediated PCR; TS-PCR: two-stage PCR; SEQ: 
sequencing; d 5′ UTR: 5′ untranslated region. 
 
2.2.1 Construction of gene deletion strains  
Chromosomal deletion of speB from S. pyogenes genome was performed using the Cre-Lox 
system. Regions upstream and downstream of the speB gene were amplified by PCR from WT 
genomic DNA with Phusion polymerase (Thermo Fisher) using OLEC7565/OLEC7566 
(upstream fragment) and OLEC7569/OLEC7902 (downstream fragment). The last portion of the 
of speB CDS (156 nt) was not removed in order to keep the RBS of the following gene (SPy_2038) 
intact. PCR-mediated ligation with OLEC7565/OLEC7569 was used to ligate the upstream and 
downstream regions with the lox71-ermAM/B-lox66 cassette, which was amplified from the vector 
pEC454 using OLEC1899/OLEC1900. The fragment obtained was cloned in BamHI 
(Fermentas)-digested pSEVA141, which is a suicide vector for S. pyogenes (i.e. it does not replicate 
in this bacterium) (see section above for cloning strategy). Prior transformation in S. pyogenes, the 
obtained plasmid was linearized by cleaving in the ampR cassette with SacII (New England Biolabs). 
Insertion of the lox71-ermAM/B-lox66 cassette was checked by PCR and DNA sequencing 
(Microsynth, Switzerland). Elecro-compentent S. pyogenes cells, from an erythromycin resistant 
clone, were transformed with pEC455 expressing the Cre recombinase, in order to remove the 
ermAM/B cassette resulting in the lox72 site. Kanamycin-resistant and erythromycin-sensitive 
clones were grown without antibiotic at 37°C to lose the pEC455 vector. The integrity of the 
generated strain was checked by both PCR and DNA sequencing (Microsynth, Switzerland). 
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2.2.2 Construction of plasmids for the speB promoter study 
The plasmid-based reporter system (pLZ12Km2-P23R:TA:ffluc) described in a previous 
study357 was used as a backbone to generate plasmid pEC2248, in which the ffluc (firefly luciferase 
gene) expression is controlled by the speB promoter region (PspeB). This region, containing both speB 
promoters (P and P1), comprises the DNA portion from − 940 to − 697 nt relative to speB start 
codon and contains the predicted binding sites of the transcriptional regulator RopB301,315. 
pLZ12Km2-P23R:TA:ffluc was digested with SacI and SacII (Thermo Scientific) to eliminate the 
lactococcal promoter P23, a constitutive promoter upstream of the ffluc ORF356,357. PspeB, inclusive 
of P and P1, was amplified from WT genomic DNA using primers containing the SacI and SacII 
restriction sites (OLEC8386/OLEC8387) and cloned (see section 2.2) in the digested pLZ12Km2-
P23R:TA:ffluc.  
 
2.2.3 Construction of plasmids for speB ectopic expression  
The shuttle vector pEC85 was used to ectopically express speB in the ∆speB strain328,353. speB 
(including 5′ UTR and CDS) was amplified from WT genomic DNA using primers 
OLEC7970/7971. The fragment was ligated by PCR-mediated ligation with 
OLEC7968/OLEC7971 to the gyrA promoter (PgyrA) from Streptococcus agalactiae, which was 
amplified from pEC455 using OLEC7968/7969. The resulting fragment was cloned (see section 
2.2) in XbaI and EcoRI (Fermentas)-digested pEC85, to generate plasmid pEC2146, which was 
used as a template to construct the variant plasmids with mutations in speB 5′ UTR. These variant 
plasmids were generated according to the two-stage PCR mutagenesis protocol358 with the Pfu 
Turbo DNA polymerase (Stratagene) and primers indicated in Table 6. 25 μl from the PCR reaction 
were then treated with 10U of DpnI (Fermentas) for at least 1h at 37°C and 5 μl were transformed 
in E. coli chemically competent cells as descried in section 2.1.2. 
 
2.3 RNA techniques 
2.3.1 RNA extraction  
The S. pyogenes WT and deletion mutant overnight cultures were diluted 1:200 in 300 ml of 
THY and harvested at early-logarithmic (EL) (OD620 nm= 0.1), mid-logarithmic (ML) (OD620 nm = 
0.25) and early-stationary (ES) (OD620 nm= 0.4) phases of growth (see Figure 7A). In particular, 25 
ml of cultures were mixed with 25 ml of 1:1 ice-cold acetone (Sigma)/ethanol (AppliChem) 
solution, centrifuged at 3500 g for 10 min at 4°C and washed twice with 5 ml and 1 ml of ice-cold 
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TE-sucrose buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, pH 8.0, 50 mM NaCl, 25% sucrose), 
respectively. The cell lysis was performed incubating for 5 min on ice and at 95°C for 1.5 min with 
100 μl of lysis buffer (20 mM Tris-HCl pH 8.0, 50 mM EDTA pH 8.0, 20% sucrose, 5 μl of 
lysozyme (Sigma) 50 mg/ml, 5 μl of mutanolysin (Sigma) 10 μg/μ) and 150 μl of lysis executioner 
(2% Dodecyl sulfate sodium salt (SDS; Applichem) and 1 mg/ml Proteinase K (Fisher Scientific)), 
respectively. The lysed cells were mixed with 750 μl of TRIzol (Life Technologies) and incubated 
at room temperature for 5 min. Subsequently, 200 μl of chloroform (Sigma) were added and mixed 
with the samples by vertexing for 15 sec. The mixture was incubated at room temperature for 10 
min and centrifuged at 11300 g for 10 min at 4°C. Following the centrifugation, the sample 
separated into three phases: upper aqueous phase containing the RNAs, an interphase and lower 
organic phase. The upper aqueous phase (approximately 700 μl) was transferred into a fresh tube 
and the RNAs were precipitated by adding 700 μl of ice-cold isopropanol (Sigma-Aldrich) and 
incubating at least 1 h at − 20°C. The RNAs were pelleted by centrifugation conducted at 11300 g 
for 10 min at 4°C. The supernatant was removed without disturbing the RNA pellet and 
subsequently washed with 1 ml of 70% EtOH and centrifuged at 15800 g for 5 min at 4°C. The 
supernatant was discarded and the RNA pellet was air-dried at room temperature for at least 10 
min and resuspended in approximately 50 μl of autoclaved Milli-Q H20. The RNA concentrations 
were measured using a NanoDrop (Thermo Scientific) and the RNA integrity was analyzed by 
agarose gel (2%) electrophoresis conducted at 100 V for 30 min and staining with ethidium 
bromide (Merck). 
 
2.3.2 Rifampicin assay  
Overnight cultures were diluted 1:200 in 250 ml of medium and the bacteria were grown 
until mid-logarithmic and/or early-stationary growth phases. At these time points, the rifampicin 
(Sigma-Aldrich), which was previously freshly dissolved in methanol (Sigma-Aldrich), was added 
to a final concentration of 250 μg/ml. 25 ml of cultures were harvested immediately (0 min) and 
at specific time points (5, 10, 20, 30, 45 min or 1, 2, 4, 8 min) after the addition of rifampicin, by 
mixing with 1:1 ice-cold acetone (Sigma)/ethanol (Applichem) solution and centrifuging at 3500 g 
for 10 min at 4°C. Total RNA was extracted as described in the previous section 2.3.1 and used to 
perform Northern blot analyses. 
 
2.3.3 Agarose Northern blot analysis 
The RNAs (15 μg or 20 μg) were mixed to 2X RNA loading buffer, (95% Formamide 
(Sigma Aldrich), 0.025% SDS (AppliChem), 0.025% Bromophenol Blue (Merck) and 0.5 mM 
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EDTA) and were separated on an agarose gel (1% agarose, 30 ml of 10X MOPS (200 mM 3-N-
morpholinopropanesulfonic acid, 50 mM sodium acetate and 10 mM EDTA, pH 7), 6.6% 
formaldehyde), in 1X MOPS running buffer (20 mM 3-N-morpholinopropanesulfonic acid, 5 mM 
sodium acetate and 1 mM EDTA, pH 7) supplemented with 0.7% formaldehyde (Merck). The gel 
was pre-run for 15 min at 80 V and the running procedure was conducted at the same voltage for 
2h. The gel was then washed in autoclaved water (3X for 5 min, at room temperature) and 
incubated in 20X SSC (3 M NaCl and 0.3 M sodium citrate pH 7.0) for 5 min at room temperature. 
The RNAs were transferred onto a Nylon Hybond N+ membrane (GE Healthcare) using a 
capillarity system consisting of a large container, filled with 1L of transfer buffer (20X SSC) and 
multiple layers of absorbing material. In particular, three sheets of Whatman paper (Omnilab) were 
pre-wet with 20X SSC and placed on top of a support positioned within the large container, in 
order to allow the contact of the Whatman papers with the transfer buffer. After the incubation in 
20X SSC, the gel was placed on top of the three Whatman papers. The Nylon Hybond N+ 
membrane was pre-wet in both autoclaved MQ-H20 and 20X SSC and subsequently positioned on 
top of the gel. Additional Whatman papers (3X), of the size of the gel, were pre-wet in 20X SSC 
and placed on top of the Nylon Hybond N+ membrane. In all the above-mentioned steps, the air 
bubbles between the different layers of the system were removed, to allow homogeneous transfer 
of the RNAs to the membrane. Finally towel papers and weights were placed on top of the 
absorbing material. This set-up was used to transfer the RNA overnight at room temperature. The 
RNAs were UV-crosslinked to the 6X SSC-rinsed membrane using the UV Stratalinker 1800 
(Stratagene) with 2X autocrosslinking mode. The oligonucleotides probes (Table 7) were 
radioactively labelled as was previously described359. In brief, 2 μl oligonucleotides (from a 20 
pmol/μl solution) were first denatured (10 min at 95°C and on ice, respectively) and then incubated 
with, 2 μl of gamma-32P ATP (Hartmann analytics), 1 μl of T4 Polynucleotide Kinase (T4-PNK, 
Fermentas) (10 U/μl) and 2 μl of T4 PNK-Buffer A (10X) at 37°C for 30 min in a final volume of 
20 μl. The labelled oligonucleotides were purified over G-25 columns (GE Healthcare), following 
the manufacturer’s instructions, in order to remove the unincorporated nucleotides. Following 
incubation at 95°C for 10 min and subsequently on ice for other 10 min, the probes were incubated 
with the membranes in approximately 15 ml of hybridization buffer (Rapid-hyb buffer, GE 
Healthcare). The hybridization was performed overnight at 50°C with rotation in a hybridization 
oven (Analytic Jena). The membranes were then rinsed twice with pre-warmed 1X SSC-0.1% SDS 
buffer and washed for 20 min at 50°C with pre-warmed 1X SSC-0.1% SDS buffer and then with 
pre-warmed 0.5X SSC-0.1% SDS for 20 min. Visualization of the radioactive signal was done after 
approximately one week of exposure to a BSA phosphor screen (GE Healthcare) using a 
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phosphorimager (Typhoon Fla 9000, Fujifilm). 16S rRNA was used as a loading control. The 
approximate sizes of the RNAs were estimated using the RiboRuler High Range Ladder (Thermo 
Scientific), which was radioactively labelled with 5′ 32P pCp (Hartmann analytics) using T4 RNA 
Ligase I (NEB) overnight at 16°C. The radioactively labelled ladder was then purified using the 
RNeasY MinElute Kit (QIAGEN) following the manufacturer’s instructions. Each Northern blot 
was performed at least in biological triplicates. 
 
Oligo Sequence 5′-3′ a F/R b Usage c Target d 
Northern blot analyses    
OLEC5802 AACCACATAGTAGGCGCCTC R NB speB 5′ UTR 
OLEC7431 GCAACACATCCTGTAGCTGC R NB speB CDS 
OLEC6215 TGGTTATCATACGATGTCGC R NB speB 5′ UTR 
OLEC2410 ATTTGCTTTTAACGGTACAT R NB speB 5′ UTR 
OLEC5803 GGTGCATAAGGTCAATAGCCA R NB ropB 5′ UTR 
OLEC1542 CATGACACGATTCATATTAGTC R NB covR CDS 
OLEC8864 CTAAGCGACTACCTTATCTCA R NB TPP riboswitch 
OLEC8857 TCACAGCATCCACAGACTCT R NB serS 
OLEC8860 CGATTTCCGCGGTACCAC R NB SPy_1570-SPy_1569-valS 
OLEC8856 CTTTCCACCAACCAGCACTC R NB thrS 5′ UTR 
OLEC8866 TTAATCACACTGCCCAAACGG R NB glyQ 5′ UTR 
OLEC5805 TATCTTCGATACCGCCCAAG R NB rpsB CDS 
OLEC8344 CTTCGACTTGCAGGCTAACC R NB rpsB 5′ UTR 
OLEC5807 TCGTTGTTAGCTGGTTTGCC R NB tsf CDS 
OLEC5799 ACAGCCACTGACGCTAAACC R NB bmpA CDS 
OLEC5797 TCTGCCATTACCTGACGACA R NB cdd CDS 
OLEC10381 TTGCGCTGCCTTCAATGAAT R NB SPy_1551 CDS 
OLEC10384 GATAGTGATGCCCGCTTGTT R NB murC CDS 
OLEC10501 TGCCACCGTTCTTACCGTA R NB SPy_0316 CDS 
OLEC8749 CACGTTGAATATTGCCAGCTTCA R NB pyrH CDS 
OLEC8754 CGACTGTCAGTGCTATTTCGCC R NB SPy_2197 
OliRN243 CGTTGTACCAACCATTGTAGC R NB 16S rRNA 
OLEC288 CTAAGCGACTACCTTATCTCA R NB 5S rRNA 
 
Table 7. Oligonucleotides used as probes in Northern blot analyses. 
The name, the sequence, the directionality, the function and the respective targets of the oligonucleotide 
probes used in this thesis are reported. a italic: sequence annealing to the template; b F: forward primer; R: 
reverse primer; d 5′ UTR: 5′ untranslated region; CDS: coding DNA sequence. 
 
2.3.4 Polyacrylamide Northern blot analysis 
10 μg of total RNAs mixed 2X RNA loading buffer were separated on 10% or 8% 
polyacrylamide – 8 M urea gels in Tris-Borate-EDTA (TBE) 1X buffer (89 mM Tris Base, 89 mM 
Boric Acid, and 2 mM EDTA) for approximately 1h and 30 min at 100 V. RNAs were then 
transferred on Nylon Hybond N+ membrane (GE Healthcare) either by electro-blotting (Trans-
Blot SD semi-dry transfer apparatus, Bio-Rad) using Whatman papers pre-wet with TBE for 1h at 
18 V or by wet transfer using a Biorad Trans-Blot Cell system in 1X TBE for 1h and 15 min at 
50 V. The RNA molecules were chemically cross-linked to the membranes at 60°C for 1h using 
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EDC (N-(3-Dimethylaminopropyl)-N-Ethylcarbodiimide Hydrochloride, Sigma) (0.375 g per 
membrane) dissolved in H20 (pH adjusted to 8.0) and 12.5 M 1-Methylimidazole (Sigma). 
Alternatively, the RNAs were cross-linked as described above (section 2.3.3) using UV. 
Oligonucleotides probes (Table 7) were labelled with 32P using the T4 Polynucleotide Kinase (T4-
PNK, Fermentas) as described above (see section 2.3.3). After pre-incubating the membranes with 
approximately 15 ml of hybridization buffer (Rapid-hyb buffer, GE Healthcare) at 42°C for at least 
1 h, the labelled oligonucleotides were added. The hybridization was carried out overnight at 42°C, 
with rotation in a hybridization oven (Analytic Jena). The membranes were then washed for 15 
min at 42°C with washing buffer I (5X SSC, 0.1% SDS) and washing buffer II (1X SSC, 0.1% SDS) 
for additional 15 min at 42°C. The BSA phosphor screen (GE Healthcare) was exposed for at least 
one week and the signal was visualized with a phosphorimager (Typhoon Fla-9000, Fujifilm). The 
5S rRNA served as a loading control. The RNA approximate sizes were estimated according to the 
30-330-bp AFLP® DNA ladder (Invitrogen) or to the RNA decadeTM Marker (Invitrogen). Both 
ladders were radioactively labelled according to the manufacturer’s instructions, respectively. 
 
2.3.5 RNA half-life measurements 
The transcript abundance was measured by densitometry with FiJi360. The obtained values, 
deriving from three independent blots, were fitted on an exponential decay curve and the half-life 
was calculated. The speB transcript abundance comparison between the WT and ∆rny strains was 
performed using a t-test. 
 
2.3.6 Primer extension 
10 μg of total RNAs were denatured with subsequent incubations at 95°C and on ice for 
10 min, respectively. The denatured RNAs were then annealed with 3 μl oligonucleotides (Table 
8), previously radiolabeled as described in section 2.3.3., in the presence of 0.8 mM dNTPs, at 65°C 
for 30 min and chilled for 1 min on ice. The reverse transcription was performed using 200 U of 
Superscript III Reverse Transcriptase (Invitrogen), 1X first strand buffer, 5 mM Dithiothreitol 
(DTT) and 40 U of RNaseOUT Recombinant Ribonuclease Inhibitor (Invitrogen), for 1h at 55°C 
in a final volume of 20 μl. The cDNA products were precipitated with 0.1 volume of 3M NaAc 
pH 5.2 (room temperature) and 3 volumes of 100% ethanol (ice-cold) and subsequently centrifuged 
at 20000 g for 30 min at 4°C. After removal of the supernatant, the pellets were washed with 1 ml 
of 70% ethanol and centrifuged at 20000 g for 10 min at 4°C. The supernant was discarded and 
the pellets were air-dried for 10 min and resuspended in 10 μl of 2X RNA loading dye (95% 
formamide, 0.025% SDS, 0.025% bromophenol blue and 0.5 mM EDTA). The samples were 
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denatured at 95°C for 5 min and resolved on a 10% polyacrylamide – 8 M urea gels in TBE 1X 
buffer. The cDNA approximate sizes were estimated using 30-330-bp AFLP® DNA ladder 
(Invitrogen). Alternately, sequencing ladder was generated with a dideoxy chain termination 
reaction, using SequenaseTM Version 2.0 DNA Sequencing Kit (Affymetrix USB), according to the 
manufacturer’s instructions. The DNA template used during the termination reaction was 
generated by PCR from WT genomic DNA with OLEC3903/OLEC3970 (Table 8). 
 
Oligo Sequence 5′-3′ a F/R b Usage c Target d 
Primer extension analyses   
OLEC3966 TGTCATATGTTAAACCTTTCTAATC R PE ropB 5′ UTR 
OLEC2406 ACTACCATTTTGCAAAAGGAAC R PE  
speB 5′ UTR 
 
OLEC3903 TAACGGTACATTGGACACACCTCC R PE 
OLEC3904 TATACCTCTTTCAAAATAAGTTAATCTACTGC R PE 
OLEC3970 TGGGTTAGCAAGAACAAATCC R PE speB CDS 
OLEC4030 GTGTTTGTCTTTTGGCGATAACC R PE SPy_0116 CDS 
OLEC4031 CACTGACGCTAAACCAAGAC R PE bmpA CDS 
OLEC4033 TCCTAGCTGTCCATCTGTGC R PE SPy_sRNA1680670 
OLEC4036 AATGCTTCATTCTTGAGTTGGC R PE SPy_1845 CDS 
 
Table 8. Oligonucleotide primers used in primer extension analyses. 
The name, the sequence, the directionality, the function and the respective targets of the oligonucleotides 
used in primer extension analyses are reported. a italic: sequence annealing to the template; b F: forward 
primer; R: reverse primer; c PE: primer extension analysis; d 5′ UTR: 5′ untranslated region; CDS: coding 
DNA sequence. 
 
2.3.7 Simultaneous mapping of RNA 5′ and 3′ ends 
Total RNA was extracted as described above (see section 2.3.1) and treated with Turbo 
DNase (4 U/ μl) (TURBO DNA-free™, Ambion) according to the manufacturer’s instructions and 
the RNA integrity was checked using a bioanalyzer (Agilent). 1 µg of DNase-treated RNA was 
incubated with 1X Thermopol buffer (NEB) in presence or absence of 50 U of RNA 5′ 
pyrophosphohydrolase (RppH; NEB), which transforms the 5′ triphosphate (5′ PPP) of primary 
transcripts to 5′ monophosphate (5′ P), in a final volume of 20 µl at 37°C for 1h. Autoclaved MQ-
H20 was added to the samples to reach a final volume of 200 µl and the RNAs were purified using 
phenol-chloroform purification. 200 µl of Acid Phenol:Chloroform (5:1; Ambion) were mixed with 
the samples by vertexing. The mixture was subsequently centrifuged at 10270 g for 10 min at 4°C 
and divided in an aqueous phase on top and an organic phase at the bottom. The aqueous phase 
(approximately 200 µl) was transferred to a fresh reaction tube, mixed with 200 µl of Chloroform 
(Sigma) and centrifuged at 10270 g for 10 min at 4°C. Repeatedly, the aqueous phase was 
transferred in a fresh reaction tube, mixed with 0.1 volume of 3M NaAc pH 5.2 (at room 
temperature), 3 volumes of 100% ethanol (ice-cold), 0.5 µg/µl Glycogen (Thermo Fisher) and 
incubated for at least 1 h, at − 20°C. The samples were then centrifuged at 10270 g for 30 min at 
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4°C and the supernatant were discarded. After a wash step with 1 ml of ice-cold 80% EtOH and 
centrifugation at 10270 g for 5 min at 4°C, the RNA pellet was air-dried at room temperature for 
10 min and resuspend in 12 µl of autoclaved MQ-H2O and the RNA concentration was determined 
using a NanoDrop (Thermo Scientific). 50 ng of RppH-treated and non-treated RNA were self-
ligated at 17°C overnight with 40 U T4 RNA Ligase (NEB), 1X Ligase buffer, 8% v/v DMSO, 
10 U Ribonuclease inhibitor (RNaseOUT, Thermo Fisher Scientific) and 1 U DNase I (NEB), in 
a final volume of 20 µl. Following phenol-chloroform extraction and ethanol precipitation, the self-
ligated RNAs were retrotranscribed and the cDNAs amplified using OneStep RT-PCR kit 
(QIAGEN) following the manufacturer’s instructions with specific pairs of outward and inward 
(used as a control) primers listed in Table 9. RT-PCR products were visualized on a 2% TAE 
(0.4 M Tris acetate, pH 8.3, and 0.01 M EDTA) agarose gel and 5 µl of the RT-PCR reaction was 
used to clone the RT-PCR products in the vector of the TOPO TA cloning kit (Invitrogen) 
according to the manufacturer’s instructions. Up to ten clones were selected and analyzed by DNA 
sequencing (Microsynth, Barcode Economy Run Service) with two different primers (OLEC3224/ 
OLEC3225) listed in Table 6. To map the RNA 5′ and 3′ ends, the sequences were compared with 
S. pyogenes M1 SF370 genome. 
 
Oligo Sequence 5′-3′ a F/R b Usage c Target d 
Simultaneous mapping of RNA 5′ and 3′ ends    
OLEC7573 (inward) CATACGATGTCGCTGATACCATG R Circ-RT-PCR 
speB 5′ UTR 
 
OLEC7574 (inward) ACCGTTAAAAGCAAATGCAGTAG F Circ-RT-PCR 
OLEC7575 (outward) ATGATAACCATACGATTCAGCTAAG F Circ-RT-PCR 
OLEC7576 (outword) TTTTAACGGTACATTGGACACAC R Circ-RT-PCR 
 
Table 9. Oligonucleotide primers used in the simultaneous mapping of RNA 5′ and 3′ ends. 
The name, the sequence, the directionality, the function and the respective targets of the oligonucleotides 
used in the simultaneous mapping of the 5′ and 3′ ends are reported. a italic: sequence annealing to the 
template; b F: forward primer; R: reverse primer; c Circ-RT-PCR: circularization of RNA by self-ligation 
followed by Reverse Transcriptase-Polymerase Chain Reaction; d 5′ UTR: 5′ untranslated region. 
 
2.4 Protein detection 
2.4.1 Luciferase reporter assay 
The plasmids constructed to study the activity of speB promoters (described above) were 
transformed in S. pyogenes WT and ∆rny competent cells as described above (see section 2.1.2). 
Single clones, containing the plasmid, were subsequently grown in THY supplemented with 
kanamycin. WT and ∆rny cells derived from a single clone and containing the constructs for 
studying the activity of speB promoters were grown overnight in 2 ml of THY with kanamycin. 
1 ml was used to inoculate 50 ml medium in 100 ml-flasks for the over-day cultures. At mid-
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logarithmic and early-stationary growth phases, beetle luciferin (Promega) was added, to a final 
concentration of 50 ng/μl, to 200 μl of cultures in a white opaque 96-well microtiter plate (Greiner 
Bio-OneTM). Luminescence was measured, at room temperature, using a microplate reader 
(BioTekTM Cytation 3) with the following conditions: integration time of 1 sec, gain of 120 and read 
height of 1 mm. The signal was normalized with the OD620 nm and with the luminescence measured 
from bacterial cells with the pEC2173 construct harboring the constitutive promoter P23. The 
experiments were performed in biological triplicates, each with technical triplicates and the 
standard deviation was calculated. 
 
2.4.2 Exoprotein precipitation  
20 ml of bacterial cultures were harvested at mid-logarithmic and early-stationary growth 
phases, centrifuged at 3500 g for 10 min at 4°C and the respective supernatants were filtered with 
a 0.45 μm syringe filter (VWR). The proteins, contained in the cell-free supernatants, were 
precipitated with a final concentration of 10% of ice-cold trichloroacetic acid (Sigma) for 30 min 
on ice. After centrifugation at 8400 g for 10 min at 4°C, the proteins were washed with ice-cold 
acetone, air-dried and resuspended in 70 μl of 1 M Tris-HCl, pH 8.0. Equal volumes of protein 
preparation, derived from the different S. pyogenes cultures, were mixed with 5X SDS loading dye 
(250 mM Tris-HCl pH 6.8, 10% SDS, 0.02% of bromophenol blue, 30% (v/v) glycerol, 5% β-
mercaptoethanol (Sigma)), incubated at 95°C for 5 min and subsequently on ice. The proteins were 
resolved on a 15% polyacrylamide gel by sodium dodecyl sulfate – polyacrylamide gel 
electrophoresis (SDS-PAGE). SDS-PAGE gels are composed of a separation gel at the bottom 
and a stacking gel on top. The separation gel solution was prepared as follows: 2.1 μl 1M Tris-HCl 
at pH 8.8, 1.875 ml of 40% polyacrylamide solution, 50 μl of 10% SDS, 0.975 ml MQ-H2O, 50 μl 
of 10% ammonium persulfate solution (APS; AppliChem) and 3 μl of N,N,N′,N′-
tetramethylethylene-diamine (TEMED; Sigma-Aldrich). When the separation gel was completely 
polymerized, the stacking gel solution was prepared (390 μl of 1M Tris-HCl at pH 6.8, 450 μl of 
40% polyacrylamide solution (AppliChem), 30 μl of 10% SDS, 2.13 ml MQ-H2O, 30 μl of 10% 
APS and 1.8 μl TEMED) and added on top of the separation gel. The protein run was conducted 
at 80 V for 25 min in the stacking gel and at 100 V for 2.5 h, in 1X SDS running buffer (25 mM 
Tris-HCl, 250 mM glycine, 0.1% SDS). The proteins in the separation gel were stained with 
Coomassie Brilliant Blue (Sigma-Aldrich), following the manufacturer’s instructions, and imaged 
with a scan (CanoScan LiDE 700F). The PageRulerTM Plus Prestained Protein ladder (Thermo 
Fisher) was used to approximately estimate the protein masses in kilodaltons (kDa). 
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2.5 RNA sequencing 
2.5.1 Library preparation  
Total RNA was prepared, as described above (see section 2.3.1), from the WT and ∆rny 
strains grown until mid-logarithmic growth phase and from WT grown until early-stationary phase 
growth and depleted from Genomic DNA using Turbo DNase (Ambion), following the 
manufacturer’s instructions. Following sample quality control using a bioanalyzer (RNA 6000 
Nano Kit, Agilent) and Qubit (RNA BR Assay, Invitrogen) the rRNAs were removed with Ribo-
Zero rRNA Removal Kit (Illumina). 5′ PPP RNAs were converted into 5′ P RNAs using either 
TAP (Tobacco Acid Pyrophosphatase, Epicentre) (for the WT sample at early-stationary growth 
phase) or using RppH (New England Biolabs) (for the WT and ∆rny samples at mid-logarithmic 
growth phase). The TAP treatment was conducted in a microcentrifuge tube and in a 50 μl final 
volume, including 25 μl of total RNA derived from the previous step, 5 μl of 10X TAP reaction 
buffer, 1 μl of TAP enzyme (10 U) and 19 μl nuclease-free water. The RppH was similarly 
conducted in a 50 μl final volume, including 25 μl of total RNA, 5 μl of 10X RppH reaction buffer, 
2 μl of RppH enzyme (10 U) and 18 μl of nuclease-free water. Both the mixtures were incubated 
at 37°C for 1.5 h and the RNAs were then purified using Phenol/Chloroform extraction as follows. 
250 μl of nuclease-free water was added to the reaction and mixed with 300 μl of 
Phenol:Chloroform:Isoamylalcohol (25:24:1; Roth), at pH 4.5-5, by vertexing for 10 sec. The 
samples were then centrifuged at 15800 g for 10 min at room temperature. The obtained aqueous 
phase, was transferred in a fresh reaction tube and mixed with 300 μl of 
Chloroform:Isoamylalcohol (24:1; Sigma) by vertexing for 30 sec. The samples were then 
centrifuged at 15800 g for 5 min at room temperature and the aqueous phase transferred in a fresh 
reaction tube. The last two described steps (washes with Chloroform:Isoamylalcohol and 
centrifugation) were repeated for a second time. The RNAs were then precipitated by mixing the 
aqueous phase with 1/10 volume of 3M NaAc, 2.5 μl Glycogen (20 mg/ml; Fermentas), 3 volumes 
of ice-cold EtOH and subsequently incubating the samples at – 80°C for 1 h or overnight at 
– 20°C. Following RNA precipitation, the samples were centrifuged at 15800 g for 30 min at 4°C. 
The respective supernatants were discarded and 500 μl of ice-cold 70% EtOH was added to the 
pellets. After centrifugation at 15800 g for 5 min, the supernatants were removed and the pellets 
were air-dried from 5 to 15 min. The TAP-treated and the RppH-treated RNAs were resuspended 
in 25 μl of TE-buffer and in 15.2 μl of nuclease-free water, respectively. 15 μl from each of the 
RNA samples were treated with T4 Polynucleotide kinase (T4 PNK; Thermo Scientific) in order 
to phosphorylate the RNA 5′ ends and to remove the 3′ phosphoryl groups. The reaction was 
carried out for 25 min at 37°C in presence of 2 μl 10X buffer A, 1.8 μl 10mM ATP, 1 μl T4 PNK. 
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The RNAs were then purified using the RNA Clean & Concentrator kit (Zymo Research), 
following the manufacturer’s instructions and separated in two different fractions (short and long 
RNAs). The fraction of long RNAs was fragmented either by chemical fragmentation using NEB 
Next Magnesium RNA Fragmentation Module (NEB E61505) (for the WT sample at early-
stationary growth phase) or by mechanical fragmentation for 140 s using Covaris M220 and 
microtube AFA Fiber Pre-Slit Sbak-Cap tubes (for the WT and ∆rny samples at mid-logarithmic 
growth phase). The cDNA libraries were prepared using NEXTflex® Small RNA Sequencing Kit 
v3 (Bioo Scientific), The manufacturer’s instructions were followed until step G, consisting of 22 
cycles of PCR. After replacing step H with the final purification of the cDNA library, executed 
using Agencourt AMPure XP beads (Beckman Coulter), instructions of step I from the protocol 
of the NEXTflex® Rapid Directional qRNA-Seq Kit (Bioo Scientific) were followed. The cDNA 
library quality control was assessed using Qubit (dsDNA HS Assay, Invitrogen) and a bioanalyzer 
(High sensitivity DNA kit, Agilent). The preparation of the cDNA libraries was performed by K.H. 
For all samples the high-throughput RNA sequencing was executed on a HiSeq3000 with a paired-
end mode and 150 nt of read-length (for the WT sample at mid-logarithmic growth phase) and 75 
nt of read-length (for the WT and ∆rny samples at early-stationary growth phase) at the Max Planck-
Genome-centre Cologne. The data have been deposited at NCBI under the accession number 
SRP149897 and SRP149896 for the WT sample at early-stationary growth phase and for the WT 
and ∆rny samples at mid-logarithmic growth phase, respectively.  
 
2.5.2 Read processing 
FastQC (v0.11.5) was used to analyze the quality of the data. Reads were filtered and 
eliminated if the quality score was <10 and if smaller than 22 nt. The sequences corresponding to 
the adapters were removed using Cutadapt (v1.11)361. The mapping of the reads was performed 
with STAR (v2.5.2b) in both ‘random best’ and ‘end to end’ modes362. NC_002737.2 was used as 
S. pyogenes reference genome363. Samtools (v1.3.1) was used to sort and index the obtained BAM 
files. Including four random bases at the RNA 3′ and 5′ ends, during the library preparation, allowed 
the detection and filtering of potential PCR artefacts. These bases serve as Unique Molecular 
Identifiers UMIs and they were identified applying the UMI Tools (v0.4.1). The coverage files 
(total, 5ʹ and 3ʹ ends) were generated with the HTSeq library (v0.9.1) using a custom script and 
were visualized with the Integrative Genomics Viewer (IGV)364. The read processing procedure 
was performed by R.A.-B. from the MPUSP bioinformatic research platform. 
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2.5.3 Differential expression analysis 
Gene counts were determined using FeatureCounts (v1.5.2)365 with the S. pyogenes gene 
annotation NC_002737.2 in which the sRNAs, previously identified359 were included. Genes that 
were differentially expressed in the ∆rny strain compared to the WT strain were identified utilizing 
edgeR (v3.20.6)366,367 using an absolute log2 fold change (log2 FC) ≥ 1 and a false discovery rate 
(FDR) < 0.05. The differential expression analysis was performed by R.A.-B, from the MPUSP 
bioinformatic research platform, and analyzed by A.L.R., A.-L.L. and L.B. 
 
2.5.4 Identification of RNase Y processing sites 
The identification of processing positions was performed, using a method developed in 
our laboratory185,204. After data normalization, the differential expression analysis of the 5′ and 3′ 
read ends was performed by comparing the data deriving from triplicate samples of the WT and 
∆rny strains (WT vs ∆rny and ∆rny vs WT). When a 5′ or 3′ RNA end was identified as more abundant 
in the WT strain than in ∆rny strain it was annotated as 5′ or 3′ rny_end, respectively (Tables A2 
and A4). Conversely when a 5′ or 3′ RNA end was more abundant in the ∆rny strain than in the 
WT strain it was mapped as 5′ or 3′ ∆rny_end, respectively (Table A10). A “counts per million 
(cpm)” value ≥ 0.05 was set for each comparison in order to prefilter the genome coverage. Only 
the 5′ and 3′ end positions that have a cpm ≥ 5 were further analyzed. The differential expressed 
ends were obtained using edgeR (v3.20.6) with an absolute log2 fold change (FC) ≥ 1 and false 
discovery rate (FDR) < 0.05. The obtained results were filtered by applying previously developed 
parameters to identify specific cleavage positions185 including: (i) the proportion of ends ≥ 2% 
(reads stopping at the position of interest compared to all the reads mapping at that position is 
least 2%), (ii) the ratio of proportion of ends between WT and ∆rny ≥ 3 (ensuring that the position 
of interest is identified as a cleavage position independently of the RNA abundance). 
 
2.5.5 Comparison of RNase Y and 3′-to-5′ exoRNases targetomes 
The identified 5′ and 3′ rny_ends were compared to the PNPase, YhaM and RNase R 
targetomes (i.e. 3′-to-5′ exoRNase trimming start and stop positions), which were previously 
identified by our laboratory204 (see Figure 4) and the RNA sequencing data relative to the 3′-to-5′ 
exoRNases are deposited in NCBI under the accession number (SRP149887). Different strategies 
were used to compare these RNA ends. When at least two successive positions were identified as 
3′ rny_ends in a window of 5 nt, the position with the highest ratio of proportion of ends between 
the WT and ∆rny strains was selected for following analyses. First, the 3′ rny_ends were compared 
with the PNPase, YhaM and RNase R trimming stop positions, allowing for a shift of +/− 5 nt 
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(see Table A5). Second, the 3′ rny_ends matching 3′-to-5′ exoRNase trimming stop positions, 
identified above, were compared with the trimming start positions located downstream (see Table 
A6). A 200 nt maximum distance between these trimming stop and start positions was set for 
PNPase and RNase R, and 10 nt for YhaM. In the case of RNase R, by allowing a maximum 
distance of 200 nt, no trimming start positions downstream of the 3′ rny_ends, which matched 
RNase R stop positions, were identified. Third, the 3′ rny_ends were compared with the PNPase, 
YhaM and RNase R trimming start positions, allowing for a shift of +/− 5 nt (see Table A7). 
Finally, the 5′ rny_ends were paired to the PNPase, YhaM and RNase R trimming start positions 
found 10 nt upstream (see Table A9). The comparisons, described above, were performed with 
Python (v3.6.3) by T.T.R together with A.L.R., A.-L.L. and L.B. 
 
2.5.6 Sequence alignments and RNA secondary structure prediction 
The sequence logos were generated using WebLogolib (v3.5.0)368 with sequences of 20 nt 
centred at the processing site and a GC content of 38.5%. The minimum fee energy (MFE, ∆G in 
Kcal mol-1) was calculated using a sliding window of 50 nt sequences, 100 nt upstream and 
downstream of the processing position of interest, using RNAfold (v2.4.3)369. The average MFE at 
each nt was then calculated. The sequence and structural analysis of the sequences of interest was 
performed by T.T.R together with L.B. A.L.R. and A.-L.L 
The structure predication of the speB mRNA 5′ UTR was conducted using RNAfold 
(v2.4.3)369 and by calculating the ∆G in Kcal mol-1 of 25 nt sequences 100 nt upstream and 100 nt 
downstream of the RNase Y processing position at – 137 nt from the speB mRNA start codon. 
The RNA structure of a portion of speB mRNA 5′ UTR including the sequence from – 153 nt to 
the speB start codon was predicted with RNAfold WebServer and visualized using VARNA370. 
  









3.1 Characterizing the global functions of S. pyogenes RNase Y  
3.1.1 Deletion of rny affects the expression of virulence genes 
o study the role of RNase Y in S. pyogenes, the gene encoding this endoRNase (SPy_1633, 
named here rny) was deleted, generating the ∆rny strain (constructed by A.-L.L.). The rny 
gene is not essential for the growth of S. pyogenes, as also reported for S. aureus167 and B. subtilis162 
and unlike C. perfringens where even the depletion of the enzyme causes severe effects on growth166. 
We observed that the ∆rny strain was delayed in growth compared to the wild type (WT) strain 
under the conditions tested (Figure 7A).  
To examine the global impact of RNase Y on the transcriptome, differential gene 
expression analysis was performed.  Due to the difference in growth between the ∆rny and WT 
strains, the cultures for the RNA isolation were harvested when the same optical density (OD620 nm 
0.25), corresponding to mid-logarithmic phase of growth, was reached regardless of the growth 
time (Figure 7A and B). The differential gene expression analysis revealed that 80 genes that were 
significant differentially expressed, with an absolute log2 fold change (log2 FC) ≥ 1 and a false 
discovery rate (FDR) < 0.05 (Table A1). Among the differentially expressed genes, 22 and 58 genes 
were down and upregulated, respectively. In the absence of RNase Y, the expression of genes 
involved in different physiological processes, including nucleotide and vitamins metabolism, were 
altered. For instance, the folEPQK operon, involved in the folate synthesis, was upregulated in the 
∆rny strain compared to the WT strain (Table A1). In S. pyogenes, the folEPQK transcript was 
previously shown to be stabilized in the ∆rny strain371. In addition, genes involved in protein 
synthesis and folding were also upregulated in the ∆rny strain, including genes encoding ribosomal 
proteins (i.e. rpsB and rpsL), the elongation factor thermos-stable EF-Ts (tsf) and protein chaperons 
(groEL and groES) (Table A1). 
T 
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We did not identify any major transcriptional regulator (see also section 1.3.7) whose 
mRNA abundance was altered in the ∆rny strain (Table A1). However, we observed that the 
expression of 6 different putative sRNAs was affected in the absence of RNase Y (Table A1).  
Of note, the expression of genes encoding for S. pyogenes virulence factors (slo, speB, grab 
and sic) was affected in the ∆rny strain. In particular, speB and the neighboring genes in the 
chromosome (SPy_2040, SPy_2041 and Spy_sRNA1699993) were strongly downregulated in the 
∆rny strain (Figure 7B and Table A1). 
 
 
Figure 7. Effects of rny deletion in S. pyogenes. 
A. Growth curve analysis of the wild type (WT) and rny (RNase Y) deletion mutant (∆rny) strains in THY 
at 37°C with 5% CO2 in triplicates. The error bars indicated the standard deviation of the mean. At mid-
logarithmic (ML) phase growth the samples were harvested to perform RNA sequencing. K.H. contributed 
in the replicate generation of the S. pyogenes growth curves. B. Mean difference plot of the WT strain versus 
the ∆rny strain, showing the log-fold change and the average log reads per million reads (RPM), a unit that 
reflects transcript abundance for each gene (represented as dots). The dark green dots represent the genes 
that were further selected with an absolute log2 fold change ≥ 1 and false discovery rate < 0.05 and that 
were also identified in the comparison ∆rny versus complemented rny deletion strain (∆rny::rny). speB and the 
genes expressed within the same polycistronic transcript (SPy_2040, SPy_sRNA1699993 and SPy_2038 were 
downregulated in the ∆rny strain compared to the WT strain. Differential expression analysis was performed 
by R.A.-B and analysed by A.L.R, A.-L.L. and L.B. 
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3.1.2 RNase Y regulates speB expression 
To give insights into the role of RNase Y in speB regulation, the speB expression pattern 
during the bacterial growth, was evaluated by Northern blot analyses and the production of the 
SpeB protease was analysed by SDS-PAGE (Figure 8). As mentioned in the introduction, it is well 
known that speB expression is growth phase-dependent and tightly controlled by a plethora of 
factors and environmental conditions290. Consistent with the observation that speB expression 
depends on the bacterial growth phase, speB mRNA abundance increased from early-logarithmic 
to early-stationary growth phase (Figure 8).  
 
 
Figure 8. RNase Y controls speB expression. 
A. Total coverage profiles of speB and surrounding genes resulting from RNA sequencing (black for the 
positive strand and grey for the negative strand). The coverage scale is indicated between brackets. The 
genes (arrows) with the predicted promoters and terminators are shown. ropB (Regulator of protease B) is a 
transcriptional activator of speB expression301; SPy_2038 was shown to encode for an inhibitor of SpeB 
protease activity; prsA encodes for the PrsA foldase, which is involved in the maturation process of SpeB 
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protease. The ropB-speB intergenic regions harbours several ORFs: SPy_2040, orf-2, the SpeB inducing 
peptide (SIP) and SPy_2041. P and P1 are the speB transcriptional start sites161 and P2 depicts an RNA 5′ 
end, which was previously identified as a speB TSS301, but then annotated as a putative cleavage site161. The 
arrows below the locus indicate the labelled oligonucleotide probes used in the Northern blot analyses (NB 
probe) and binding either to the speB 5′ untranslated region (5′ UTR) or to the coding DNA sequence (CDS). 
B and C. speB expression profile and transcript abundance was investigated by Northern blot analyses 
performed in the WT, rny (RNase Y) deletion mutant (∆rny) and rny chromosomal complemented deletion 
mutant (∆rny::rny) strains that were grown until early-logarithmic (EL), mid-logarithmic (ML) and early-
stationary (ES) growth phases. The different speB transcript isoforms are indicated (from t1 to t5). The 
poorly detectable isoforms are shown in a contrasted portion of the blot. The 16S rRNA was used as a 
loading control. The results of one representative Northern blot analysis (n>3) are shown. D. The effect of 
RNase Y deletion on SpeB protease levels was studied by analysing the extracellular fraction on a sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) stained with Coomassie blue in the WT, 
∆rny and ∆rny::rny strains. The SpeB zymogen (SpeBz, 40 kDa) and the SpeB mature form (SpeB, 28 kDa) 
are indicated on the right side of the gel. The results of one representative SDS-PAGE gel (n=3) are shown. 
K.H. contributed in the extracellular protein extraction and SDS-PAGE analysis. 
 
To facilitate the identification of the speB transcript isoforms (i.e. transcript variants 
originating from the same locus), Northern blot analyses were performed using a labelled 
oligonucleotide probe binding to either the speB mRNA 5′ UTR or to the speB CDS, respectively 
(Figure 8A, B and C).  
First, by using the probe binding to the speB mRNA 5′ UTR, ~ 4kb transcript isoforms (t1), 
deriving from the co-transcription of speB with SPy_2038 and prsA2, were observed. Transcription 
driven from speB promoters until the predicted terminator downstream of the SPy_2038, led to the 
production of the t2 transcript isoforms (Figure 8B and C). Smaller isoforms (t3) were also visible 
and it is likely that the 5′ end of these transcripts coincides with the previously annotated P2 
transcriptional start site (TSS), but recently annotated as a putative cleavage site161.  Two additional 
isoforms (t4 and t5) were detected when the probe binding to the speB CDS was used, but their 
origin is unclear (Figure 8C). The abundance of speB transcript was reduced at mid-logarithmic and 
early-stationary growth phases in the ∆rny strain when compared to the WT and to the ∆rny::rny 
strains, confirming the RNA sequencing data (Figure 8B and C). In agreement with the speB 
transcript levels, the amount of both the zymogene and the mature forms of extracellular SpeB 
protease was decreased in the ∆rny strain and was restored in the ∆rny::rny strain (Figure 8D). 
 
3.1.3 RNase Y controls speB promoter activity 
The downregulation of speB expression observed in the ∆rny strain (Figure 8) could be 
caused by (i) an indirect effect of RNase Y on speB expression (e.g. RNase Y affects a regulator of 
speB), (ii) a direct effect (e.g. RNase Y processes the speB transcript) and (iii) both scenarios. To 
examine whether the reduction in speB abundance in the ∆rny strain was due to an indirect 
transcriptional effect, the luciferase reporter gene (ffluc) was fused to the speB promoters and ffluc 
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gene expression was measured in the WT, ∆rny and ∆rny::rny strains (Figure 9A and B). The 
luminescence signal was strongly reduced in the ∆rny strain when compared to the WT and the 
∆rny::rny strains, during both mid-logarithmic and early-stationary growth-phases (Figure 9B). This 
result indicated that speB promoters were less active in the ∆rny strain than in the WT strain. The 
luminescence signal was instead equal in the WT and ∆speB strains, indicating that putative SpeB-
mediated autoregulatory circuits were not occurring at the experimental conditions used. (Figure 
9C). All together these results demonstrated that RNase Y is indirectly involved in promoting the 
activation of speB promoters. 
 
 
Figure 9. RNase Y regulates speB expression indirectly at the transcriptional level. 
A. Schematic representation of the luciferase (ffluc) fusion vectors used to study the speB promoter activity 
in the WT and rny (RNase Y) deletion mutant (∆rny) strains. The speB promoter region (containing P and 
P1 TSSs) were cloned upstream of the ffluc. The cloned region also comprises the putative binding sites of 
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the RopB transcriptional activator301. A control vector (P23-ffluc) in which the ffluc expression is under the 
control of a constitutive promoter (P23) was used in the experiment. B and C. Luminescence assay to study 
speB promoter activity in the WT, rny (RNase Y) deletion mutant (∆rny) and speB (SpeB) deletion mutant 
(∆speB) strains at both mid-logarithmic (ML) and early-stationary (ES) phases of growth. The luminescence 
intensity of the samples is relative to the plasmid control (P23-ffluc) and normalized to the OD620 nm. The 
experiment was performed in three biological replicates each with technical triplicates and the standard 
deviation is shown. S.M., master student in the Charpentier group, contributed in the luminescence assay 
experiments. D. Analysis of speB transcript stability using rifampicin assay at ES growth phase in the WT 
and ∆rny strains. The minutes after the addition of the rifampicin are indicated. The region of speB mRNA 
5′ UTR targeted by the labelled oligonucleotide probe in the Northern blot analysis is shown in Figure 8A. 
The speB transcript isoforms are indicated (see also Figure 8B) and the 16S rRNA was used as a loading 
control. The results of one representative Northern blot analysis (n=3) are shown. The calculated half-life 
of the t2 and t3 isoforms are reported in the right panel. The half-life of the t1 isoform could not be 
calculated due to the low intensity of the band and the high background of the blot. The values of the half-
life, determined from three independent experiments, were compared using a t-test. Single and double 
asterisks depicted a p-value inferior of 0.05 and 0.01, respectively. The n.s. indicates that there is not 
significant difference between the samples. 
 
Next, to decipher whether the reduction in speB abundance in the ∆rny strain was also due 
to a direct role of RNase Y on speB mRNA, the speB transcript stability was analysed by rifampicin 
assay followed by Northern blot analyses at early-stationary growth phase using the labelled 
oligonucleotide probe binding to the speB mRNA 5′ UTR (Figure 9D). The speB transcript isoforms 
were not destabilized in the absence of RNase Y, on the contrary the half-life of the speB isoforms 
t2 was increased in the ∆rny strain (40 min ± 3.34) compared to the WT strain (19.57 min ± 2) 
(Figure 9D). Taken together, these results indicate that in S. pyogenes SF370 strain, RNase Y causes 
speB downregulation mainly indirectly at the transcriptional level. However, the observation that 
the stability of speB isoform t2 increased in the ∆rny strain suggested that RNase Y might also affect 
speB expression at the post-transcriptional level. Interestingly, when speB expression pattern was 
examined by Northern blot analysis with a labelled oligonucleotide probe binding to the speB 
mRNA 5′ UTR, the smaller isoforms t3 were not detectable in the ∆rny strain (Figure 9D), 
suggesting that RNase Y was involved in their production and that they likely resulted from the 
processing of the transcript isoforms t2. This hypothesis would explain the stabilization of the t2 
isoforms in the ∆rny strain and will be corroborated in the next sections. 
 
3.1.4 The expression of some speB regulators is affected by rny deletion 
RNase Y affects the covRS transcript stability 
Several transcriptional regulators were described to control speB expression (Table 1 and 
Figure 10A) and the effect of RNase Y on few of these regulators has been described so far. A 
microarray analysis of RNA samples extracted from cultures treated with rifampicin was previously 
performed to estimate the half-life of S. pyogenes RNAs in both the WT and ∆rny strains106. The 
transcripts encoding for the CovRS two-component system, composed of the response regulator 
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(CovR) and sensor kinase (CovS) were reported to be stabilized, however this result was never 
validated106. CovRS was shown to repress the speB transcription by directly targeting the speB 
promoter region307,308,335. Here, the stability of the covRS transcript was analysed by Northern blot 
analysis at mid-logarithmic growth phase, using a labelled oligonucleotide probe binding the covR 
CDS (Figure 10B). One long (tl) and one short (ts) transcript isoforms were identified by Northern 
blot analysis (Figure 10B). The stability of the long isoform was equal in the WT and ∆rny strains. 
This transcript could result from the co-transcription of covR and covS, which were already 
demonstrated to be transcribed as a sole mRNA372. Indeed, a terminator for covR and a promoter 
for covS were not identified in the short intergenic region between the two genes. The short 
transcript isoform, containing the covR CDS, was highly increased in the ∆rny strin and the 
transcript was still detectable up to 45 min after the addition of the rifampicin, compared to the 
WT strain (Figure 10B). This result suggested that the covR transcript is possibly an RNase Y direct 
target and that the CovRS system could be involved in the RNase Y-mediated regulation of speB 
expression. 
 
RNase Y and RNase III process the ropB mRNA 
speB expression can be activated by the stand-alone transcriptional regulator RopB, which 
is encoded adjacent to speB. Based on the observation that ropB overexpression in the ∆rny strain 
re-established the SpeB production to the WT level, RopB was proposed to be involved in the 
RNase Y control of speB expression168. Analysis of ropB transcript stability revealed that ropB mRNA 
was highly stabilized in the ∆rny strain (Figure 10C, left), as already reported in S. pyogenes106,161. 
Whereas in the WT strain only one ropB transcript isoform (t2) was detected, two additional 
transcript isoforms (t1 and t3) were present and highly stabilized in the ∆rny strain (Figure 10C, 
left). Based on the increase of ropB transcript stability in the ∆rny strain, it is likely that RNase Y is 
the endoRNase responsible for the initiation of ropB transcript degradation. 
Next, we evaluated the ropB expression pattern in the WT strain, in three different growth 
phases and we observed a reduction of ropB transcript abundance from early-logarithmic to early-
stationary growth phases (Figure 10C, right). Conversely, the analysis of the ropB expression profile 
in the ∆rny strain unveiled that the ropB abundance increased during growth, indicating that 
RNase Y controls the ropB temporal expression pattern (Figure 10C, right).  
The ropB mRNA 5′ UTR was suggested to be targeted by endoRNases, including 
RNase Y106,106,161. We mapped the RNA 5′ ends in the ropB mRNA 5′ UTR by RNA sequencing and 
primer extension analyses, at mid-logarithmic growth phase (Figure 10D). The ropB TSS was 
annotated at – 369 nt from the ropB start codon and the signal intensity of the cDNA product 
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corresponding to this position was increased in the ∆rny strain compared to the WT, ∆rny::rny and 
the rnc (RNase III) deletion mutant (∆rnc) strains (Figure 10D). This observation could be explained 
by the higher level of ropB transcript in the ∆rny strain during mid-logarithmic phase of growth 
(Figure 10C, right). Importantly, a low-abundance RNA 5′ end, at − 218 nt from ropB start codon, 
was observed by primer extension in the WT, ∆rny::rny and ∆rnc strains, but not in the ∆rny strain, 
indicating that this 5′ end resulted from RNase Y processing of the ropB mRNA 5′ UTR (Figure 
10D, see contrasted portion), in accordance with a previous study106. A second RNA 5′ end was 
not present in the ∆rny strain, indicating that it was also likely produced by RNase Y (Figure 10D, 
see contrasted portion). 
Additional RNA 5′ ends were observed in the ropB mRNA 5′ UTR and probably 
corresponding to other RNase processing positions. One of these RNA 5′ ends was not detected 
in the ∆rnc strain indicating that was likely generated by RNase III. The processing by RNase III, 
which is a dsRNA-specific endoRNase, generates two new RNA 5′ ends. While one RNA 5′ end 
was detected, the second was not retrieved by primer extension analysis (Figure 10D). It is possible 
that the second RNase III processing position was not detected because: (i) RNase III cleaves the 
RNA duplex formed by ropB mRNA 5′ UTR and another RNA molecule, (ii) RNase III nicks only 
one strand of a stem loop structure, (iii) the second RNA 5′ end is rapidly degraded, or (iv) the 
primer used in the primer extension analysis did not allow to capture this RNA 5′ end. The ropB 
mRNA 5′ UTR is predicted to be highly structured106 and the RNase Y and RNase III processing 
events could be responsible for a structural rearrangement of this region, which could have 
consequences, for instance, on the ropB transcript translation and/or degradation. 
In summary, RNase Y likely regulated ropB expression and transcript stability through the 
processing of the ropB mRNA 5′ UTR (Figure 10C and D). If the higher ropB mRNA stability in 
the ∆rny strain causes an increase in the RopB protein levels, then RopB, which is an activator of 
speB transcription, would not be involved in the RNase Y-mediated regulation of speB expression. 
However, it must be noted that in the Northern blot analysis, performed after the rifampicin assay, 
three different ropB transcript isoforms were identified and while two were highly stabilized in the 
∆rny strain, one was destabilized in this strain (Figure 10C). It is unknown whether the three 
isoforms are equally translatable or if only one specific isoform is efficiently translated, therefore 
the RopB protein level cannot be deduced from the sole increase of ropB transcript abundance and 
stability. 
 




Figure 10. The mRNA stability of the RopB and CovR regulators is affected in the ∆rny strain. 
A. Schematic representation of the major speB transcriptional regulators (see section 1.3.6 and Table 1). The 
arrows indicate whether the regulator activates (black arrowhead) or represses (no arrowhead) speB 
expression. RopB, CovR and CcpA are direct transcriptional regulators, acting at the speB promoter region. 
Vfr, LacD.1 and SIP are indirect speB regulators, acting through RopB. The question marks indicate that the 
mechanism of speB regulation is not characterized yet. The asterisk depicts the speB regulators whose 
expression is affected by RNase Y. B. and C. Study of ropB (in panel B) and covR (in panel C) transcript 
stability in the WT and rny (RNase Y) deletion mutant (∆rny) strains at mid-logarithmic (ML) phase of 
growth. The pattern of ropB expression was analysed at early-logarithmic (EL), ML and early-stationary (ES) 
growth phases. The minutes after addition of the rifampicin are indicated. The labelled oligonucleotide 
probes  used in the Northern blot analyses (NB probe) are show below the schematic representation of the 
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loci. The 16S rRNA was used as a loading control. The results of one representative Northern blot analysis 
(n=3) are shown. The study of covR mRNA stability was performed by L.B. and A.-L.L. D. Analysis of ropB 
mRNA 5′ UTR by RNA sequencing (top and bottom). Total and 5′ end coverage profiles from RNA 
sequencing of a region of ropB mRNA 5′ UTR which includes the putative SPy_2041 ORF. The black bent 
arrow depicts the ropB transcriptional start sites (TSS) at – 369 nt from ropB start codon. The coverage scales 
are indicated between brackets. A zoom of the RNA 5′ end coverage profile showing the putative RNase Y 
cleavage site in ropB mRNA 5′ UTR at 218 nt upstream of the ropB start codon is shown below. The expected 
cDNA products obtained in the primer extension analysis and the primer used in the experiment are 
represented with green lines and a black arrow, respectively. The primer extension analysis was performed 
in the WT, ∆rny, ∆rny::rny and rnc (RNase III) deletion mutant (∆rnc) strains at ML growth phase. The results 
of one representative primer extension analysis (n=3) are shown.  RNase Y and RNase III putative cleavage 
sites are indicated by purple and blue scissors, respectively. For the poorly detectable cDNA products of 
interest, a contrasted portion is shown. 
 
 
3.1.5 Conclusions I 
In the absence of RNase Y, 80 genes were differentially expressed, including speB, which was 
strongly downregulated in the ∆rny strain. A transcriptional reporter system analysis revealed that 
RNase Y regulates speB expression mainly indirectly at the transcriptional level through the activity 
of a so far unidentified intermediate factor. The expression of two major speB regulators (RopB 
and CovRS) is controlled by RNase Y and we hypothesized that CovRS could be involved in the 
RNase Y-mediated regulation of speB expression, without excluding the possibility that other 
factors are also involved in this process. Finally, from the analysis of speB transcript isoform 
stability, we deduced that RNase Y likely also cleaves the speB mRNA.  
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3.2 Identifying the requirements for RNase Y processing 
3.2.1 Mapping of RNA 5′ ends in the WT and ∆rny strains: RNase Y 
preferentially cleaves after a guanosine 
The differential expression analysis performed in the WT and ∆rny strains revealed genes 
which are regulated by RNase Y in a direct and/or an indirect manner (Figure 7B and Table A1). 
We next aimed to specifically identify, at a single nucleotide resolution, the direct targets of 
RNase Y (e.g. RNAs which are processed by this endoRNase). To pinpoint the RNase Y processing 
positions genome-wide, the abundance of the RNA 5′ ends in the WT, ∆rny and ∆rny::rny strains 
was compared, in three biological replicates at mid-logarithmic phase of growth, using a method 
previously developed in our laboratory185,204 (Figure 11A and B, see Material & Methods).  The 
RNA 5′ ends that were more abundant in both the WT and ∆rny::rny strains than in ∆rny strain were 
annotated as 5′ rny_ends (Figure 11A and B). When the RNA abundance was too low either in the 
WT strain or in ∆rny strain, the processing positions were not annotated (see Material & Methods). 
We identified 190 RNA 5′ ends whose abundance was RNase Y-dependent and therefore likely 
resulted from RNase Y processing (Table A2). Selected 5′ rny_ends were validated by primer 
extension analysis (Figure 11C), which was performed in the WT and ∆rny strains at mid-
logarithmic growth phase. The expected cDNA products, from the primer to the predicted RNA 
5′ end, were observed for the four tested targets (Figure 11C).  
The RNA 5′ end generated by RNase Y after processing of the ropB mRNA 5′ UTR 
previously identified by primer extension (Figure 10D) was not identified here (Table A2). This 
can be explained by the observation that the ropB mRNA 5′ UTR was poorly expressed (see 
coverage profile in Figure 8A and 11D) and as already mentioned, positions located in regions not 
sufficiently expressed were excluded from the analysis (see Material & Methods)185,204. 
To evaluate whether RNase Y exhibited any structural or sequence preference, we analysed 
the sequences surrounding the 5′ rny_ends. To examine the presence of putative secondary 
structures around the 5′ rny_ends, the minimum free energy (∆G in Kcal mol-1) was estimated 100 
nt upstream and downstream of the 5′ rny_ends (Figure 11D, see Material & Methods). An overall 
increase of the ∆G was observed at the 5′ rny_ends compared to the neighboring regions, indicating 
that the RNase Y processing occurred at ssRNA regions (Figure 11D). Sequence alignment of the 
190 5′ rny_ends revealed the preference of a guanosine one nucleotide upstream of the cleavage 
site in 87.4 % of the cases. This result indicates that this nucleotide likely plays an important role 
in RNase Y processing of the target RNA (Figure 11D).  
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Figure 11. RNase Y preferentially cleaves after a guanosine.  
A. Example of an RNA molecule which is processed by RNase Y (scissors) generating a new RNA 5′ end 
detectable in the WT strain but not in the rny (RNase Y) deletion mutant (∆rny) strain. B. Representation of 
RNA sequencing 5′ end profile. The RNA 5′ end more abundant in the WT and in the complemented rny 
deletion mutant (∆rny::rny) strains than in the ∆rny strain were annotated as 5′ rny_end (purple arrowhead). 
The “UAUGAUG” represents a random sequence cleaved by RNase Y. C. Subset of 5′ rny_ends that were 
selected and validated by primer extension analysis performed at mid-logarithmic growth phase in the WT 
and ∆rny strains. The primer used is indicated in black and the green lines depict the length of the cDNA 
product from the primer to the predicted 5′ rny_end. The results of one representative primer extension 
analysis (n=3) are shown. The validation of the 5′ rny_end by primer extension analysis was performed 
together with A.-L.L. Note that for all the targets tested other RNA 5′ ends (sometimes coinciding with the 
TSS) were detected upstream of the RNase Y processing positions by primer extension analysis in both the 
WT and ∆rny strains, confirming that the RNA analysed were expressed in both strains. D. Structure (on 
the top) and sequence (on the bottom) conservation of the 5′ rny_ends. The minimum free energy (∆G, in 
kcal/mol-1) was calculated at each nucleotide using a sliding window of 50 nt, 100 nt upstream and 
downstream of the 5′ rny_ends. The logo was generated by aligning 10 nt each side of the 190 5′ rny_ends. 
The sequence and structure analyses at the 5′ rny_ends were conducted by T.T.R. with A.L.R., A.-L.L. and 
L.B. 
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3.2.2 Mapping of the RNA 5′ ends in speB mRNA 5′ UTR 
The study of speB expression pattern performed in section 3.1.2 revealed that the 5′ end of 
the t3 transcript isoforms might derive from RNase Y processing of the speB primary transcript 
(t2) (Figure 8A-C and 9D). In the genome-wide mapping of RNase Y-dependent RNA 5′ ends, 
two RNA 5′ ends generated by RNase Y were identified in the speB CDS (Table A2). However, 
these positions did not correspond to the 5′ termini of the t3 transcript isoforms and therefore the 
origin of these transcripts remained unclear. To elucidate the mechanism of the speB transcript 
isoform generation, the speB 5′ UTR was re-annotated by mapping the speB mRNA 5′ boundaries 
at early-stationary growth phase, during which speB is highly expressed. 
First, the speB mRNA 5′ ends coinciding with the speB TSSs were annotated (Figure 12). 
Two speB TSSs, located at 697 and 842 nt from the speB start codon, were identified by RNA 
sequencing and confirmed by primer extension analyses at early-logarithmic, mid-logarithmic and 
early-stationary growth phases (Figure 12A and B). At early-stationary phase of growth additional 
RNA 5′ ends were also detected by primer extension analysis between the positions corresponding 
to the predicted TSSs P and P1 (Figure 12A and B), thus it is possible that they correspond to 
processing sites or to alternative TSSs. 
The – 10 boxes for P and P1 promoters and a putative − 35 motif for the P promoter were 
manually predicted (Figure 12C). A previous study of the speB promoter region identified a − 35 
motif for the P1 promoter, which was located at 16 nt upstream of the – 10 box301. In our strain, a 
canonical − 35 motif upstream of the P1 promoter was absent (Figure 12C). RopB binding sites 
were identified upstream of the P and P1 promoters301,315, indicating that RopB can initiate speB 
expression from both the annotated promoters (Figure 12C). These results are in agreement with 
previous studies, since P1 (− 697 nt) was already described as speB TSS301 and position P (− 842 
nt) was recently captured by 5′ rapid amplification of cDNA ends161.  
The mapping of the speB TSS (Figure 12A) and ropB TSS (Figure 10D) confirmed that the 
two promoters overlap and that these two genes are divergently transcribed (Figure 8A). The long 
ropB-speB intergenic region (940 nt) encompasses several small ORFs. Originally, the two putative 
ORFs SPy_2040 and SPy_2041 were annotated upstream of speB and ropB, respectively363 (Figure 
8A and Figure 12C). However, a more recent study proposed a new annotation with SPy_2040 
(named orf-3), SpeB inducing peptide (SIP) and orf-2, but not SPy_2041, which was not reported315. 
The RNA sequencing data and the primer extension analysis with the primer targeting the RNA 
downstream of the ropB TSS did not reveal a TSS for SPy_2041. In addition, the ropB TSS was 
located downstream of the SPy_2041 start codon, therefore this ORF could not be co-transcribed 
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with ropB (Figure 10D). Beside SIP, which is involved in the RopB-mediated regulation of speB 
expression, the function of the other putative ORFs is currently unknown.  
 In conclusion, we re-mapped the features of the S. pyogenes SF370 serotype M1 speB-ropB 
intergenic region, which has been not coherently annotated106,161,301,303,315,331. 
 
Figure 12. speB is transcribed from two promoters.  
A and C. Total and 5′ end coverage profiles (black from the positive strand and grey for the negative strand) 
from RNA sequencing. The scales are indicated between brackets. A. The portion of speB 5′ UTR analysed 
contains the ORF encoding the SpeB inducing peptide (SIP), and a portion of the putative ORF SPy_2041. 
P and P1 (black bent arrows) depict the speB transcriptional start sites (TTSs) at – 842 and – 697 nt from 
the speB start codon, respectively. The expected cDNA products obtained in the primer extension analysis 
and the primer used in the experiment are represented with green lines and a black arrow, respectively. B. 
speB TSSs (P and P1) were validated by primer extension performed at early-logarithmic (EL), mid-
logarithmic (ML) and early-stationary (ES) phases of growth. The results of one representative primer 
extension analysis (n=3) are shown. C. Zoom on speB promoters. The putative – 35 and – 10 motifs (in 
green) were identified by visual screening. The direct repeats (light blue rectangle) containing inverted 
repeats (dark blue rectangle and arrows) are part of the putative RopB binding sites located upstream of the 
P and P1 promoters301. 
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3.2.3 RNase Y processes the speB mRNA 5′ UTR after a guanosine 
Besides P and P1, a third speB TSS (P2) at – 137 nt relative to the speB start codon was 
previously annotated301. However, a study of the P2 activity revealed that this promoter was unable 
to sustain the expression of a reporter gene301. It has been then proposed that this RNA 5′ end 
would derive from the processing of speB mRNA 5′ UTR by endoRNase(s)161. Here, the RNA 5′ 
end at the P2 position was identified by RNA sequencing (Figure 13A), but we could not identify 
the – 10 and – 35 boxes upstream of P2 by manual screening. To explore the origin of this RNA 
5′ end, primer extension analyses were performed in the WT and in different RNase deletion 
mutant strains (Figure 13A and B). The cDNA product corresponding to the RNA 5′ end at P2 
was absent only in the ∆rny strain (Figure 13A and B), demonstrating that RNase Y was responsible 
for the production of this RNA 5′ end. A second RNA 5′ end, located 6 nt downstream was also 
detected by RNA sequencing and generated by RNase Y (Figure 13A-C). In addition, both these 
RNA 5′ ends produced by RNase Y in speB mRNA 5′ UTR were mapped downstream of a G 
residue as most of the RNase Y-dependent RNA 5′ ends (Figure 11D). 
Another RNA 5′ end was identified in the speB mRNA 5′ UTR, 78 nt upstream of the speB 
start codon, by both RNA sequencing and primer extension analyses (Figure 13A-D).  It is unlikely 
that this position corresponded to a TSS because: (i) we did not identify – 10 and – 35 motifs and 
(ii) the region upstream of this RNA 5′ end (up to 623 nt) was previously analysed in a 
transcriptional reporter assay and it was showed that it did not harbour any promoter activity301. 
Therefore, we hypothesized that this position corresponded to a cleavage site. To pinpoint the 
RNase responsible for this processing event, primer extension analyses were performed in different 
RNase deletion mutant strains (Figure 13B).  Because this RNA 5′ end was present in all the RNase 
deletion mutant strains tested, the RNase responsible for this processing remains unknown (Figure 
13B).  It should be notated that RNase J1 is essential for growth in S. pyogenes195, therefore a 
conditional mutant (constructed by A.-L.L.) was used. In this strain the expression of the rnjA gene 
(coding for RNase J1) is controlled by the tetracycline-inducible promoter (Ptet)195,347,348. However, 
due to the leakiness of the Ptet promoter, rnjA is expressed also under repression conditions (i.e. in 
the absence of the inducer) (data not shown). Therefore, we could not conclude whether RNase J1 
was involved in this processing event. This RNA 5′ end could be produced by RNase(s) for which 
the deletion mutant was not examined (e.g. RNase J2). Alternatively, as RNases often act 
redundantly, it is possible that more than one RNase can cleave at this position and therefore 
multiple RNase deletion strains, are required to identify the RNase(s) responsible for the 
processing. 
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Figure 13. RNases target the speB mRNA 5′ UTR. 
A, C and D. Total and 5′ end coverage profiles from RNA sequencing of portions of the speB 5′ UTR. The 
coverage scales are indicated between brackets. A. The grey rectangles depict the regions that were further 
analyzed. The RNA 5′ ends that correspond to RNase Y (purple scissors) and unidentified RNase(s) (grey 
scissors) processing sites are indicated with purple and grey arrowheads. A and B. Mapping of the RNA 5′ 
ends in speB 5′ UTR by primer extension analyses at early-stationary growth phase. The primers and the 
length of the expected cDNA products are shown by an arrow and green lines, respectively. The 
experiments were performed in the WT, rny (RNase Y) deletion mutant (∆rny) and chromosomal 
complemented rny deletion mutant (∆rny::rny) strains in panel A and also in the rnc (RNase III) deletion 
mutant (∆rnc), mrnC (Mini-III) deletion mutant (∆mrnC), rnhB (RNase HII) deletion mutant (∆rnhB), pnpA 
(PNPase) deletion mutant (∆pnpA), yhaM (YhaM) deletion mutant (∆yhaM), rnr (RNase R) deletion mutant 
(∆rnr) and rnjA (RNase J1) conditional mutant (PtetrnjA) strains in panel B. The latter strain was grown in 
the absence or presence of anhydrotetracycline hydrochloride (AHT), used at a final concentration of 0.1 
ng/µL. The results of one representative primer extension analysis (n>3) are shown. S.M. contributed in 
production of the replicates of the primer extension analysis in the different RNase deletion mutants.  C. 
Zoom on the RNase Y processing sites at – 131 and – 137 nt relative to the speB start codon validated by 
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primer extension analyses using a sequencing ladder. The two cleavage sites are located after a guanosine 
(G). D. Zoom on the processing site(s) of unidentified RNase(s) located at – 78/79 nt from speB start codon. 
 
In light of the re-annotation of speB transcript 5′ ends, we concluded that the t3, t4 and t5 
transcript isoforms derived from RNase Y processing of the t1 and t2 transcripts. In particular, the 
t3 transcript isoforms corresponded to the processed RNAs upstream of the RNase Y cleavage in 
the speB mRNA 5′ UTR (Figure 14 and Figure 8B). Instead, the t4 and t5 isoforms corresponded 
to the processed RNA downstream of the RNase Y cleavage site(s) (Figure 14 and Figure 8C). The 
t5 isoforms that was detected in the ∆rny strain (Figure 8C) could be generated by the unidentified 
RNase(s) processing the speB 5′ mRNA UTR (Figure 14). 
 
Figure 14. speB transcript isoforms detected by Northern blot analyses. 
Total and 5′ end coverage profiles from RNA sequencing of speB and downstream genes. The coverage scale 
is indicated between brackets. speB 5′ UTR comprises small putative ORFs: SPy_2040, orf-2 and the SpeB 
inducing peptide (SIP). The predicted transcriptional start sites and terminators are depicted in black. speB 
   
 
   
    
Results 76 
is co-transcribed together with SPy_2038 and prsA as previously described331. The processing positions of 
RNase Y and unidentified RNase(s) are indicated with purple and grey arrowheads, respectively. The labelled 
oligonucleotide probes binding to the speB 5′ untranslated region (5′ UTR) (in Figure 8B) and to the speB 
coding DNA sequence (CDS) (in Figure 8C) for the Northern blot analysis (NB probes) are depicted by 
black arrows below the loci representation. The transcripts that were detectable or undetectable are indicated 
by black and grey curved lines, respectively. The expected sizes in nucleotides (nt) are reported for each 
transcript isoform. 
 
3.2.4 Mutation of the G downstream of the RNase Y cleavage sites in speB 
mRNA 5′ UTR impedes RNase Y processing  
We observed that the majority of the RNA 5′ ends produced by RNase Y were mapped 
after a G (Figure 11F), as also described in S. aureus160, and that RNase Y cleavage sites specifically 
located in the speB mRNA 5′ UTR occurred as well downstream of a G (Figure 13C). The role of 
this nucleotide in RNase Y target recognition remains unknown. To explore whether the G is 
required for RNase Y processing in vivo, speB 5′ UTR and CDS were cloned under the control of a 
constitutive promoter on a plasmid, which was transformed in a speB (SpeB) deletion mutant 
(∆speB) strain (Figure 15). The Gs found upstream of the RNase Y processing positions at − 137 
nt and – 131 nt from the speB start codon were named G1 and G2, respectively. These nucleotides 
were individually or simultaneously substituted into A (Figure 15). Additionally, deletions of 10 or 
20 nt upstream and downstream of the RNase Y cleavages were also performed, including the 6 nt 
between the two cleavage sites (∆26 and ∆46 nt) (Figure 15). Primer extension analysis was used 
to assess the impact of these mutations on RNase Y activity in the speB mRNA 5′ UTR. (Figure 
15). The usage of a ∆speB strain and of a primer targeting the speB CDS in the primer extension 
analysis, ensures to detect the processing sites occurring on the speB mRNA transcribed from the 
plasmid and not from the bacterial genome. The replacement of G1 by A1 strongly impaired 
RNase Y processing at − 137 nt position (Figure 15; lanes 2 and 5). In contrast, the substitution of 
G2 with A2 completely abolished the processing by RNase Y (Figure 15; lanes 4 and 5). Interestingly, 
when G1 was substituted by A1, an alternative processing site was observed around 2 nt upstream 
of the cleavage site at – 137 nt (Figure 15; lanes 3 and 5). Sequence analysis of the speB mRNA 
5′ UTR revealed that a G is located 2 nt upstream of the processing at − 137 nt position (Figure 
15; see box alternative processing sites). Other alternative processing sites were identified when 10 
nt both upstream and downstream of the RNase Y processing positions were deleted (Figure 15; 
lane 6). These cleavages were mapped approximately 115 nt and 116 nt upstream of the speB start 
codon and they were also detectable when both the G1 and G2 were mutated in A (Figure 15; lanes 
3, 4 and 5). Of note, a G was also identified at both the − 115 nt and − 116 nt positions, in the 
speB mRNA 5′ UTR (Figure 15; see box alternative processing sites). The observation that the 
alternative cleavage sites likely mapped at a G led to the hypothesis that also these processing 
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events are performed by RNase Y. This would suggest that, in the absence of the canonical 
processing site, RNase Y is able to target the speB mRNA 5′ UTR and to cleave at different Gs 
located upstream or downstream of the original RNase Y processing sites. However, this 
hypothesis awaits further evidence, since it is possible that other endoRNase(s) cleave the speB 
mRNA 5′ UTR when the processing sites of RNase Y are disrupted. To evaluate whether RNase Y 
is responsible for the alternative processing sites, these experiments should be performed in the 
double deletion mutant ∆speB∆rny strain. Nonetheless, in this condition, RNase(s) that act 
redundantly could replace RNase Y activity complicating the analysis of the alternative processing 
site origin. Finally, no processing events were identified when 20 nt were deleted upstream and 
downstream of the RNase Y cleavage sites, respectively (Figure 15; lane 7). Therefore, these 
deletions likely perturbed the speB mRNA 5′ UTR such that RNase Y and/or other endoRNase(s) 
were unable to cleave it. 
 
Figure 15. RNase Y requires a guanosine upstream of the processing site to cleave speB mRNA. 
Mutational study to assess the importance of the G located upstream of the RNase Y processing sites in the 
speB mRNA 5′ UTR. The primer extension analyses were performed at early-stationary growth phase in the 
speB (SpeB) deletion mutant (∆speB) strain, which was transformed with different plasmids, schematically 
represented in each of the boxes. The plasmids contain the speB 5′ UTR and CDS under the control of the 
constitutive promoter PgyrA (see Material & Methods). An empty vector was used as a control in lane n° 1. 
The Gs upstream of the cleavage sites at – 131 nt and (G1) – 137 nt (G2) were mutated into adenosine (A) 
(lines n° 2, 3, 4 and 5). Alternatively, 10 or 20 nt were deleted upstream and downstream of the RNase Y 
processing sites, including the 6 nt between the two RNase Y processing positions (lines n° 6 and 7). The 
primer used in the experiments is shown in black and binds at the beginning of the speB CDS. The results 
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of one representative primer extension analysis (n=3) are shown. The purple arrowheads depict the 
RNase Y cleavage positions and the light purple arrowheads depict the alternative processing sites detected. 
The box named “alternative processing sites” contains a representation of the speB 5′ UTR with the 
nucleotide sequence from – 145 nt to – 110 nt relative to speB start codon and the annotated alternative 
processing sites.  
 
Overall, these results demonstrated that the G upstream of the RNase Y cleavage sites is 
crucial for RNase Y processing in S. pyogenes and validated the finding of the genome-wide mapping 
of RNase Y cleavage sites, in which the G upstream of most of the 5′ rny_ends was predicted to be 
important for RNase Y activity. On the contrary, RNase Y processing in S. aureus was shown to 
depend on secondary structure elements 6 nt downstream the processing site169. Therefore, we next 
proceeded to investigate the presence of structured RNA regions in proximity of the RNase Y 




Figure 16. Prediction of RNA secondary structures in the speB mRNA 5′ UTR. 
A. Prediction of secondary structures surrounding the RNase Y cleavage sites in the speB mRNA 5′ UTR. 
The minimum free energy (∆G in kcal mol-1) was calculated with a 50 nt sliding window, both 100 nt 
upstream and downstream of the RNase Y cleavage site at 137 nt before the speB start codon. RNase Y 
(purple scissors) and unidentified RNase(s) (grey scissors) processing sites are indicated. The ∆G calculation 
was conducted by T.T.R with A.L.R and L.B. B. Prediction of the RNA folding of a region of speB mRNA 
5′ UTR performed with RNAfold (see Material & Methods). The free energy of the thermodynamic 
ensemble is – 31.48 kcal/mol. The speB ribosome binding site (RBS) and the speB start codon are indicted. 
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The cleavage positions by RNase Y and unidentified RNase(s) are depicted by purple and grey scissors, 
respectively. The RNA folding color-scheme is shown on the right. For unpaired regions the colour 
represents the probability of being unpaired. 
 
At the RNase Y processing sites in speB mRNA 5′ UTR, an increase of the minimum free energy 
(∆G) was observed compared to the surrounding regions (Figure 16A). This is in accordance with 
the observation that RNase Y cleaves ssRNA regions, as described for the total 5′ rny_ends mapped 
in S. pyogenes (Figure 11D). A decrease of the ∆G was observed between 40 and 50 nt downstream 
of the RNase Y processing sites, indicative of a putative RNA structure (Figure 16A, B). Due to 
the distance of this putative RNA structure from the RNase Y processing in speB mRNA 5′ UTR, 
we exclude that the 6 nt ruler and cut mechanism suggested for RNase Y in S. aureus169 and 
B. subtilis119 is applicable in S. pyogenes, at least for the speB mRNA processing. 
 
3.2.5 RNase Y produces putative sRNA(s) from speB mRNA 5′ UTR 
A previous RNA sequencing analysis performed in our laboratory uncovered a putative 
sRNA (Spy_sRNA1699993) expressed from the speB mRNA 5′ UTR, which I will refer to as speB-
sRNA in this thesis359 (Figure 17A). Interestingly, the speB-sRNA 5′ end corresponded to the 
RNase Y processing position at –137 nt relative to speB start codon. Therefore, it is possible that 
the speB-sRNA biogenesis relied on RNase Y activity in the speB mRNA 5′ UTR (Figure 17A). 
According to the previous annotation, the speB-sRNA 3′ end would coincide with the processing 
of the unidentified RNase(s), resulting in an approximately 59 nt long-sRNA359. However, the 
maximal length of the reads in this previous study was 85 nt, therefore the RNA 3' ends of longer 
RNAs could not be determined accurately. Here, the new RNA sequencing data revealed that the 
speB-sRNA 3' end is likely located downstream of the processing event by the unidentified 
RNase(s), at – 27/– 28 nt from the speB start codon, thus the speB-sRNA is approximately 110 nt 
long (Figure 17A). Consequently, the processing by the unidentified RNase(s) is located between 
the speB-sRNA 5' and 3' ends. The speB-sRNA 5' and 3' ends were validated by circularization of 
the RNA after self-ligation followed by reverse transcriptase-polymerase chain reaction (Figure 
17B and see Materials & Methods). Most of the self-ligated products harboured the RNA 5' end at 
– 137 nt, coinciding with the first RNase Y processing site in the speB mRNA 5' UTR, and the 
RNA 3' ends were located between – 25 and – 28 nt from the speB start codon (Figure 17B; Table 
A3). The observation that the speB-sRNA 3' end did not map at one exact nucleotide, was 
consistent with the RNA sequencing data, in which several RNA 3' ends were identified at 
consecutive positions (Figure 17A). This could be indicative of the activity of a 3'-to-5' exoRNase 
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that trims the target RNA and do not stop precisely at one position, but instead on successive 
nucleotides373–375. 
The production of the speB-sRNA was analysed over growth using Northern blot analyses 
in both the WT and ∆rny strains (Figure 17C and D). The speB-sRNA generation was RNase Y-
dependent and occurred only at early-stationary growth phase (Figure 17C and D). The analysis of 
the transcript stability unveiled that the speB-sRNA accumulated over time likely because, although 
transcription was repressed by rifampicin, the speB-sRNA continued to be generated by the 
RNase Y processing of the speB mRNA 5' UTR (Figure 17C). To accurately evaluate the speB-sRNA 
stability, both transcription and RNase Y activity should be inhibited. Two speB-sRNA isoforms 
were detected using a labelled oligonucleotide probe hybridizing to the region of speB mRNA 
5' UTR between RNase Y and the unidentified RNase(s) processing sites. These two isoforms 
could correspond to the products resulting from RNase Y processing and ending at the predicted 
RNA 3' end (Figure 17A and C). When the speB-sRNA region between the cleavage site by the 
unidentified RNase(s) and the predicted speB-sRNA 3' end was probed in the Northern blot 
analysis, a 50 nt-long RNA was detected and it likely resulted from the unidentified RNase(s) 
processing (Figure 17A and D). The transcript isoforms upstream of the unidentified RNase(s) 
processing event were not observed, indicating that were likely degraded (Figure 17A and D).  
While we determined that the speB-sRNA isoform 5' ends were generated by RNase Y 
processing, the origin of the speB-sRNA 3' end is unclear. We did not find any predicted intrinsic 
terminator upstream of the speB CDS, which would explain the generation of the speB-sRNA 3' 
end. It is possible that after transcription termination further down in the speB CDS or an 
endoRNase cleavage, the RNA 3' end is processed by 3'-to-5' exoRNase(s), which would give rise 
to the mature speB-sRNA 3' end. Several attempts to overexpress the speB-sRNA from a vector, in 
which a terminator was inserted downstream of the speB-sRNA sequence, were unsuccessful as the 
production of the speB-sRNA 3' end was impaired (data not shown). This observation indicates 
that the terminator structure could interfere with the mechanism of the speB-sRNA 3' end 
generation. For instance, if the speB-sRNA 3' end would be generated by a 3'-to-5' exoRNase, as 
hypothesized above, the terminator structure could block the 3'-to-5' exoRNase trimming.  
These results indicate that a possible functional consequence of the RNase Y processing 
of the speB mRNA 5' UTR is the production of a putative sRNA, which could exert potentially a 
regulatory role in gene expression. 
 





Figure 17. Putative sRNA(s) derive from the RNase Y processing of the speB mRNA 5′ UTR. 
A. Total, 5′ end and 3′ end coverage profiles from RNA sequencing of the putative sRNA 
(Spy_sRNA1699993) previously identified in the speB mRNA 5′ UTR359, named here speB-sRNA. The 
coverage scale is indicated between brackets. The purple and grey bars denote the processing positions by 
RNase Y (purple scissors) and unidentified RNase(s) (grey scissors), respectively. The green bar denotes the 
putative sRNA 3′ end. The numbers indicate the location of the positions described above relative to the 
speB-sRNA start codon. The labelled oligonucleotide probes used in the Northern blot analyses (in panels 
C and D) and the expected detectable transcripts are shown below the locus representation. B. Simultaneous 
mapping of the speB-sRNA 5′ and 3′ ends by circularization of RNA after self-ligation followed by Reverse 
Transcriptase-Polymerase Chain Reaction (Circ-RT-PCR). On the top, schematic representation of the 
procedure (see also Material & Methods). On the bottom, the identified speB-sRNA 5′ and 3′ ends are 
reported together with the proportion of clones in which these RNA ends were mapped. The sequenced 
speB-sRNA self-ligated region is reported in Table A3. The positions are referred to the speB start codon 
(see panel A). The n.d. (not determined) indicates the cases in which the mapping of the RNA 5′ and 3′ ends 
was unsuccessful. C. and D. Study of speB-sRNA production by Northern blot analyses, the labelled 
oligonucleotide probes used and the expected detectable RNAs are reported in panel A. The arrows at the 
side of the blot indicates the bands that could correspond to the predicted speB-sRNA isoforms shown in 
panel A. The 5S rRNA was used as a loading control. The results of one representative Northern blot 
analysis (n=3) are shown. C. The speB-RNA stability was analysed at early-stationary (ES) phase of growth 
in the WT and the rny (RNase Y) deletion mutant (∆rny) strains. The minutes after stopping the transcription 
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upon addition of the rifampicin are indicated. A contrasted portion of the blot is shown below the full blot. 
D. The pattern of speB-sRNA production was analysed at early-logarithmic (EL), mid-logarithmic (ML) and 
early-stationary (ES) growth phases in the WT, ∆rny and in the chromosomal complemented rny deletion 




3.2.6 Conclusions II  
The genome-wide mapping of the RNA 5' ends produced by RNase Y revealed that RNase Y 
recognizes a G located upstream of the processing sites. We re-annotated the speB mRNA 5' UTR 
and observed that it was highly processed by RNases, including RNase Y that cleaved at two 
different locations after a G. The speB mRNA 5' UTR was used as a model target to dissect the 
importance of the G for RNase Y activity. This work demonstrates for the first time that this 
nucleotide is essential for RNase Y activity, because the substitution of the G with A either 
inhibited or strongly impaired the processing of the speB mRNA 5' UTR. It is unclear what is the 
functional consequence of the RNase Y processing on the SpeB production. We propose that 
RNase Y activity on the speB mRNA 5' UTR leads to the generation of short RNA fragments. 
From the observation that the generation of these fragments is growth phase-dependent and 
requires RNase Y, we predict that these RNA fragments might correspond to regulatory sRNA(s).   
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3.3 Determining the fate of RNase Y-targeted RNAs 
3.3.1 Mapping of RNA 3′ ends in the WT and ∆rny strains 
The cleavage by an endoRNase results in the production of two RNA products, harbouring 
at the termini the newly generated 5′ and 3′ ends, respectively. To provide a more comprehensive 
picture of the RNase Y targetome, the RNase Y-dependent RNA 3′ ends were also mapped (Figure 
18A, B and Table A4), as previously described for the RNA 5′ ends (see Figure 11 and Table A2). 
The RNA 3′ ends that were more abundant in the WT and the ∆rny::rny strains than in the ∆rny 
strain were annotated as 3′ rny_ends (Figure 18B). The abundance of 130 RNA 3′ ends depended 
on the presence of RNase Y (Table A4). As for the 5′ rny_ends, the structural and sequence context 
around the identified 3′ rny_ends were examined and strikingly, the latter harboured distinct 
characteristics compared to the former. First, a decrease in the ∆G, indicative of a structured RNA 
region, was observed upstream of the 3′ rny_ends (Figure 18C), but not for the 5′ rny_ends (Figure 
11D). Second, we did not identify a G or any other conserved sequence in proximity of the 
3′ rny_ends, by examining the sequence alignment of 10 nt upstream and downstream of the 
3′ rny_ends (Figure 18C and see Material & Methods).  
 
 
Figure 18. Mapping of the RNase Y-dependent RNA 3′ ends.  
A. Example of an RNA molecule which is processed by RNase Y (scissors) producing a new RNA 3′ end 
detectable in the WT strain but not in the rny (RNase Y) deletion mutant (∆rny) strain. B. Representation of 
RNA sequencing 3′ end profile. The RNA 3′ end more abundant in the WT strain and in the complemented 
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rny deletion mutant (∆rny::rny) strain than in the ∆rny strain were annotated as 3′ rny_end (purple arrowhead). 
The “UAUGAUG” represents a random sequence cleaved by RNase Y. C. Structure (on the top) and 
sequence (on the bottom) conservation of the 3′ rny_ends. The minimum free energy (∆G, in kcal/mol-1) 
was calculated at each nucleotide using a 50 nt sliding window, 100 nt upstream and downstream of the 3′ 
rny_ends. The logo was generated by aligning 10 nt each side of the 130 5′ rny_ends. The sequence and 
structure analyses at the 3′ rny_ends were conducted by T.T.R. with A.L.R, A.-L.L. and L.B. 
 
3.3.2 RNA 3′ ends produced by RNase Y are trimmed by 3-to-5′ exoRNases 
The analysis of the 3′ rny_end and 5′ rny_end positions revealed that these RNA ends were 
never mapped at consecutive nucleotides (Tables A2 and A4), suggesting that they did not derive 
from the same processing event. Based on this observation, we concluded that RNase Y processing 
always led to RNA degradation, likely performed by exoRNases, of one or both the generated RNA 
products (Figure 19A).  
The identified 3′ or 5′ rny_ends were mapped either at consecutive nucleotides or at one 
specific nucleotide (Figure 19B, Tables A2 and A4). When the rny_ends were found at successive 
nucleotides, only one position corresponding to the one with the highest proportion of ends was 
annotated (see Material & Methods) and defined as “stepped” (S)-RNA end (Figure 19B). In 
contrast, the RNA ends identified at only one nucleotide were named “unique” (U)-RNA end 
(Figure 19B). We observed that the 3′ rny_ends were predominantly S-RNA ends, while the 
5′ rny_end were in most of the cases U-RNA ends (Figure 19C, Tables A2 and A4). 
 Based on the observations that (i) the 3′ rny_ends, but not the 5′ rny_ends, were located 
downstream of a secondary structure, (ii) the conservation for the G was not observed at the 
3′ rny_ends, and that (iii) the 3′ rny_ends were mainly classified as S-RNA ends, we hypothesized 
that the 3′ rny_ends actually derived from the trimming of 3′-to-5′ exoRNase upon RNase Y 
processing (represented in Figure 19D). As mentioned before, 3′-to-5′ exoRNases, during RNA 
trimming usually do not stop at one specific position but rather in a region spanning few 
consecutive nucleotides373–375, therefore explaining the 3′ rny_ends “stepped” profile observed in 
the RNA sequencing. 
 The trimming positions of three 3′-to-5′ exoRNases: YhaM, PNPase and RNase R were 
previously identified and characterized by our laboratory in S. pyogenes204 (see Figure 29) . The RNA 
3′ ends that were more abundant in one of the three 3′-to-5′ exoRNase deletion mutant strains (i.e. 
∆yhaM, ∆pnpA or ∆rnr) than in the WT strain corresponded to the positions where the 3′-to-5′ 
exoRNases started the degradation (Figure 19E). Conversely, the RNA 3′ ends that were more 
abundant in the WT strain than in the ∆yhaM, ∆pnpA or ∆rnr strains were designated as the position 
where the 3′-to-5′ exoRNase stopped the trimming204 (Figure 19E). These available data were used 
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to study the RNA degradation initiated by RNase Y processing and performed by the three 3′-to-
5′ exoRNases.  
 
 
Figure 19. RNase Y processing initiates RNA degradation. 
A. RNase Y (scissors) processing generates two RNA products, one upstream and one downstream relative 
to the RNase Y cleavage site. The two RNA products derived from one processing events were never 
detected together. B. Representation of total and 5′ or 3′ end coverage profiles from RNA sequencing. The 
rny_ends mapping at one single position or at consecutive positions were defined as “unique” (U)-RNA 
ends or “stepped” (S)-RNA ends, respectively. C. Bar plot depicting the portion of 5′ rny_ends and 3′ 
rny_ends that were classified as U- and S-RNA ends. The analysis of the U- and S-RNA ends was performed 
by A.L.R., A.-L.L. and L.B. D. Upon RNase Y (scissors) processing, the RNA product upstream of the 
processing site is likely further trimmed by 3′-to-5′ exoRNase(s) (“pacman” symbol). E. The 3′-to-5′ 
exoRNases (PNPase, YhaM and RNase R) trim the RNA 3′ end from the start position (corresponding to 
the 3′ end present in the ∆exornase, green arrowhead) to the stop position (corresponding to the 3′ end 
present in the WT strain, red arrowhead). The RNA 3′ ends produced by 3′-to-5′ exoRNases in S. pyogenes 
were previously identified by our laboratory204. 
 
3.3.3 PNPase and YhaM trim the RNA products upon RNase Y processing 
To explore whether the identified 3′ rny_ends derived from trimming of the 3′-to-5′ 
exoRNases, as hypothesized above, the RNase Y targetome was compared with the PNPase, YhaM 
and RNase R targetomes204. In other words, the genomic locations of the 3′ rny_ends were 
compared with the ones of the 3′-to-5′ exoRNase trimming start and stop positions, previously 
identified (Figure 20, see Materials & Methods). This comparative analysis revealed that 58% of 
the annotated 3′ rny_ends corresponded either to 3′-to-5′ exoRNase trimming start or stop 
positions, with most of the trimming positions resulting from PNPase activity (Figure 20A). 
Although the remaining 42% was not associated to any trimming position (Figure 20A), this 
portion of 3′ rny_ends was also likely subjected to 3′-to-5′ exoRNase activity, as no preference for 
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a G was observed at the 3′ rny_ends. It is possible that either these 3′ rny_ends were trimmed by 
several 3′-to-5′ exoRNases acting redundantly or that they were targeted by other unidentified 3′-
to-5′ RNases 
 
Figure 20. PNPase and YhaM trim the RNAs processed by RNase Y. 
A.  The bar plot on the top shows the portion of RNA 3′ ends (3′ rny_ends) that: (i) were not associated to 
3′-to-5′ exoRNase processing positions (top in white), (ii) corresponded to the 3′-to-5′ exoRNase trimming 
stop positions (middle in red) and (iii) corresponded to the 3′-to-5′ exoRNase trimming start positions 
(bottom in green). The bar plots at the bottom show the portions of trimming stop (on the right) and 
trimming start (on the left) corresponding to 3′ rny_ends, which were generated by one 3′-to-5′ exoRNase 
(PNPase, YhaM or RNase R) or dependent on two 3′-to-5′ exoRNases. B. and D. The 3′ rny_ends, from 
the RNase Y targetome, were compared with the 3′-to-5′ exoRNase trimming stop (right) and start (left) 
positions. RNA-seq: schematic representation of the 3′ end coverage profile from RNA sequencing; 
Comparison: RNA ends were included in the comparative analysis. The RNA ends more abundant in the 
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WT strain than in the rny (RNase Y) deletion mutant (∆rny) strain are depicted with purple arrowheads (3' 
rny_ends) and the 3'-to-5' exoRNase trimming start and stop positions are indicated with green and red 
arrowheads, respectively (see Figure 19). The targetome comparisons were performed by T.T.R. and the 
analyses were conducted by L.B, A.L.R, and A.-L.L. B. The 3' rny_ends corresponded to the 3′-to-5' 
exoRNase trimming stop positions (Table A5). Model: the 3'-to-5' exoRNase starts trimming the target 
RNA at the RNase Y initial processing position and stops before the RNA termini. D. The 3' rny_ends 
corresponded to 3'-to-5' exoRNase trimming start positions (Table A6). Model: a 3'-to-5' exoRNase digests 
the RNAs cleaved by RNase Y. A subset of the 3'-to-5' exoRNase start positions is detectable in the WT 
strain, suggesting the 3'-to-5' exoRNase does not degrade the whole pool of RNAs. C. Alignment of the 
sequences 10 nt upstream and downstream of the 19 trimming start positions identified downstream of the 
3' rny_ends corresponding to the PNPase trimming stop positions. The sequence alignment around the 
PNPase trimming start positions was executed by L.B. and A.L.R. 
 
The comparative analysis of the 3′ rny_ends with the trimming stop positions revealed the 
RNAs that were processed by RNase Y and subsequently trimmed by a 3′-to-5′ exoRNase, which 
stopped the degradation before the RNA 3′ terminus (Figure 20A, B and Table A5). In few cases, 
the RNAs were trimmed by more than one 3′-to-5′ exoRNase, either by YhaM and RNase R or by 
YhaM and PNPase (Figure 20A and Table A5). 
Since these 3′ rny_ends corresponded to the position where the 3′-to-5′ exoRNase stopped 
digesting the RNAs we searched for the trimming positions that should coincide with the initial 
RNase Y processing event (Figure 20B). Therefore, to provide a more accurate annotation of the 
RNase Y processing sites, we inspected the trimming start positions located downstream of the 
3′ rny_ends corresponding to the trimming stop positions (Figure 20B and Table A6). We identified 
19 and 5 trimming start positions of PNPase and YhaM, respectively (Table A6). From the 
alignment of the sequences surrounding the 19 trimming start positions, we observed a preference 
for a G in proximity of the PNPase start positions (Figure 20C and Table A6). From this 
observation we deduced that the location where PNPase started the trimming could correspond to 
the initial RNase Y processing site. Nine of these trimming start positions were not found exactly 
at a G, but 1 or 2 nt before. It is possible that this shift from the G was a consequence of YhaM 
trimming, which removes on average 3 nt from the 3′ ends of the majority of all the RNAs in 
S. pyogenes. For YhaM, 4 trimming start positions were identified at a G (Table A6) and one was 
mapped at an A, which coincided to a PNPase stop position in SPy_0316 (Tables A5 and A6) 
which will be further analysed in section 3.3.4. 
 The comparison analysis described above allowed to identify the RNAs cleaved by 
RNase Y and already trimmed by 3′-to-5′ exoRNase. Next, to detect the RNAs which were not yet 
targeted by a 3′-to-5′ exoRNase, the 3′ rny_ends were compared to the 3′-to-5′ exoRNase trimming 
start positions and we identified six and two 3′ rny_ends corresponding to PNPase and YhaM 
trimming start positions, respectively (Figure 20A and D, Table A7). Although, these RNA 3′ ends 
were targeted by the 3′-to-5′ exoRNases, they were still detectable in the WT strain, suggesting that 
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a subset of each RNA was not degraded yet by the 3′-to-5′ exoRNases. PNPase trimming start 
positions were either perfectly matching the 3′ rny_ends, located after a G, or they were few 
nucleotides apart (Figure 21A). In the latter case, PNPase start positions were mapped after a G, 
thus likely pinpointing the initial RNase Y cleavage position. For some of the RNAs (rofA, 
SPy_sRNA482963, ezrA and htrA), the 3′ rny_ends and PNPase trimming start positions were at 
the RNA termini of previously observed decay intermediate fragments, which were completely 
degraded by PNPase204 (Figure 21A). Instead, the 3′ rny_ends and PNPase trimming start in rpsU 
and in the intergenic region between Spy_sRNA1696464 and Spy_sRNA1696905 did not 
correspond to the 3′ termini of decay intermediate fragments. In these cases, the PNPase trimming 
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Figure 21. RNase Y-dependent RNA 3′ ends correspond to PNPase or YhaM trimming starts. 
A. and B. RNA 3′ end profiles from RNA sequencing in WT, rny (RNase Y) deletion mutant (∆rny) and 
pnpA (PNPase) deletion mutant (∆pnpA) strains and in panel B also in the yhaM (YhaM) deletion mutant 
(∆yhaM) strain, showing the 3′ rny_ends corresponding to PNPase (in panel A) or YhaM (in panel B) 
trimming start positions (see Figure19D). The coverage scales are indicated between brackets. As both the 
3′ rny_end and the 3′-to-5′ exoRNase trimming start positions were present in the WT strain, we deduced 
that not all the RNA 3′ ends were targeted by the 3′-to-5′ exoRNases (green “pacman” symbols). The 3′ 
rny_ends were often the RNA termini of decay intermediate fragments. The fragment 5′ ends were produced 
by RNase Y (purple scissors) or by an unidentified endoRNase (grey scissors). For the RNAs targeted by 
YhaM, the trimming stop positions were not identified. However, downstream of the 3′ rny_ends matching 
the YhaM trimming start positions, we observed, by manual screening, RNA 3′ ends which were more 
abundant in the WT strain than in the ∆yhaM strain, suggesting that these 3′ ends could correspond to 
putative YhaM stop positions not retrieved by the bioinformatic analysis used to identify the RNase 
processing sites. 
 
stop positions were not identified and the RNAs were likely fully degraded by this exoRNase 
(Figure 21A). The two YhaM trimming start positions were located at an A, 1 or 3 nt upstream of 
the 3′ rny_ends. The locations where YhaM stopped the trimming of these two RNAs were not 
identified (Figure 21B). However, by manual screening we observed upstream of the YhaM 
trimming start positions RNA 3′ ends which were more abundant in the WT strain than in the 
∆yhaM strain, indicating that these RNA 3′ ends could correspond to putative YhaM trimming stop 
positions that were not identified in the previous analysis204 (Figure 21B).  
 
3.3.4 RNA structures protect RNase Y targets from PNPase degradation 
Based on the comparative analysis of the 3′ rny_ends with the trimming stop positions, we 
could observe that upon RNase Y processing the RNA target was incompletely degraded by a 3′-
to-5′ exoRNase. As mentioned already, YhaM trims on average 3 nt after terminator regions or 
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after endoRNase processing204, explaining the incomplete degradation observed for the RNAs 
targeted by RNase Y and subsequently trimmed by YhaM (Figure 20A and B). To elucidate the 
reason why PNPase stopped trimming the RNAs produced by RNase Y, we inspected for 
secondary RNA structures (see Material & methods) that could resist the enzyme 
exoribonucleolytic activity. We first compared the ∆G upstream of the RNase Y-depending RNA 
3′ ends that corresponded or not to PNPase stop positions (Figure 22A). As previously observed 
for the total 3′ rny_ends (Figure 18C), the sequences upstream of both the 3′ rny_ends trimmed and 
not trimmed by PNPase were structured. However, the decrease in ∆G upstream of the 3′ rny_ends 
trimmed by PNPase was stronger than the one observed before the 3′ rny_ends not targeted by this 
exoRNase, suggesting that the structures before these 3′ RNA ends, trimmed by PNPase, were 
more stable (Figure 22A).  
 
Figure 22. PNPase degrades the RNAs after RNase Y processing until secondary structures. 
A. and B. Structure conservation analysis by calculating the minimum free energy (∆G in kcal mol-1) in a 
window of 200 nt around the positions of interest. A. Structure conservation at the 3' rny_ends not 
corresponding to PNPase trimming stop positions (n=84) and at the 3' rny_ends corresponding to PNPase 
trimming stop positions (n=46). Upon RNase Y processing, PNPase degrades the RNA up to a putative 
secondary structure. B. Structure conservation at the total number of PNPase trimming stop positions 
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(n=183), which were previously identified in our laboratory204. The structure analyses were conducted by 
T.T.R. with A.L.R, A.-L.L. and L.B. 
 
Next, we analysed the ∆G upstream and downstream of the total PNPase trimming stop 
positions, which were previously identified by our laboratory in S. pyogenes204, using RNAfold 
(Figure 22B and see Material & Methods). We observed a decrease in ∆G just upstream of the total 
PNPase trimming stop positions identified, implying the presence of stable RNA structure (Figure 
22B). It is possible that such structure could have a role in blocking PNPase degradation as already 
described for other bacteria in vitro99,374,376. In the previous study from our laboratory in S. pyogenes, 
the analysis of the average ∆G upstream of the total PNPase trimming stop positions did not reveal 
the presence of stable structures204, in contrast to the current observation. This can be explained 
by the different window size parameter used in this analysis (see Material & Methods). In the 
aforementioned study, structures corresponding to terminator stem-loops were identified using a 
window size of 25 nt204. Here, larger and weaker structures than terminator stem-loops were 
identified by using a larger window size (50 nt) compared the one previously used. 
In some cases, the 3′ rny_ends, which corresponded to a PNPase trimming stop position, 
also correspond to an YhaM trimming stop position, as observed in the SPy_0316 ORF (coding 
for a putative transcriptional regulator) and in the intergenic region between the Spy_sRNA73113 
and rplO (coding for the 50S ribosomal protein L15) (Figure 23A and B). PNPase started degrading 
the Spy_sRNA73113 and rplO target RNAs at a G, corresponding to the initial RNase Y processing 
positions, located 34 or 120 nt upstream of the predicted trimming stop position, respectively. 
(Figure 23C and D). PNPase degraded the transcript until stem-loop structures which were 
predicted in both the targets, downstream of the trimming stop positions (Figure 23E and F). As 
suggested by the global prediction of RNA structures upstream of the total PNPase trimming stop 
position (Figure 22B), these RNA stem-loops could prevent PNPase degradative activity. 
We also observed that YhaM trimmed these targets and while the trimming stop positions 
coincided with the ones of PNPase, the YhaM trimming start position was not detectable in the 
∆pnpA strain, indicating the YhaM activity on these targets required PNPase. Thus, YhaM likely 
trimmed the RNA 3′ end that was generated by the preceding PNPase trimming. This result 
indicates that YhaM also trims RNA 3′ ends produced by other exoRNases besides the RNA 
3′ ends deriving from endoRNase processing or transcription termination. In the case of 
Spy_sRNA73113 and rplO intergenic region, the YhaM trimming stop position coincides with the 
previously identified 3′ end of the Spy_sRNA7311359, for which a terminator was not predicted. It 
is possible that the subsequent trimming of PNPase and YhaM, until the predicted stem-loop 
structure, is involved in the generation of the Spy_sRNA7311 3′ end. 
   
 
   




Figure 23. Subsequent trimming of PNPase and YhaM after RNase Y processing. 
A and B. Total coverage profiles in the WT strain obtained from RNA sequencing and schematic 
representation of genomic loci: SPy_0316 encoding a putative transcriptional regulator (in panel A) and the 
intergenic region between the putative sRNA Spy_sRNA73113 and rplO encoding the 50S ribosomal 
protein L15 (Spy_sRNA73113 ↔ rplO) (in panel B). The grey boxes highlight the regions where the 
processing positions of RNase Y, PNPase and YhaM were identified. C and D. On the top, 3' coverage 
profiles of SPy_0316 and Spy_sRNA73113 ↔ rplO in the WT, rny (RNase Y) deletion mutant (∆rny), pnpA 
(PNPase) deletion mutant (∆pnpA) and yhaM (YhaM) deletion mutant (∆yhaM) strains. The coverage scale 
is indicated between brackets. On the bottom, processing sites detected (3' rny_ends, trimming start 
positions, trimming stop positions depicted with purple, green and red arrowheads, respectively) are 
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indicated together with a schematic representation of the PNPase and YhaM (“pacman” symbols) trimming 
upon RNase Y (scissors) processing. For both the examples, RNase Y processed the transcripts at a 
guanosine (G), which corresponded to the location where PNPase started digesting these targets. PNPase 
stopped the trimming after 34 nt and 120 nt in SPy_0316 and Spy_sRNA73113 ↔ rplO, respectively. The 
RNA 3' ends generated by PNPase were then targeted by YhaM that subsequently trimmed few nucleotides. 




3.3.5 Short RNA fragments are produced by RNase Y and eventually 
trimmed by PNPase and/or YhaM 
Several 3′ rny_ends, targeted by PNPase and/or YhaM, corresponded to the RNA termini 
of fragments generated by RNase Y (Table A8). These RNA fragments were identified by 
comparing the nucleotide position of the 5′ rny_ends and 3′ rny_ends (Figure 24A, B and Table A8).  
 
Figure 24. Short fragments are produced by RNase Y and trimmed by PNPase and YhaM. 
A. Representation of total, 3' and 5' end coverage profiles from RNA sequencing in the WT and rny 
(RNase Y) deletion mutant (∆rny) strains of short RNA fragments whose termini (5' rny_end and 3' rny_end) 
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production depends on RNase Y (Table A8). B. Comparison of 5' rny_end and 3' rny_end location, with a 
minimum and maximum distance set at 40 and 1000 nt, respectively. The paired 5′ rny_ends and 3' rny_ends 
are depicted as dots. The analysis of the RNA fragments produced by RNase Y was performed by L.B. and 
A.-L.L. C. Structure conservation analysis at the total transcript fragment 3' ends (n=52, top), at the 
transcript fragment 3' ends that did not correspond to any 3'-to-5' exoRNase trimming stop positions (n=31, 
left) and at the transcript fragment 3' ends targeted by 3'-to-5' exoRNases (n=21, right). The minimum free 
energy (∆G in kcal mol-1) was calculated 100 nt upstream and downstream of the positions of interest with 
a sliding window of 50 nt. The structure analyses were conducted by T.T.R. with A.L.R, A.-L.L. and L.B. 
Below the ∆G graphs, schematic representation of the fragment production and subsequent trimming by 
3'-to-5' exoRNase (“pacman” symbol). RNase Y (scissors) generates the transcript fragment 3' and 5' end. 
In some cases, PNPase and/or YhaM further trim the fragment 3' end. 
 
The paired 5′ rny_ends and 3′ rny_ends were mainly found at 50 to 200 nt of distance, when 
allowing for a maximal separation of 1000 nt between the two rny_ends (Table A8). We observed 
that 60% of the fragment 3′ ends were subjected to 3′-to-5′ exoRNase trimming by PNPase and/or 
YhaM (Table A8). It is possible that the remaining 40% of fragment 3′ ends were (i) trimmed but, 
the 3′-to-5′ exoRNases trimming positions were not identified in our analysis, (ii) trimmed by other 
exoRNases (iii) not trimmed at all. In all the cases, by analysing the ∆G around the fragment 3′ 
ends we observed a drop in ∆G upstream of the 3′ rny_ends, indicating that the 3′ fragment region 
was structured (Figure 24C). During RNA decay, the endoRNase-generated RNA fragments are 
usually rapidly degraded by exoRNases and undetectable in a WT strain. Here, the RNA fragments 
produced by RNase Y were instead present in the WT strain. The reason why these fragments were 
not completely degraded is unclear; they could correspond to decay intermediate fragments, that 
were not efficiently degraded because of the RNA structure at the fragment 3′ ends (Figure 24C). 
Alternatively, these fragments could exert a biological role and therefore they were stabilized 
because necessary in the bacterial cell. 
 
RNA fragments produced by RNase Y are specifically degraded in the absence of YhaM 
Among the fragments described above, the ones deriving from the murC (encoding the 
UDP-N-acetylmuramate-L-alanine ligase), SPy_1551 (encoding a hypothetical protein) and 
SPy_0316 (encoding a putative transcriptional regulator) mRNAs were validated by Northern blot 
analysis (Figure 25). These fragments were detected in the WT strain, but not in the ∆rny strain, 
demonstrating that their production was RNase Y-dependent. These fragments were either 
trimmed by YhaM (Figure 25A and B) or by both YhaM and PNPase (Figure 25C). The exoRNase 
trimming start positions corresponded to the initial RNase Y processing position, which could be 
identified for the fragments derived from murC and SPy_0316 mRNAs (Figure 25A and C; Table 
A8), as was previously described (see Figure 20B). Since YhaM trims on average only 3 nt at the   




Figure 25. RNase Y-generated RNA fragments are degraded in the absence of YhaM. 
Subset of fragments generated by RNase Y and trimmed by 3'-to-5' exoRNases. A-C. On the left, 3' coverage 
profile of portions of murC (encoding the UDP-N-acetylmuramate-L-alanine ligase), SPy_1551 (encoding a 
hypothetical protein) and SPy_0316 (encoding a putative transcriptional regulator) in the WT, rny (RNase Y) 
deletion mutant (∆rny), yhaM (YhaM) deletion mutant (∆yhaM) strains and also in the pnpA (PNPase) 
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deletion mutant (∆pnpA) strain in panel C. The coverage scale is shown between brackets. The 5' and 3' 
rny_ends (purple arrowheads), the 3'-to-5' exoRNase start and stop positions (green and red arrowheads) 
are indicated. RNase Y (scissors) generates both the fragment 5' and 3' ends. The fragment 3' ends were 
trimmed by YhaM or by PNPase/YhaM. On the right, Northern blot analyses of the fragments in murC, 
SPy_1551 and SPy_0316. In the WT, ∆rny, ∆yhaM, yhaM and rny double deletion mutant (∆yhaM∆rny), pnpA 
and yhaM double deletion mutant (∆pnpA∆yhaM) and rnr (RNase R) and yhaM double deletion mutant 
(∆rnr∆yhaM) strains. For the fragment in SPy_0316, the Northern blot analysis was performed also in the 
∆pnpA and in the rny and pnpA double deletion mutant (∆rny∆pnpA) strains. The labelled oligonucleotide 
probes used for the Northern blot analyses (NB probe) are shown below the loci representation and 
coverage profiles. When the fragments were poorly detectable a contrasted portion of the blot is shown. 
The 5S rRNA was used as a loading control. The results of one Northern blot analysis (n=3) are shown. In 
panel C, the star depicts an RNA not specifically recognized by the probe. K.H. contributed in generating 
the replicates of the Northern blot analyses. 
 
RNA 3′ ends, we at first expected to detect fragments that were few nucleotides longer in the 
∆yhaM strain than in the WT strain. Conversely, the fragments were not detected in the ∆yhaM 
strain by both RNA sequencing and Northern blot analyses (Figure 25A-C). We next predicted 
that these fragments were degraded by PNPase and/or RNase R in the absence of YhaM. To test 
this hypothesis the Northern blot analyses were also performed in the double deletion mutant 
∆pnpA∆yhaM and ∆rnr∆yhaM strains (Figure 25A-C). However, the fragments were also not 
detected in these strains (Figure 25A-C), suggesting that either RNase R and PNPase acted 
redundantly or that another RNase was involved in the fragment degradation.  
 
3.3.6 PNPase completely degrades the RNAs generated by RNase Y 
processing 
In the comparative analysis of the 3′ rny_ends with the 3′-to-5′ exoRNase trimming start 
and stop positions, we observed that most of the RNA 3′ ends were further trimmed upon RNase Y 
processing. The 5′ rny_ends were in 87.4 % of the cases located at G and in only 12.6% of the cases 
not mapped at a G. The RNA 5′ ends, starting at a G, likely coincides with the RNase Y processing 
positions, while the other could result from the subsequent activity of other RNase(s) (Figure 26A). 
This observation indicates that while most of the RNA 3′ ends produced by RNase Y were trimmed 
by 3′-to-5′ exoRNases, the RNA 5′ ends were not targeted by other RNases. 
As already mentioned before, after RNase Y processing either one or both the RNase Y-
generated RNA products were degraded (i.e. either the 3′ rny_end or the 5′ rny_end was detected) 
(Figure 18A). Therefore, the RNA 3′ ends produced during the same processing events responsible 
for the generation of the 190 5′ rny_end could not be identified (Figure 26A). To examine the fate 
of the undetected RNA products upstream of the 190 5′ rny_ends, the last were paired to the 3′-to-
5′ exoRNase trimming start positions that were located up to 10 nt before the 5′ rny_ends (Figure 
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26B and Table A9; see Material & Methods). We observed that 12% of the 5′ rny_ends were in 
vicinity of the PNPase trimming start positions (Figure 26B and C). 
 
 
Figure 26. PNPase degrades completely the transcripts processed by RNase Y.  
A. Representation of RNase Y (scissors) processing event generating an RNA 5' and 3' end. The two newly 
generated RNA ends were never simultaneously detected. The RNA 5' ends detected were in 87.4% located 
at a G, likely at the initial RNase Y processing site, and in 12.6% of the cases were not found upstream of a 
G suggesting that they were further processed/trimmed after the RNase Y processing event. B. 
Identification of the RNA products upstream of the RNase Y processing positions (i.e. upstream of the 
detected 5' rny_ends). The 5' rny_ends were compared with the 3'-to-5' exoRNase trimming start positions 
located at least 10 nt upstream, (see Material & Methods and Table A9). The pairing of the 5' rny_ends with 
PNPase trimming start positions was performed by T.T.R. with A.L.R, A.-L.L. and L.B. RNA-seq: 
schematic representation of the 3' and 5' end coverage profiles from RNA sequencing; Comparison: the 
RNA ends that were included in the comparative analysis are indicated. The RNA ends more abundant in 
the WT strain than in the rny (RNase Y) deletion mutant (∆rny) strain and the 3'-to-5' exoRNase trimming 
start positions are depicted with purple and green arrowheads, respectively; Model: After RNase Y 
processing, PNPase completely degrades the RNA product upstream of the RNase Y processing site. C. 
The bar plot shows the portion of RNA 5' ends (5' rny_ends) that were paired to 3'-to-5' exoRNase trimming 
start positions (bottom in green), and the portion of the 5' rny_ends which were not associated to any 3'-to-
5' exoRNase trimming start (top in white). All the 3'-to-5' exoRNase trimming start positions paired to 5' 
rny_ends were PNPase trimming starts. D. 5' and 3' end coverage profiles from RNA sequencing of portions 
of the cdd (coding for a cytidine deaminase) and bmpA (coding for a lipoprotein) ORFs and the intergenic 
region between the two genes in the WT, ∆rny and pnpA (PNPase) deletion mutant strains. The coverage 
scale is indicated between brackets. The 5' rny_end (purple arrowheads) and the PNPase trimming start 
position (green arrowheads) are indicated. RNase Y (scissors) processed the cdd-bmpA intergenic region 
subsequent targeted by PNPase (“pacman” symbol). 
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This result suggested that PNPase was responsible for the complete degradation of the RNA 
products upstream of the RNase Y processing event (Figure 26C and Table A9). The trimming 
start positions of PNPase were not identified exactly one nucleotide upstream of 5′ rny_ends, but 
these positions were in most of the cases up to 4 nt apart (Table A9). This divergence is likely due 
to the involvement of YhaM, which in general trims few nucleotides from the RNA 3′ ends. An 
example of a 5′ rny_end paired with a PNPase trimming start position was identified in the 
intergenic region between cdd (coding for a cytidine deaminase) and bmpA (coding for a lipoprotein) 
(Figure 26D). The 5′ rny_end, previously validated by primer extension analysis (Figure 11C), was 
found 3 nt upstream of a PNPase start position. Since the PNPase trimming stop position was not 
identified, we concluded that PNPase was most likely responsible for degrading completely the 
RNA containing the cdd ORF. 
The majority of the 5′ rny_ends (88%) were not paired to any PNPase trimming start 
position (Figure 26C), therefore the degradation mechanism of the RNA products upstream of the 
RNase Y processing positions was not deciphered. 
 
3.3.7 Conclusions III 
We characterized the RNase Y-dependent RNA 3′ ends and observed that they exhibit 
different characteristics from the RNA 5′ ends (e.g. lack of G conservation). Therefore, the origin 
of the RNase Y-dependent RNA 3′ ends (3′ rny_ends) was further investigated by using an RNA 
sequencing comparative approach. In most of the cases the 3′ rny_ends resulted from trimming of 
3′-to-5′ exoRNases. In particular, we concluded that PNPase is the main 3′-to-5′ exoRNase that 
acts in concert with RNase Y in RNA degradation. 
  




3.4 Investigating the role of RNase Y and PNPase interplay 
3.4.1 RNase Y and PNPase allow differential RNA stability of the rsmC-cdd 
and bmpA RNAs 
Based on the previous observation that RNase Y and PNPase targeted the cdd-bmpA 
intergenic region (Figure 26), we further explored the role of both RNases on the post-
transcriptional regulation of the cdd and bmpA mRNAs. The cdd and bmpA genes are part of a longer 
operon including rsmC (coding for a 16 rRNA methyltransferase), SPy_1227, SPy_1226 and 
SPy_1225 (coding for a sugar ABC transporter) (Figure 27A). To explore the effect of RNase Y 
and PNPase activity in the cdd-bmpA intergenic region, rifampicin assays followed by Northern blot 
analyses were performed with labelled oligonucleotide probes targeting cdd (Figure 27B) and the 
bmpA mRNAs (Figure 27C). Transcription driven from the rsmC promoter to the predicted 
transcriptional terminator downstream of the bmpA ORF led to the production of a ~ 2900 nt long 
primary transcript that was highly stabilized in the ∆rny strain compared to the WT strain (Figure 
27A and B). The increased stability of the primary transcript in the ∆rny strain is explained by the 
fact that RNase Y cleaved this transcript in the UTR between cdd and bmpA, as previously 
demonstrated (Figure 26). RNase Y activity generated a ~ 1700 nt RNA product upstream of the 
processing site, which comprises the rsmC and cdd ORFs (Figure 27A and B). This RNA isoform 
was scarcely detectable in the WT strain and stabilized in the ∆pnpA strain, indicating that it was 
likely degraded by PNPase (Figure 27B). This observation suggested that RNase Y processing 
provided access to PNPase, which subsequently degraded the generated rsmC-cdd RNA isoform. 
Contrary to the latter isoform, the stability of the ~ 1200 nt bmpA RNA isoform, coinciding with 
the RNA product downstream of the RNase Y processing site, did not vary between the WT and 
∆pnpA strains and its half-life was higher than the one of the rsmC-cdd RNA isoform (Figure 27A 
and C). These results provided evidence that RNase Y and PNPase activity ensured the differential 
decay of the rsmC-cdd and bmpA transcripts. 
The primary rsmC-cdd-bmpA-SPy_1227-SPy_1226-SPy_1225 polycistronic transcript is also 
processed by RNase III in the intergenic region between bmpA and SPy_1227185. Two RNA 5′ ends 
produced by RNase III were annotated; one was identified bioinformatically (in blue) and the other 
by manual screening of the RNA sequencing data (in light blue) (Figure 27D). RNase III produced 
these two RNA 5′ ends by processing both sides of a stem loop, generating the characteristic 2 nt 
3′ overhang in the dsRNA products179 (Figure 27D). Deletion of rnc (encoding RNase III) led to 
the accumulation of a long transcript (> 6000 nt) corresponding to the full operon transcript 
isoform that was not detectable in the WT strain (Figure 27E). 
   
 
   





Figure 27. RNase Y and PNPase allow differential stability of co-transcribed mRNAs. 
A. Total and 5' end coverage profiles from RNA sequencing of the rsmC-cdd-bmpA-SPy_1227-SPy_1226-
SPy-1225 operon in the WT strain. The scales are indicated between brackets. Representation of the operon 
with the predicted promoters, terminators, RNase Y processing site (purple arrowhead) and RNase III 
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processing sites (blue arrowheads) that we previously identified185. The labelled oligonucleotide probes used 
in the Northern blot analyses (NB probe) and the primer used in the primer extension analysis (PE primer), 
are depicted with black arrows below the respective targeted locus. The RNA isoforms detectable by 
Northern blot analyses and processed by RNase Y (purple scissors), by RNase III (blue scissors) and 
eventually degraded by PNPase (“pacman” symbol) are represented with the expected sizes in nt. B. and C. 
Transcript stability study by Northern blot analyses, up to 45 or 8 minutes (min) after the addition of the 
rifampicin in the WT and in the rny (RNase Y) deletion mutant (∆rny) strains or in the pnpA (PNPase) 
deletion mutant (∆pnpA) strain. The 16S rRNA was used as a loading control. D. On the left: RNA folding 
of the region surrounding the RNase III processing sites (20 nt upstream and downstream of the two 
processing sites, respectively) in the untranslated region between bmpA and SPy_1227185. On the right: 
primer extension analyses in the WT and rnc (RNase III) deletion mutant (∆rnc) strains at mid-logarithmic 
growth phase. The primer extension analysis was performed with A.-L.L. E. The operon rsmC-cdd-bmpA-
SPy_1227-SPy_1226-SPy-1225 expression profile was assessed by Northern blot analysis at early-logarithmic 
(EL), mid-logarithmic phase (ML) and early-stationary (ES) growth phases in the WT, ∆rnc, ∆rny and rny 
and rnc double deletion mutant (∆rny∆rnc) strains. The transcript stability was analysed at mid-logarithmic 
phase of growth in the WT, ∆rny and ∆rnc strains. The 16S rRNA was used as a loading control. The results 
of one representative Northern blot analysis (n=3) are shown. 
 
Therefore, it is likely that RNase III cleaved the readthrough RNAs after the rcmC-cdd-bmpA 
terminator, separating the SPy_1227-SPy_1226-SPy_1225 RNA isoform from the rsmC-cdd-bmpA 
RNA isoform, which was cleaved by RNase Y. 
 
3.4.2 RNase Y produces short decay intermediate fragments rapidly 
degraded by PNPase 
As described in the introduction, RNA degradation is usually initiated by an endoRNase 
processing that leads to the production of decay intermediate fragments normally degraded by 
exoRNases and therefore not detectable in the WT strain. It was shown in S. pyogenes that PNPase 
is involved in the degradation of 185 decay intermediate fragments of 50 to 200 nt in length204. The 
sequence around these fragment 3′ and 5′ ends was analysed (Figure 28A). Strikingly, we observed 
the conservation of a G just upstream of the decay intermediate fragment 5′ ends (i.e. RNA ends 
more abundant in the ∆pnpA strain than in the WT strain and named 5′ ∆pnpA_ends) (Figure 28A). 
Therefore, we deduced that RNase Y was responsible for the production of most of these decay 
intermediate fragment 5′ ends. To support this hypothesis, two decay intermediate fragments 
(produced from pyrH and SPy_2197 mRNAs) were examined by Northern blot analyses in the WT, 
∆rny, ∆pnpA and ∆rny∆pnpA strains (Figure 28B and C). The decay intermediate fragments were 
detectable in the ∆pnpA strain but not in the ∆pnpA∆rny strain (Figure 28B and C). This result 
confirms that RNase Y participates in the generation of the decay intermediate fragment 5′ ends. 
We did not observe any G conservation at the decay intermediate fragment 3′ ends suggesting that 
they could originate from the processing of an unidentified endoRNase or from RNase Y cleavage 
and subsequent trimming by a 3′-to-5′ exoRNase. 
   
   
 
   




Figure 28. PNPase degrades decay intermediate fragments generated by RNase Y. 
A. Alignment of the sequences around the RNA 5' and 3' ends of decay intermediate fragments (n=185) 
that were previously identified only in the ∆pnpA strain204. The fragment 5' end, which is more abundant in 
the ∆pnpA strain than in the WT strain, is indicated as 5' ∆pnpA_end. Below the sequence alignments 
(conducted with T.T.R, A.L.R. and A.-L.L.) a schematic representation of the fragment 5' and 3' ends 
generation and degradation is depicted. B and C. On the left, total coverage profile from RNA sequencing 
of the decay intermediate fragments identified in pyrH-frr and in SPy_2197, the coverage scales are reported 
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between brackets. The 5' ∆pnpA_end and the PNPase trimming start positions are indicated with green 
arrowheads. RNase Y (purple scissors) and an unidentified endoRNase (grey scissors) generate a decay 
intermediate fragment subsequently degraded by PNPase. The labelled oligonucleotide probe (NB probe) 
used in the Northern blot analyses and the predicted size of the fragments are shown. On the right, Northern 
blot analyses in the WT, rny (RNase Y) deletion mutant (∆rny), pnpA (PNPase) deletion mutant (∆pnpA) and 
in the pnpA and rny double deletion mutant (∆rny∆pnpA) strains at mid-logarithmic growth phase. When the 
fragment was poorly detectable, a contrasted region of the blot is shown. The 5S rRNA was used as a 
loading control. The results of one representative Northern blot analysis (n=3) are shown. Northern blot 
analyses were performed together with K.H. 
 
3.4.3 Decay of 5′ regulatory elements depends on the concerted action of 
RNase Y and PNPase 
We further analysed the decay intermediate fragments produced by RNase Y and degraded 
by PNPase and we observed that they often derived from the processing of regulatory RNA 5′ 
UTRs (e.g. T-boxes and riboswitches) (Figure 29). A role for PNPase in the degradation of decay 
intermediate fragments deriving from 5′ regulatory elements was previously reported by our 
laboratory204. (Figure 29A). In the thiamine pyrophosphate riboswitch (TPP) a 3′ rny_end coinciding 
with a PNPase trimming start position was identified (Figure 29A and Table A7). This RNA 3′ end 
corresponded to the 3′ termini of a decay intermediate fragment that was already identified in the 
TPP riboswitch204. This fragment was detectable in the ∆pnpA strain, indicating that it was degraded 
by PNPase as previously shown204, but was not present in the ∆rny∆pnpA strain, suggesting that 
the fragment generation was depending on RNase Y (Figure 29A). Therefore, the decay of the TPP 
riboswitch occurred through the endoribonucleolytic processing of RNase Y, which generated an 
RNA 3′ end targeted by PNPase. The fragment 5′ end, which was originally identified as a 5′ end 
more abundant in the ∆pnpA strain than in the WT strain (5′ ∆pnpA_end), was likely generated by 
an unidentified endoRNase. 
RNase Y also processed the serS, SPy_1570_SPy_1569_valS and thrS 5′ UTRs, generating 
the RNA 3′ end of the decay intermediate fragment, whose 5′ end coincided with the regulatory 
element TSS (Figure 29B-D). We did not identify any PNPase trimming start position in the 5 nt 
upstream of the 3′ rny_ends in the T-boxes serS and valS (Table A7 and see Material & Methods). 
However, based on the Northern blot analysis results we concluded that the decay intermediate 
fragments originating from serS and valS 5′ UTRs were degraded by PNPase (Figure 29B and C). 
To pinpoint the PNPase trimming start positions, we extended the search to 1000 nt upstream of 
the 3′ rny_ends (see Material & Methods) and we identified a PNPase trimming start position that 
coincides with RNase Y processing site in both serS and valS (Figure 29B and C). Indeed, the length 
of the serS and valS decay intermediate fragments detectable by Northern blot analysis in the 
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∆rny∆pnpA strain corresponded to the distance between PNPase trimming start positions (i.e. 
RNase Y processing sites) and the TSS of the regulatory element.  
In the serS 5′ UTR, a short fragment was visible only in the WT strain and the fragment 5′ 
and 3′ end corresponded to the serS TSS and to the 3′ rny_end, respectively (Figure 29B). It is likely 
that during the degradation of the serS decay intermediate fragment, PNPase paused at the 3′ 
rny_end (putative PNPase stop position), thereby producing this short fragment isoform (Figure 
28B).  
The decay of the serS and valS T-boxes was also shown to be initiated by RNase Y in 
S. aureus160. The authors observed that the RNA products downstream of the RNase Y processing 
site were detectable only in a strain expressing an inactivated variant of the 5′-to-3′ exoRNase J1, 
suggesting that this exoRNase was responsible for the degradation of these fragments160. While the 
decay intermediate fragment in serS was also shortened at the 3′ end by 3′-to-5′ exoRNase, the one 
in valS was degraded by RNase J1 up to the transcriptional terminator160. Here we did not 
investigate the fate of the RNase Y-generated downstream fragments in serS and valS T-boxes, but 
we studied the degradation of the fragment upstream of the RNase Y processing site and observed 
that PNPase was responsible for the decay of these products. We do not exclude that RNase J1 is 
also involved in the serS and valS T-box decay, as described for S. aureus. 
In the thrS 5′ UTR, we identified two PNPase trimming start positions that did not 
correspond to any rny_ends. By Northern blot analysis, we deduced that PNPase was responsible 
for the degradation of two decay intermediate fragments deriving from thrS 5′ UTR204 (Figure 29D). 
To examine the origin of these fragments, we performed Northern blot analyses also in the 
∆pnpA∆rny strain and we observed that they were present in the ∆pnpA strain, but not in the 
∆pnpA∆rny strain, demonstrating that their production was RNase Y-dependent (Figure 29D).  
These are examples of how the screening for endoRNase processing sites in an exoRNase deletion 
mutant facilitates the identification of the endoRNase processing events. 
Finally, only for the glyQ T-box RNase R was also involved in the degradation of the 
RNase Y-generated decay intermediate fragment, beside PNPase (Figure 29E). However, while 
PNPase stopped the degradation of this decay intermediate fragment downstream of the TSS204, 
RNase R completed it (Figure 29E). An alternative processing position was detected in the absence 
of RNase Y (i.e. RNA end more abundant in the ∆rny strain than in the WT strain and named 5′ 
∆rny_end) (Figure 29E, in grey and Table A10). Therefore, it is likely that another endoRNase, by 
substituting RNase Y, is responsible for the degradation of the glyQ T-box. Indeed, the Northern 
blot analysis revealed the presence of a short RNA fragment detectable only in the ∆rny stain 
(Figure 29E).  
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Overall, these results point to the conclusion that the interplay of RNase Y and PNPase is 
responsible for the decay of the transcripts resulting from premature termination of T-box and 
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Figure 29. Role of RNase Y and PNPase in the degradation of 5' regulatory elements. 
A-E. Representation of the predicted regulatory elements (i.e. T-boxes or riboswitches) with the predicted 
promoter, terminator, 5' rny_ends (purple arrowheads), 3'-to-5' exoRNase trimming start and stop positions 
(green and red arrowheads, respectively). The labelled oligonucleotide probes used in the Northern blot 
analyses and the expected size of the full length (fl) regulatory element transcripts and of the decay 
intermediate fragments, generated by RNase Y (purple scissors) and degraded by PNPase and/or RNase R 
(“pacman” symbols), are indicated. Northern blot analyses of the 5' regulatory element in the WT, rny 
(RNase Y) deletion mutant (∆rny), pnpA (PNPase) deletion mutant (∆pnpA), rny and pnpA double deletion 
mutant (∆rny∆pnpA), rnr (RNase R) deletion mutant (∆rnr) strains and also in the rny and rnr double deletion 
mutant (∆rny∆rnr) strain for glyQ T-box. The 5S rRNA was used as a loading control. The results of one 
representative Northern blot analysis (n=3) are shown. E. In the glyQ T-box an RNA 5' end more abundant 
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in the ∆rny strain than in the WT strain was identified and named 5' ∆rny_end (grey arrowhead). Below the 
5' regulatory element representation, the 5' end coverage profiles in the WT and ∆rny strains, obtained from 
RNA sequencing, is shown. The coverage scale is indicated between brackets. K. H. generated the replicates 
of the Northern blot analyses of the 5' regulatory elements. 
 
3.4.4 RNase Y affects the rpsB and rpsB-tsf transcript stability 
The abundance of the rpsB (encoding the 30S ribosomal protein S2) and tsf (encoding the 
elongation factor thermos-stable, EF-Ts) transcripts was strongly increased in the ∆rny strain 
compared to the WT strain (Table A1). In addition, proteomic analysis performed in both the WT 
and ∆rny strains indicated that the EF-Ts protein was overexpressed in the ∆rny strain (data not 
shown).  To decipher whether this upregulation was due to an increase in transcript stability, we 
performed a stability assay followed by Northern blot analyses (Figure 30A-C). By probing rpsB 
and tsf mRNAs, we detected two and one transcript isoforms, respectively (Figure 30A-C). The 
longer RNA isoform corresponded to the full-length transcript, comprising both rpsB and tsf ORFs. 
Transcription driven from the rpsB promoter up to the predicted terminator in the rpsB-tsf 
intergenic region gave rise to the second transcript isoform, corresponding to the rpsB 
monocistronic transcript (Figure 30A). All the transcript isoforms were strongly stabilized in the 
∆rny strain (half-life greater than 45 minutes) compared to the WT strain (half-life shorter than 5 
min) (Figure 30B and C). 
 RNase Y was previously shown to affect the expression of rpsB-tsf operon also in S. aureus160. 
In this bacterium the rpsB-tsf operon architecture differs for the one observed in S. pyogenes, as tsf 
harbours its own promoter and a small ORF is located in the rpsB-tsf intergenic region160. In the 
abovementioned study, RNase Y processing sites were identified in both rpsB mRNA and rpsB-tsf 
UTR. However, we did not detect any RNase Y processing events in this operon. We instead 
observed, in the rpsB 5′ UTR, several 5′ RNA ends present in the ∆rny strain, but not in the WT 
strain (5′ ∆rny_end) (Table A10), suggesting that another RNase is acting on the rpsB transcript in 
the absence of RNase Y (Figure 30D and E). In addition, two PNPase trimming stop positions 
were previously identified in the rpsB 5′ UTR, by our laboratory204 (Figure 30D). The abundance of 
the RNA 3′ ends corresponding to these PNPase trimming stop positions was reduced in the ∆rny 
strain compared to the WT strain, suggesting that PNPase activity in the rpsB 5′ UTR was 
depending on RNase Y. Two short RNA isoforms were detected by Northern blot analyses in the 
WT strain, which could originate from the rpsB TSS and terminate at the two PNPase trimming 
stop positions (Figure 30D and F). These two RNA isoforms, detectable up to 8 min after the 
addition of the rifampicin, were not present in the ∆pnpA and ∆rny strains, indicating their 
production requires both RNase Y and PNPase activity. Different RNA isoforms were detected in 
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the absence of RNase Y (∆rny and ∆rny∆pnpA) and likely originated from the alternative processing 
events identified in the ∆rny strain (Figure 30D and F). 
 
 
Figure 30. Stabilization of the rpsB and rpsB-tsf transcripts in the absence of RNase Y. 
A. Total coverage profile of the rpsB-tsf operon in the WT strain, obtained from RNA sequencing. The scale 
is indicated between brackets. Below the coverage profile, the rpsB-tsf operon is schematically represented 
with the predicted promoter, terminators and the labelled oligonucleotide probes used for the Northern 
blot analyses (NB probes). The transcripts detectable in Northern blot analyses are shown with the expected 
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sizes. B. and C. Transcript stability studied by Northern blot analyses, up to 45 or 8 minutes (min) after the 
addition of the rifampicin in the WT and in rny (RNase Y) deletion mutant (∆rny) strains. The 16S rRNA 
was used as a loading control. The results of one representative Northern blot analysis (n>3) are shown D. 
Total coverage profile from RNA sequencing of the rpsB 5' UTR and a portion of rpsB ORF with the 
identified PNPase trimming stop positions (red arrowheads) and the RNA 5' ends more abundant in the 
∆rny strain than in the WT strain (5' ∆rny_ends, grey arrowheads). The rectangles highlight the portions of 
the rpsB 5' UTR further analysed in panel E. E. 3' end coverage profiles in the WT, ∆rny and pnpA (PNPase) 
deletion mutant (∆pnpA) strains and 5' end coverage profiles in the WT and ∆rny strains obtained from 
RNA sequencing. The coverage scales are indicated between brackets. The trimming stop positions within 
the purple box are likely to be RNase Y dependent. F. On the left, Northern blot analysis with a labelled 
oligonucleotide probe targeting the rpsB mRNA 5' UTR (see primer in panel D) in the WT, ∆rny, ∆pnpA 
and rny and pnpA double deletion (∆rny∆pnpA) strains. On the right, transcript stability was evaluated by 
Northern blot analysis up to 8 minutes (min) after the addition of the rifampicin in the WT and ∆pnpA 
strains. The 5S rRNA was used as a loading control. The results of one representative Northern blot analysis 
(n=3) are shown. The study in the rpsB mRNA 5' UTR by Northern blot analysis was conducted with A.-
L.L. and K.H.  
 
Overall, it is unclear how the rpsB and rpsB-tsf transcript stability is strongly affected in the 
absence of RNase Y in S. pyogenes. Here, we showed that both RNase Y and PNPase participate in 
the production of short RNA isoforms deriving from the rpsB mRNA 5′ UTR. Of note, a putative 
sRNA of 136 nt deriving from the rpsB mRNA 5′ UTR was previously annotated, based on the 
structure conservation of this 5′ UTR in E coli26,377. Successively, in this bacterium, the rpsB mRNA 
5′ UTR was shown to play a regulatory role in cis, as it is recognized by the 30S ribosomal protein 
S2 (encoded by rpsB), which in turn affects its own and tsf expression378. In the possibility that the 
S2 protein autoregulates its own expression at post-transcriptional level also in S. pyogenes, it is 
possible the RNase Y and PNPase activity in the rpsB mRNA 5′ UTR is involved in this process.  
 
 
3.4.5 Conclusions IV 
We investigated the interplay between RNase Y and PNPase and we observed that these 
two enzymes are involved in the RNA degradation of 5′ regulatory elements and in uncoupling the 
stability of mRNAs that are part of the same polycistronic transcript. Importantly, the study of 
RNase Y activity in the ∆pnpA strain, by the transcriptome comparison, permitted the identification 
of processing events not detectable otherwise. We therefore provide a more accurate annotation 
of the RNase Y targetome in S. pyogenes. Overall, from the study of the RNase Y and PNPase 
concerted action we demonstrated that our RNA sequencing comparative approach successfully 
allows to study the bacterial RNase interplay and mechanisms of RNA degradation in vivo. 
 
  
   
 
   
    
Results 110 
  








4.1.1 Role of RNase Y in the regulation of speB expression 
n this thesis, to gain insight into the broad activity of RNase Y in S. pyogenes we first determined 
the genes that were differentially expressed in the ∆rny strain compared to the WT strain. We 
identified 80 genes that were either upregulated or downregulated in the absence of RNase Y. 
Considering that M1 S. pyogenes strain SF370 has a genome with 1801 genes annotated363,379, in the 
∆rny strain only 4.4% of the transcriptome is affected, at mid-logarithmic growth phase and in rich 
medium (Figure 7 and Table A1). A previous study revealed that in the absence of RNase Y, the 
expression of almost 30% of the transcriptome was altered. However, this analysis was performed 
in M14 S. pyogenes H5C5 strain, at stationary growth phase and using a medium poor in 
carbohydrates and rich in amino acids168. Therefore, it is possible that the role of RNase Y in 
transcript degradation might differ depending on the environmental conditions, including nutrients 
availability. 
Different functional gene categories were affected in the absence of RNase Y, comprising 
genes involved in bacterial metabolism and in protein synthesis (Table A1). The expression of 
several virulence genes (slo, speB, grab and sic) was altered in the ∆rny strain. This observation was 
consistent with the known role of RNase Y in virulence genes regulation described in S. aureus167 
and C. perfringens166 and also in S. pyogenes168. The slo gene, encoding the Streptolysin O, and speB, 
encoding for the SpeB protease, were already shown to be regulated by RNase Y168,329. However, 
while slo was described to be upregulated in the ∆rny strain, here we observed that slo mRNA 
abundance was decreased in the ∆rny strain. This observation can be explained by the different 
strain and growth conditions used in this thesis compared to the previous study168. We identified 
also two virulence genes (i.e. grab and sic) that were not previously reported as regulated by RNase Y. 
Whereas grab encodes for a G-related alpha2-macroglobulin-binding protein, a surface protein that 
inhibits extracellular proteases380,381, the sic gene encodes the Streptococcal inhibitor of 
complement, which protects the bacteria from lysis caused by the complement system.  
I 
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It was shown that RNase Y is required for speB expression in S. pyogenes168,329, and our data 
confirmed this observation (Figure 8). The SpeB protease is one of the major virulence factors 
associated to S. pyogenes pathogenesis and toxicity, therefore it is of interest to understand how the 
production of this enzyme is regulated. We therefore aimed at deciphering the role of RNase Y in 
the regulation of speB expression and we reported that (i) RNase Y indirectly affects speB 
transcription (Figure 9) and (ii) RNase Y processes the speB mRNA 5′ UTR (Figure 13) producing 
a stable putative sRNA (Figure 17). 
 
4.1.2 RNase Y impact on speB transcription 
The study of the speB promoter activity revealed that, in the absence of RNase Y, the 
transcription from speB promoter was strongly reduced (Figure 9). From this observation we 
deduced that speB expression is controlled at the transcriptional level by RNase Y. In an effort to 
pinpoint the unknown intermediate factor involved in the RNase Y-mediated regulation of speB 
mRNA abundance, we tested the impact of RNase Y on the expression of known speB 
transcriptional regulators. RopB (speB activator) and the CovRS two-component system (speB 
repressor) are the best characterized speB direct transcriptional regulators and previous observation 
indicated that RNase Y is involved in their regulation106, therefore they were selected for further 
analysis (Figure 10C and D). Here we observed that both ropB and covRS transcript stability was 
increased in the ∆rny strain. If this increased transcript stability would correlate with a higher 
amount of RopB and CovR protein levels, then CovR (but not RopB), could be a possible factor 
involved in the downregulation of speB in the ∆rny strain. This hypothesis could be validated by 
generating a double deletion mutant of rny and covRS or by mutating the CovR binging site in the 
speB promoter region and subsequently examining the speB promoter activity. Thus, the impact of 
RNase Y on the protein levels of these regulators should be investigated. It has been recently 
shown that RopB production is reduced in the ∆rny strain compared to the WT strain, although 
the ropB mRNA abundance was identical in the two strains371. In this case, the downregulation of 
speB expression in the ∆rny strain could be explained by the decrease of RopB levels. However, it 
must be noted that in the abovementioned study, the S. pyogenes NZ131 serotype M49 was used 
and in this strain the ropB transcript pattern differs from the one observed in the strain SF370 
serotype M1 studied in this thesis106. It is also possible that in the absence of RNase Y, RopB 
production varies among different strains. 
As described in the introduction, speB expression is controlled by several regulators and 
likely additional unknown factors. Therefore, it is likely that the reduction of speB expression in the 
∆rny strain results from the action of several regulators, which are controlled by RNase Y. For 
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instance, the SIP peptide, which indirectly induces speB expression by enhancing RopB activity315, 
is co-transcribed with speB (Figure 8A and B) and its expression is downregulated in the ∆rny strain. 
A SIP-based negative feedback signal could possibly cause speB downregulation in this strain. 
Overall, while we demonstrated that the reduction of speB abundance in the ∆rny strain is 
due to an indirect effect on transcription, a better characterization of the regulatory pathway(s) 
affected by RNase Y is needed. This may also shed light on the impact of RNase Y on other 
virulence factors (sic, slo and grab), which were found differentially expressed in the ∆rny strain 
(Table A1). In S. aureus, promoter activity analysis of virulence genes revealed that RNase Y 
regulates their expression indirectly at the transcriptional level167. The authors observed that the 
RNase Y-mediated regulation of virulence genes did not depend on the major S. aureus virulence 
regulators (i.e. the RNAIII sRNA and the two-component system SaeRS), but it was likely due to 
yet unidentified factors167. The authors hypothesized that, among these unknown regulatory 
factors, several sRNAs, which were differentially expressed in the ∆rny strain, could play a critical 
role in the RNase Y control of virulence gene expression. In our study we identified six putative 
sRNAs whose expression was altered in the ∆rny strain (Table A1) and we do not exclude their 
possible involvement in the RNase Y-mediated regulation of virulence genes, including speB. 
 
4.1.3 The effect of RNase Y processing in speB mRNA 5′ UTR 
We observed that RNase Y also cleaves the speB transcript in the 5′ UTR region (Figure 
13). The effect of these processing events on speB expression and/or SpeB production is still 
unclear and further analyses should aim at dissecting the impact of these cleavage sites on speB 
post-transcriptional regulation. In S. aureus, RNase III can enhance translation by shortening the 5′ 
UTR of mRNAs184 and we questioned whether RNase Y could similarly affect SpeB production. 
Therefore, we analysed the expression of a reporter gene fused to speB mRNA 5′ UTR and 
expressed under the control of a constitutive promoter, which is not controlled by RNase Y (data 
not shown). The results from this translational fusion experiment were inconclusive, as the 
generated measurements were not reproducible. In addition, it is worth noting that the speB 5′ UTR 
is also processed by other unidentified RNase(s) (Figure 13), thus the impact of also this processing 
event on speB mRNA translation should be assessed. 
 Recently it was demonstrated that the truncation of speB mRNA 5′ UTR alters the temporal 
pattern of speB expression and causes a general increase of the bulk mRNA stability in S. pyogenes161. 
These findings indicate that the speB mRNA 5′ UTR, could display regulatory functions. In the 
present study, we observed that the RNase Y processing of the speB mRNA 5′ UTR results in the 
production of a short RNA fragments (Figure 17), which could play regulatory roles, for instance, 
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as a trans-acting sRNA. A putative sRNA (Spy_sRNA1699993) was already annotated in the speB 
5′ UTR359 and we demonstrated that the sRNA 5′ end coincides with the RNase Y cleavage site(s) 
(Figure 17). Although the hypothesis of a regulatory sRNA deriving from speB 5′ UTR (named here 
speB-sRNA) requires validation, several observations sustain this possibility: speB-sRNA is (i) 
produced at a specific growth phase, (ii) generated by endoRNase processing, which is a common 
biogenesis strategy for sRNAs29,30,53,154, (iii) stable over time, and (iv) further processed by 
unidentified RNase(s), which could play a role either in the sRNA maturation or possibly in the 
sRNA function.  
 
4.2 RNase Y targetome and processing determinants 
The differential expression analysis, performed by comparing the RNA abundance in the 
WT and ∆rny strains, provides a global overview of the transcripts affected by RNase Y, but it does 
not allow to distinguish between direct and indirect targets. To gain a better understanding on 
RNase Y activity, we next aimed at pinpointing the direct targets of RNase Y (i.e. RNAs cleaved 
by RNase Y), by mapping the RNA 5′ and 3′ ends in both the WT and ∆rny strains (Figures 11 and 
18). Mapping of the RNA ends more abundant in the WT strain than in the ∆rny strain revealed 
190 and 130 RNA 5′ and 3′ ends that derived from RNase Y processing, respectively. While most 
of the identified RNA 3′ ends resulted from trimming of 3′-to-5′ exoRNases upon RNase Y 
processing (Figure 20), the RNA 5′ ends corresponded to the original RNase Y processing position 
(Figures 11 and 26). The different origin of the RNA 5′ and 3′ ends will be further discussed in the 
next section 4.3. 
Some of the RNA 5′ and 3′ ends were annotated within the same target and the distance 
between these ends ranged between 50 to 200 nt (Figure 24A and B, Table A8). However, since 
the RNA 3′ ends do not correspond to the original RNase Y processing positions, but rather to the 
trimming stop positions of 3′-to-5′ exoRNases, it is likely the average distance between two 
RNase Y processing positions is longer than observed.  
The analysis of RNA 5′ ends – coinciding to the original RNase Y processing positions –
allows to examine the target determinants for RNase Y processing. Consistently with the fact that 
RNase Y is a single-stranded endoRNase, we found that the minimum free energy increased at the 
RNA 5′ ends produced by RNase Y (Figure 11D). Among the RNA 5′ ends identified, 87.4% were 
located downstream of a G (Figure 11D). An RNase Y preference to cleave the transcripts 
downstream of a G was already identified in S. aureus, where 58% of the RNA 5′ ends produced by 
RNase Y were annotated after this nucleotide160. The apparent difference in the frequency of G at 
the RNase Y processing sites in the two bacteria can be explained, for example, by: (i) the diversity 
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in the RNA sequencing workflow and data analysis and (ii) the role of RNase J1, which might be 
more active in S. aureus than in S. pyogenes in degrading the RNA 5′ ends produced by RNase Y and 
(iii) the difference in the RNase Y orthologue activity. 
 As the two RNase Y cleavage sites identified in speB mRNA 5′ UTR were mapped after a 
G (Figure 13), we used this mRNA 5′ UTR as a model target to investigate the importance of the 
G for RNase Y activity. We provided in vivo evidence that the G located downstream of the 
RNase Y cleavage sites is essential for RNase Y processing of the speB mRNA 5′ UTR (Figure 15). 
Therefore, based on the genome-wide mapping of the RNase Y cleavage sites, in combination with 
the analysis of the RNase Y processing activity in the speB mRNA 5′ UTR, we concluded that 
RNase Y requires a G immediately downstream of the processing position to cleave the target. 
Interestingly, when the G was mutated in the speB mRNA 5′ UTR (i.e. the G was substituted in A), 
alternative processing events were detected (Figure 15). From the observation that these alternative 
cleavage sites were also mapped at a G, we hypothesized that they resulted from RNase Y activity.  
If this was the case, RNase Y would be still able to recognize the speB mRNA as a target, in the 
absence of the G, and other factors would be likely involved in the RNase Y identification of the 
cleavage site. It is possible indeed that, while the G could be important for the RNase Y catalytic 
activity, other determinants are necessary for the cleavage site recognition. 
 In light of the limited number of RNase Y cleavage sites identified in this study (320 5′ and 
3′ RNA ends), it is surprising that only a G can limit RNase Y activity, since all the transcripts in 
the cell would contain multiple RNase Y cleavage sites. Despite the promiscuity of RNase Y, the 
processing of an RNA target depends also on the accessibility of this RNase to it. Indeed, the Gs 
within an RNA molecule could be often masked by ribosomes, interacting proteins and sRNAs 
that limit the number of G available for RNase Y recognition. This has been demonstrated to be 
the case for RNase E in E. coli, in which the linear scanning, for cleavage site search,  within ssRNA 
regions is impeded by obstacles – including bound proteins, RNA duplexes and ribosome 
occupancy – that inhibits the processing downstream115. The ribosome-mediated protection from 
processing did not occur from shielding the cleavage site, but rather by the intense ribosome 
occupancy, which depends on the strength of the Shine-Dalgarno sequence115. 
The specificity for one single nucleotide is not unique to RNase Y, but it is employed by 
other RNases, including the fungal endoRNase T1, which also cleaves ssRNA after a G382. As a 
result, RNase T1 is largely used in molecular biology to cleave RNAs in vitro and to predict RNA 
secondary structures. RNase T1 preference for the G is explained at a structural level, as the 
guanosine is able to form several hydrogen bonds with conserved amino acids of the RNase 
catalytic site383. On the other hand, RNase E, from S. enterica, was demonstrated to cleave 
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preferentially 2 nt upstream of a U. The interaction of RNase E with this residue promotes a 
conformational change of the enzyme itself, which favours the catalytic activity and therefore the 
cleavage of the RNA30. The RNase Y crystal structure is not yet available and therefore it is unclear 
how the G is recognized and why it is important for the catalytic activity. The impact of the G on 
the RNase Y activity in vitro has not been investigated and RNase Y in vitro studies are in general 
limited109. For instance, recent attempts of studying RNase Y catalytic activity in vitro were 
performed using a great excess of protein over the RNA substrate, indicating that this enzyme is 
extremely inefficient in the conditions tested109,384. This could be due to: (i) the lack of co-factors 
or interacting proteins that are required for RNase Y activity in the reaction, (ii) the lack of 
interacting RNAs, for instance sRNAs and (iii) secondary or tertiary RNA structures that might 
not occur at the conditions used in vitro. Examples of these three possibilities are described below.  
It has been recently shown that in B. subtilis, RNase Y interacts with three proteins YlbF, 
YmcA and Yaat. This complex influences RNase Y specificity, by favouring RNase Y processing 
of certain specific mRNAs153. Besides interacting proteins, sRNAs can also modulate RNase Y 
activity. This is the case of the VR-RNA sRNA that induces a structural change of the mRNA 
target and thereby it promotes RNase Y processing166,232 (exemplified in Figure 2C). In addition, 
RNase Y activity was also shown to be affected by the presence of secondary structure a few 
nucleotides (6 nt) downstream of the processing position. This have been demonstrated for two 
targets: the yitJ S‐adenosylmethionine riboswitch in B. subtilis119 and the saePQRS transcript in 
S. aureus169. However, in our study, in agreement with previous transcriptomic analysis performed 
in both B. subtilis and S. aureus, we did not identify RNA secondary structures in proximity of the 
RNA 5′ ends produced by RNase Y (Figure 11D). Analysis of RNA secondary structures in the 
speB mRNA 5′ UTR also did not reveal the presence of a structure just after the RNase Y processing 
events (Figure 16). Importantly, bioinformatic prediction of complex RNA structures is still 
challenging at a genome-wide scale. Therefore, although it seems that RNase Y in S. pyogenes does 
not depend on the recognition of structured RNA, we do not exclude that, at least for specific 
targets, RNA structures might play a role in RNase Y specificity.  
Overall, different requirements for RNase Y processing have been identified in the Gram-
positive bacteria studied so far. It is possible that different RNase Y orthologs employ distinct 
strategies to recognize the targets and/or that various determinants affect in concert RNase Y 
activity. 
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4.3 The interplay of RNase Y and exoRNases 
In order to study the role of RNase Y in RNA degradation we compared the RNase Y 
targetome, with the 3′-to-5′ exoRNase (PNPase, YhaM or RNase R) trimming start and stop 
positions, which were previously characterized204. Although the notion that endoRNases act in 
concert with exoRNases to perform RNA degradation is well established, it has been validated only 
for a limited number of targets and in few bacterial species. Here, an RNA sequencing comparative 
approach was used to demonstrate the interplay of RNase Y with 3′-to-5′ exoRNases, genome-
wide at the nucleotide resolution. 
 We observed that 58% of the identified RNA 3′ ends generated by RNase Y were trimmed 
mainly by PNPase and/or YhaM (Figure 20). In agreement with the minor role of RNase R in 
RNA degradation at standard growth conditions204, we observed very little interplay between 
RNase Y and RNase R, with only one RNase Y-dependent RNA 3′ end further trimmed by 
RNase R (Tables A5, A7, A9). Since most of the RNA 3′ ends did not map at a G (Figure 18C), 
we hypothesized that also the remaining 42% of RNA 3′ ends were targeted by exoRNases. 
Conversely, most of the RNA 5′ ends (87.4%) corresponding to the initial RNase Y processing 
positions were mapped at a G (Figure 11D) and were not further trimmed. The remaining 12.6% 
of the RNA 5′ ends was not located at a G and could derive either from trimming, likely performed 
by the 5′-to-3′ exoRNase J1, or from processing events by an endoRNase, whose activity depends 
on RNase Y.  
The method to identify the RNase Y processing sites, developed in our laboratory204, 
depends on the detection of at least the RNA 5′ or 3′ end generated by processing event. Therefore, 
we were unable to identify RNase Y cleavage sites when both the RNA products upstream and 
downstream of the RNase Y processing site were degraded, for instance by 3′-to-5′ exoRNases. 
Therefore, it is possible that the portion of RNAs detected as cleaved by RNase Y represents only 
a subset of the total RNase Y targets. This implies that (i) the number of RNase Y processing site, 
identified in this study, is likely an underestimation and that (ii) we cannot study the interplay of 
RNase Y and 3′-5′ exoRNases in the degradation of the undetected RNAs (i.e. fully degraded 
RNAs). In addition, the method does not allow the detection of processing position that derived 
from the activity of redundant RNases (i.e. alternative RNase(s) complementing the activity of the 
missing RNase). Therefore, it is possible, that the 42% of RNA 3′ ends not corresponding to any 
trimming positions in our analysis, could derive from redundant trimming of different 3′-to-5′ 
exoRNases. 
Considering the fate of only the detected RNA ends produced by RNase Y, it seems that 
the RNA 3′ ends are subjected to exoRNase activity, while the RNA 5′ ends are resistant to further 
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degradation. The different susceptibility to RNA degradation between RNA 5′ and 3′ ends suggests 
that the interplay between RNase Y and RNase J1 is limited compared to the one observed between 
RNase Y and PNPase. This is possibly due to (i) higher PNPase protein levels compared to 
RNase J1, (ii) higher RNA degradation rates for PNPase than RNase J1, (iii) both the 
abovementioned scenarios. Alternatively, the RNA product downstream of the RNase Y 
processing site could be released, from the catalytic site into the cytosol, slower than the upstream 
fragments, explaining why the newly generated RNA 5′ end is protected from degradation. 
 
4.3.1 RNase Y mainly acts in concert with PNPase in RNA degradation 
It was previously shown that PNPase is the major 3′-to-5′ exoRNase participating in RNA 
degradation in S. pyogenes204 and B. subtilis136. It was therefore not surprising that PNPase appeared 
to be responsible for the trimming of most of the RNA 3′ ends produced by RNase Y (Figure 20). 
The two enzymes have been shown to physically interact in B. subtilis and the amino acids involved 
in this interaction have also been elucidated227. However, an in vivo localization study revealed that 
PNPase does not co-localize at the membrane with RNase Y, indicating that the interaction of 
these enzymes is likely transient229. In S. pyogenes, it is not known whether RNase Y and PNPase are 
associated, as the sole protein that was demonstrated to interact with RNase Y so far is the enolase 
enzyme. It is possible that in S. pyogenes, PNPase and RNase Y are physically close to each other, 
explaining why the two enzymes appear to act rapidly in concert in RNA degradation. 
 The decay intermediate fragments produced by endoRNases are usually efficiently 
degraded by PNPase and become detectable only in the ∆pnpA mutant123,136,204. The sequence 
conservation analysis of the decay intermediate fragments identified in the ∆pnpA strain revealed 
the presence of a G at the RNA 5′ ends of 127 decay intermediate fragments (Figure 28A). Based 
on the RNase Y preference for a G at the cleavage site (Figure 11D), it is likely that these fragment 
5′ ends were also generated by RNase Y. This led to the identification of 127 possible additional 
RNase Y cleavage sites which were not and could not have been mapped by the RNA end 
abundance comparison between the WT and ∆rny strains.  
  In addition, we also observed that the interplay of RNase Y and PNPase was crucial for 
the degradation of premature terminated transcripts derived from riboswitches and T-box 
elements. The concerted activity of RNase Y and PNPase on regulatory elements was previously 
observed in both B. subtilis119 and S. aureus160. The degradation of these premature terminated 
transcripts could play an important role in recycling of the metabolite bound to the 5′ regulatory 
element, as shown for the trp leader (controlling the expression of the tryptophan operon) in 
B. subtilis. In the presence of tryptophan the trp RNA binding attenuation protein (TRAP) interacts 
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with the trp leader, promoting transcription termination. The PNPase-mediated degradation of the 
TRAP-bound leader RNA assures the release of TRAP and therefore maintenance of the trp 
operon repression385.  
 In addition, we demonstrated that RNase Y and PNPase activity allows the differential 
RNA degradation of mRNAs comprised within the same polycistronic transcript (Figure 27). 
Indeed, we observed that RNase Y processed the rsmC-cdd-bmpA transcript operon and PNPase 
degrades the rsmC-cdd isoform, which is less stable than the bmpA mRNA (Figure 27). The effect 
of the differential RNA degradation of this operon at the protein level should be the subject of 
further investigation. Bacterial operons consist of clustered genes that are co-transcribed from a 
common promoter, resulting in the production of polycistronic transcripts. The uncoupling of the 
translation process of the co-transcribed ORFs is fundamental when the protein encoded by one 
gene is needed at a different level than the protein encoded by the other co-transcribed genes. 
Processing by an endoRNase within the polycistronic transcript can lead to the differential 
degradation of the generated RNA products (encompassing a single ORF), allowing to fine-tune 
the protein levels. The differential expression of genes encoded in the same operon was extensively 
study for the glycolytic gapA operon in B. subtilis123,151,386. The first gene of operon is cggR, encoding 
the transcriptional repressor of the operon CggR, which is followed by gapA, encoding the 
glyceraldehyde 3‐phosphate dehydrogenase. In presence of glucose, the amount of GapA glycolytic 
enzyme required by the bacterial cell is much higher compared to CggR, which is instead not 
needed151. The differential protein synthesis is obtained by the processing of RNase Y at the end 
of the cggR ORF and subsequent degradation of the RNA product containing the cggR ORF by 
PNPase and stabilization of the RNA product comprising the gapA ORF123,136,387.  
 
4.3.2 RNase Y and YhaM interplay 
S. pyogenes YhaM displays a peculiar activity as it trims not specifically most of the RNA 3′ 
ends that derive from transcription termination or endoRNase cleavage. As expected YhaM also 
trimmed the RNA 3′ ends generated by RNase Y processing (Figure 20). In the present thesis, we 
gained more insight into the activity of this peculiar 3′-to-5′ exoRNase in S. pyogenes.  
First, from the comparison of the RNase Y, PNPase and YhaM targetomes, we observed 
that YhaM also trims the RNA 3′ ends resulting from the trimming of another 3′-to-5′ exoRNase 
(i.e. PNPase), after RNase Y processing (Figure 23).  
Second, we observed that YhaM trimmed short RNA fragments, produced by RNase Y and 
that in the absence of YhaM these RNA fragments were not detectable (Figure 25). Based on this 
observation, we hypothesized that YhaM trimming exerts a protective role, by preventing RNA 
   
 
   
    
Discussion 120 
degradation performed by PNPase or RNase R. Indeed, both these two enzymes require a ssRNA 
region at the RNA 3′ end to bind and degrade the targets130,136,374. A similar function was already 
proposed in B. subtilis, where the YhaM trimming of ssRNA tails at the RNA 3′ ends prevents 
RNase R activity136.  
Some of these short RNA fragments, generated by RNase Y and detectable in WT, were 
trimmed by both YhaM and PNPase or uniquely by one of the two 3′-to-5′ exoRNases. Further 
characterization of these fragments revealed the presence of putative RNA structure at the 3′ 
fragment region (Figure 24C). While the stable structure could protect the fragments from 
degradation, we do not exclude the possibility that these short RNA fragments, derived from 
mRNA degradation, could exert a functional role, as described in E. coli. In this bacterium, indeed, 
stabilized RNA fragments, generated by RNase E processing of mRNAs, act as a source of 
regulatory sRNAs32. These fragments were also described to be structured and bioinformatic 
prediction revealed that they likely interact with Hfq and/or ProQ32. 
 
4.4 The role of RNase Y in RNA degradation 
RNase Y is often considered to functionally replace RNase E in the bacteria that do not code 
for this endoRNase84. RNase E is an essential enzyme that plays a central role in the initiation of 
RNA degradation in Gram-negative negative bacteria. Here, we have demonstrated that RNase Y, 
by cleaving an RNA molecule internally is able to initiate RNA degradation in S. pyogenes (Figures 
19, 20 and 26). However, based on the detected RNA ends, we concluded that RNase Y is probably 
not the major endoRNase in this bacterium. We have identified only 320 RNase Y processing 
positions, by mapping both the RNA 5′ and 3′ ends (Figures 11 and 18), and additional 127 putative 
RNase Y processing sites that were detected in the ∆pnpA strain. In contrast, mapping of the RNA 
5′ ends in S. enterica, revealed nearly 22000 cleavage sites of RNase E, corresponding to more than 
one processing event per transcript30. It is possible that this high number of RNase E processing 
sites identified is due to the absence of RNase J1 in this bacterium, which degrades the RNAs in 
5′-to-3′ direction, allowing therefore to capture numerous RNA 5′ ends. The sole RNase in E. coli, 
that was shown in vitro to degrade short oligoRNAs in the 5′-to-3′ direction is RNase AM186. 
However, this activity has not been characterized in vivo yet and the role of this RNase in RNA 
degradation in E. coli is not known. 
  The number of RNase Y cleavage sites identified in this study is coherent with previous 
transcriptomic studies in B. subtilis and S. aureus, in which approximately 100 RNase Y cleavage 
sites were identified by mapping only the RNA 5′ ends153,160. The relatively small RNase Y targetome 
in S. pyogenes is consistent with the limited delay in growth measured in the ∆rny strain compared to 
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the WT strain (Figure 7A). This is opposite to B. subtilis, where rny deletion results in severe 
phenotypes and changes in the expression of 13% to 23% of the transcriptome153,162.  
 Other RNases are likely involved in the initiation of RNA degradation in S. pyogenes, 
including the complex formed by RNases J1 and J2, both essential in this bacterium. Whereas 
RNase J1 plays an important role in RNA degradation in B. subtilis164, RNase J2 is considered to 
mainly function as a structural protein in the RNase J1/J2 complex. S. mutans is the sole bacterium 
where RNase J2 was demonstrated to act as an endoRNase in vivo194. In S. pyogenes, RNase J2 was 
shown to affect transcript stability195,343 and it is possible that this RNase functions as an endoRNase 
initiating RNA degradation, as described for S. mutants. 
A previous study, in M49 S. pyogenes strain NZ131, investigated the impact of RNase Y on 
transcript stability, during growth in a medium poor in carbohydrates and revealed that the 98% of 
the transcripts were stabilized in the ∆rny strain106. In this thesis, the RNase Y targetome was 
determined in M1 S. pyogenes strain SF370 grown in a medium rich in carbohydrates at mid-
logarithmic growth phase (Figure 7A). Identification of the RNase Y cleavage positions in different 
conditions (e.g. the ones used in the transcriptome stability study) will likely shed light on novel 
RNase Y direct targets and post-transcriptional mechanisms of gene expression. Interestingly, 
RNase Y was shown to affect the expression of some genes based on carbon or peptide 
availability168. For instance, the RNase Y-mediated regulation of speB, in carbon-poor medium and 
stationary phase of growth, seems to be influenced by the peptide levels168. To date, it is unclear 
how RNase Y could sense the cells nutritional status and degrade RNAs accordingly.  
 
4.5 General conclusions 
To conclude, this thesis provides insights into the activity and functions of RNase Y in 
S. pyogenes (Figure 31). First, we have investigated the RNase Y involvement in the regulation of 
speB, coding for a major virulence factor. With this regard, we have demonstrated that RNase Y, 
by acting indirectly at transcriptional level, modulates speB expression (Figure 31A). RNase Y also 
processes the speB mRNA 5′ UTR downstream of a G, giving rise to a putative regulatory sRNA 
(Figure 31B). Overall, we have established that the major mechanism of speB regulation by RNase Y 
is indirect at transcriptional level. Nonetheless, we do not exclude that the RNase Y processing of 
the speB mRNA plays a more relevant role in speB regulation, under specific circumstances (e.g. 
infection, stress etc.) differing from the standard growth conditions used in this study.  
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Figure 31. Study of RNase Y activity in S. pyogenes. 
Schematic representation of the main findings of the present thesis. A. RNase Y, through unknow 
intermediary factors, reduces speB transcription driven by the P and P1 promoters. B. RNase Y processes 
downstream of a G the speB mRNA 5′ UTR, leading to the production of a putative sRNA (speB-sRNA). C. 
Mapping of the 5′ and 3′ RNA ends generated by RNase Y uncovered 320 RNase Y processing sites and we 
observed that RNase Y preferentially cleaves downstream of a G. RNA sequencing revealed that RNase Y 
affects the expression of 80 genes in S. pyogenes. D. The detected RNase Y-generated 3′ ends were in 52% 
of the cases trimmed by PNPase or YhaM (green “pacman” symbol) and the remaining 48% of 3′ RNA 
ends were either trimmed by multiple 3′-to-5′ exoRNases or by unidentified exoRNases (grey “pacman” 
symbol). The detected RNase Y-generated RNA 5′ ends were in 87.4% of the cases not further trimmed, 
conversely the remaining 12.6% of detected RNA 5′ ends were likely targeted by a 5′-to-3′ exoRNase (i.e. 
RNase J1; light blue “pacman” symbol). 
 
Next, we have determined the targetome of RNase Y and gained insight into the substrate 
specificity of this endoRNase (Figure 31C). RNase Y preferentially cleaves the targets downstream 
of a G and we have showed that this residue is crucial for the RNase Y processing of the speB 
mRNA 5′ UTR. 
Lastly, we observed that at least one or both the RNA products deriving from RNase Y 
processing are degraded by exoRNases, indicating that RNase Y initiates RNA degradation. We 
employed an RNA sequencing based comparative approach to investigate the interplay of RNase Y 
with the three 3′-to-5′ exoRNases from S. pyogenes (Figure 31D). Our data support a model in which 
RNase Y mainly acts in concert with PNPase in RNA decay.  
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Overall, we have addressed the complexity of RNase Y role and target specificity in the 
human pathogen S. pyogenes. This study not only gave insight into the machinery and mechanisms 
of RNA degradation in this human pathogen, but it could pave the way for further understanding 
of the diversity and function of RNases in different microorganisms. 
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6.1 Supplementary tables 
Gene ID Gene name Log 2 FC FDR 
SPy_0033 purE -1.26 2.80E-02 
Spy_sRNA112285  -1.60 4.03E-03 
SPy_0167 slo -1.44 3.41E-02 
SPy_0183 opuAA 1.20 1.32E-02 
SPy_0212 speG 1.30 1.54E-02 
SPy_0374 ribU 1.71 2.80E-02 
SPy_0384 fhuB.1 -1.36 1.02E-02 
SPy_0405  1.08 2.55E-02 
Spy_sRNA350644  -2.02 3.49E-03 
SPy_0460 rplK 1.28 1.97E-02 
SPy_0461 rplA 1.41 9.32E-03 
Spy_sRNA480642  -2.15 1.49E-03 
SPy_0636 idnO -2.28 2.14E-03 
SPy_0658  2.57 1.52E-03 
SPy_0659  3.37 5.24E-03 
SPy_0660  2.98 4.25E-02 
SPy_0661  3.43 7.57E-03 
SPy_0663  3.30 3.99E-04 
SPy_0664  2.62 4.47E-04 
SPy_0665  3.03 2.31E-03 
SPy_0666  2.91 5.57E-04 
SPy_0667  2.55 5.57E-04 
SPy_0669  2.64 3.99E-04 
SPy_0670  2.55 2.14E-03 
SPy_0671  2.48 5.45E-04 
SPy_0672  2.60 1.24E-02 
SPy_0673  2.79 3.39E-03 
SPy_0676  2.08 3.81E-03 
SPy_0679  1.74 1.17E-02 
SPy_0681  1.79 1.26E-02 
SPy_0686  1.78 8.29E-03 
SPy_0688  1.56 9.32E-03 
SPy_0689  1.51 3.04E-02 
SPy_0693  1.72 4.04E-02 
SPy_0697  1.72 4.86E-03 
SPy_0698  2.12 3.49E-03 
SPy_0701 hylP1 1.93 5.24E-03 
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SPy_0702  1.96 3.39E-03 
SPy_0705  2.04 2.01E-02 
SPy_0707  2.20 1.45E-02 
SPy_0710  1.79 3.49E-03 
SPy_0723  -1.19 2.26E-02 
Spy_sRNA579683 rplS leader 2.08 1.65E-03 
SPy_0724 rplS 3.10 3.99E-04 
SPy_0888 clpL 1.22 1.60E-02 
SPy_1097 folE 1.28 7.38E-03 
SPy_1098 folP 1.64 3.25E-03 
SPy_1099 folQ 1.75 3.25E-03 
SPy_1100 folK 1.76 7.89E-03 
SPy_1270  -1.34 1.90E-02 
Spy_sRNA1109453  -2.06 3.07E-02 
SPy_1357 grab 1.40 8.60E-03 
SPy_1470  2.09 5.40E-03 
Spy_sRNA1260092  -1.87 3.49E-03 
SPy_1539 asnA -1.22 1.90E-02 
SPy_1633 rny -4.36 1.91E-04 
SPy_1643 mapZ 1.61 4.86E-03 
SPy_1644 ypsC 2.29 5.27E-04 
SPy_1646 gpsB 2.59 5.57E-04 
SPy_1823 comEB -1.21 3.04E-02 
SPy_1842 spi 1.11 3.04E-02 
SPy_1871 rpsN2 1.95 3.39E-03 
SPy_1894 pyrG 1.27 2.02E-02 
SPy_2016 sic -1.70 1.02E-02 
SPy_2038  -3.76 1.91E-04 
SPy_2039 speB -3.56 5.27E-04 
Spy_sRNA1699993  -4.02 3.99E-04 
SPy_2040  -4.12 1.91E-04 
SPy_2043 mf -1.13 2.00E-02 
SPy_2070 groEL 1.97 2.75E-03 
SPy_2072 groES 2.04 1.66E-03 
SPy_2092 rpsB 3.44 5.03E-04 
SPy_2093 tsf 3.08 5.01E-04 
SPy_2126  1.94 8.29E-03 
SPy_2127  2.02 1.60E-02 
SPy_2128  2.85 7.38E-03 
SPy_2173  -2.04 9.44E-04 
SPy_2174  -1.22 3.04E-02 
SPy_2188 mnmA 1.30 8.42E-03 
SPy_2191  1.08 2.00E-02 
 
Table A1. Genes differentially expressed in the ∆rny strain compared to the WT strain. 
The genes that are encoded within the same transcript are clustered in a grey box. The genes encoded in the 
SF370.1 prophage are indicated in grey. For each gene, the information is provided with regard the gene 
ID, the gene name, the log 2 Fold Change (Log 2 FC) (in red downregulated and in green upregulated genes) 
and the False Discovery Rate (FDR). R.A.-B. generated the raw list of differentially expressed genes analysed 




Position Strand nt in 3′ Log 2 FC FDR Gene ID Description Location Type 
336198 + G -3.9122153 0.0080557 SPy_0397 ↔ tmk "hypothetical protein" ↔ "thymidylate kinase" UTR U 
480622 + G -4.5503693 0.00117632 SPy_0596 ↔ Spy_sRNA480642 "hypothetical protein" UTR U 
1152937 − G -2.3191867 0.01106928 Spy_sRNA1153040  UTR S 
1382711 − C -4.260725 0.00242634 pbpX penicillin binding protein 2X ORF U 
1763486 − G -4.6695369 0.00045468 SPy_2111 hypothetical protein ORF U 
625092 + G -3.7094857 0.00474057 pheS ↔ pheT "phenylalanyl-tRNA synthetase subunit alpha" ↔ "phenylalanyl-tRNA synthetase subunit beta" UTR U 
112341 − G -4.9238213 0.00041443 SPy_0121 ↔ Spy_sRNA112285 "deoxyguanosine kinase/deoxyadenosine kinase(I) subunit" UTR U 
193042 + G -3.5806271 0.00154055 pgi ↔ rivR "glucose-6-phosphate isomerase" ↔ "regulatory protein" UTR S 
275237 + G -3.6375752 0.00201823 SPy_0309 hypothetical protein ORF U 
302413 + T -3.806466 0.00275994 murC UDP-N-acetylmuramate--L-alanine ligase ORF U 
473749 + G -4.6483965 0.00352477 SPy_0587 hypothetical protein ORF U 
1401255 − G -3.7594454 0.00320088 glyS glycyl-tRNA synthetase subunit beta ORF U 
744449 + G -3.3234456 0.00433312 SPy_0899 ↔ Spy_sRNA744487 "hypothetical protein" UTR U 
323093 + G -4.2776828 0.00158438 hlyX hemolysin ORF U 
1014753 − G -3.0954977 0.02448428 cdd ↔ bmpA "cytidine deaminase" ↔ "lipoprotein" UTR U 
737938 + G -4.1187432 0.00477073 Spy_sRNA737945  UTR U 
1711879 − G -3.9218442 0.0047934 SPy_2054 transcriptional regulator ORF U 
1276533 − G -2.9368277 0.03815276 SPy_1551 hypothetical protein ORF U 
409647 − G -3.5102573 0.00133109 SPy_0508 hypothetical protein ORF U 
480754 − G -4.5455981 0.00073023 gpmB1 phosphoglycerate mutase ORF U 
1300735 − G -3.7014986 0.00414061 SPy_1580 acetate kinase ORF U 
318951 + G -3.4146157 0.0029544 trmL 23S rRNA methyltransferase ORF U 
287642 − T -4.7302255 0.00074043 ntpJ V-type Na  -ATPase subunit J ORF U 
1761437 − G -3.7753131 0.00120921 nrdD anaerobic ribonucleoside triphosphate reductase ORF S 
662728 + G -5.1033771 0.00117632 rplT ↔ ltaS "50S ribosomal protein L20" ↔ "hypothetical protein" UTR U 
1403423 − G -3.996955 0.00081057 glyQ ↔ glyS "glycyl-tRNA synthetase subunit alpha" ↔ "glycyl-tRNA synthetase subunit beta" UTR U 
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1430377 − G -2.8108126 0.00891298 trmB ↔ SPy_t51 "tRNA (guanine-N(7)-)-methyltransferase" ↔ "tRNA-Ser (GGA)" UTR S 
838265 + G -3.4485711 0.00665644 acoC ↔ acoL 
"branched-chain alpha-keto acid dehydrogenase E2 
subunit" ↔ "dihydrolipoamide dehydrogenase%2C 
component E3" 
UTR U 
1634045 − A -4.0575361 0.00491335 proS prolyl-tRNA synthetase ORF U 
1152840 − G -3.6947204 0.00472336 Spy_sRNA1153040  UTR U 
1353157 − G -5.2863681 0.00030048 rpoZ DNA-directed RNA polymerase subunit omega ORF S 
1571171 − G -3.6304043 0.00143485 rpoE ↔ Spy_sRNA1571135 "DNA-directed RNA polymerase subunit delta" UTR U 
499822 + A -4.9577492 0.00117632 SPy_0622 hypothetical protein ORF U 
1796021 − A -3.283546 0.04036051 aspS aspartyl-tRNA synthetase ORF U 
1109507 − G -3.889542 0.00081057 SPy_1340 hypothetical protein ORF U 
1625568 − A -2.3886405 0.0074938 rpsO 30S ribosomal protein S15 ORF U 
1766433 − G -4.691884 0.000803 recA recombinase A ORF U 
1558584 − G -3.1672063 0.00688493 glnA glutamine synthetase ORF U 
1400285 − G -3.1794718 0.00073023 Spy_sRNA1400292  UTR U 
1225472 − G -4.3622941 0.00037248 SPy_1494 ↔ SPy_1493 "hypothetical protein" ↔ "hypothetical protein" UTR S 
381164 + G -3.5383645 0.00154055 frr ↔ SPy_0464 "ribosome recycling factor" ↔ "hypothetical protein" UTR U 
1057924 − G -4.5936208 0.0023665 pfkA ↔ pyk "6-phosphofructokinase" ↔ "pyruvate kinase" UTR U 
72783 + A -2.8157838 0.00511808 rpsE 30S ribosomal protein S5 ORF U 
472165 + G -3.668581 0.00205669 ptsK HPr kinase/phosphorylase ORF U 
1247251 − G -3.6161234 0.00339062 sepF hypothetical protein ORF U 
1023988 − G -3.3367194 0.02200802 pstB phosphate transporter ATP-binding protein ORF U 
1764034 − G -3.9296616 0.03322003 SPy_2111 hypothetical protein ORF U 
1611283 − G -3.4501462 0.00426525 SPy_1936 hypothetical protein ORF U 
1345770 − G -2.3184931 0.01759037 stkP protein kinase ORF U 
305395 + G -2.7598824 0.01365923 SPy_0348 aminodeoxychorismate lyase ORF U 
713911 + G -4.0989164 0.00154055 SPy_0865 ↔ Spy_sRNA713953 "hypothetical protein" UTR U 
518762 + G -2.9654672 0.0040871 ftsX cell-division protein ORF U 
947461 + G -3.0050101 0.00805848 gyrA DNA gyrase subunit A ORF U 
1530955 + G -2.5164073 0.01134356 SPy_1845 hypothetical protein ORF U 
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71140 + G -4.2553806 0.00162751 rpsH 30S ribosomal protein S8 ORF U 
665855 + G -3.5871165 0.00255899 rlmI hypothetical protein ORF U 
614992 + G -4.1151462 0.00317484 atpB ATP synthase F0F1 subunit A ORF U 
1085336 − G -3.4725101 0.00869713 SPy_1308 ↔ Spy_sRNA1085297 "esterase" UTR U 
1850570 + G -5.2963182 0.00117632 htrA serine protease ORF U 
107969 − G -4.3375232 0.00180923 proC ↔ SPy_0110 "pyrroline-5-carboxylate reductase" ↔ "hypothetical protein" UTR U 
1517566 + G -4.2630377 0.00187064 corA divalent cation transport protein ORF U 
320197 + G -4.4041088 0.02266403 SPy_0374 hypothetical protein ORF U 
1568240 − G -3.6909479 0.0036685 SPy_1892 ↔ SPy_t52 "hypothetical protein" ↔ "tRNA-Leu (AAG)" UTR U 
115048 − G -3.6502608 0.00046297 rofA regulatory protein ORF U 
1424789 − G -3.6244504 0.00414061 infB translation initiation factor IF-2 ORF U 
290364 + G -4.3589183 0.00300344 htpX heat shock protein HtpX ORF U 
88476 + G -6.1135341 0.00154055 adcB ABC transporter permease ORF S 
1403406 − G -4.3945381 0.00046297 glyQ ↔ glyS "glycyl-tRNA synthetase subunit alpha" ↔ "glycyl-tRNA synthetase subunit beta" UTR S 
120684 + G -3.2637025 0.00303308 SPy_0129 hypothetical protein ORF S 
1717865 + G -2.4389867 0.01191043 SPy_2063 hypothetical protein ORF S 
1454339 − G -3.2705283 0.00266228 fabH 3-oxoacyl-ACP synthase ORF S 
734526 + G -4.5910271 0.00778311 SPy_0887 hypothetical protein ORF U 
1450213 − A -2.2433414 0.04441892 fabF 3-oxoacyl-ACP synthase ORF U 
320563 + G -4.0009619 0.00158438 SPy_0374 hypothetical protein ORF U 
71149 + G -5.898757 0.00154055 rpsH ↔ rplF "30S ribosomal protein S8" ↔ "50S ribosomal protein L6" UTR U 
1453867 − G -3.4262488 0.00762705 fabH 3-oxoacyl-ACP synthase ORF U 
1838142 − G -3.5203423 0.00251456 glcU hypothetical protein ORF U 
111220 + G -5.2044057 0.00162196 ytpR  ORF U 
1329354 + G -2.6896869 0.02268772 SPy_1608 hypothetical protein ORF U 
1680611 − G -6.7989094 0.00030048 Spy_sRNA1680670  UTR U 
1183494 − G -3.8298352 0.00274189 niaX hypothetical protein ORF U 
428218 + G -4.0545526 0.00382502 vicK two-component sensor histidine kinase ORF U 
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472174 + G -4.4255648 0.00154055 ptsK HPr kinase/phosphorylase ORF U 
32908 + G -4.1072367 0.00207313 prsA ribose-phosphate pyrophosphokinase ORF U 
254023 − G -3.291518 0.01753913 dacA_2  ORF U 
112328 − G -3.9559779 0.00235458 SPy_0121 ↔ Spy_sRNA112285 "deoxyguanosine kinase/deoxyadenosine kinase(I) subunit" UTR U 
849003 + G -3.2023381 0.00717095 glmM phosphoglucosamine mutase ORF U 
1472043 − G -3.4971512 0.01513906 SPy_1781 ↔ SPy_1780 "hypothetical protein" ↔ "hypothetical protein" UTR U 
1699224 − C -6.054102 0.00037248 speB pyrogenic exotoxin B ORF U 
146735 + A -2.3924809 0.03999118 purA adenylosuccinate synthetase ORF U 
1406622 − G -3.1630325 0.02349569 nagA N-acetylglucosamine-6-phosphate deacetylase ORF U 
471430 + G -4.8222547 0.00117632 Spy_sRNA471434  UTR U 
248410 + G -4.8186438 0.00171405 rgpG hypothetical protein ORF U 
1701817 − G -4.1326919 0.00688493 mf ↔ ropB "mitogenic factor" ↔ "transcriptional regulator" UTR U 
274907 + G -3.5356776 0.02853138 SPy_0309 hypothetical protein ORF U 
1366777 + G -4.418621 0.00154055 recU Holliday junction-specific endonuclease ORF U 
978434 − G -3.2392114 0.01513906 citC citrate lyase synthetase ORF U 
1535210 − G -4.5322096 0.00073023 SPy_1850 ↔ pfl "esterase" ↔ "pyruvate formate-lyase" UTR U 
1375132 − G -3.533737 0.01201342 aapA amino acid permease ORF U 
1571150 − G -4.3566986 0.00074043 rpoE ↔ Spy_sRNA1571135 "DNA-directed RNA polymerase subunit delta" UTR U 
1345722 − G -3.2121506 0.00168462 stkP protein kinase ORF U 
115985 − G -3.1139618 0.00973486 rofA regulatory protein ORF U 
1383473 − G -4.5363271 0.00266228 ftsL cell division protein ORF U 
73054 + G -4.0339542 0.00167333 rpmD ↔ Spy_sRNA73113 "50S ribosomal protein L30" UTR U 
1840448 − G -3.5148879 0.01902795 guaB inosine 5'-monophosphate dehydrogenase ORF U 
307062 − G -3.4535335 0.00205495 yidC2 ↔ Spy_sRNA307010 "OxaA-like protein" UTR S 
1699189 − C -5.7379285 0.00074224 speB pyrogenic exotoxin B ORF U 
381172 + G -3.3579912 0.00255899 frr ↔ SPy_0464 "ribosome recycling factor" ↔ "hypothetical protein" UTR U 
1152301 − G -3.3321089 0.0274186 alaS alanyl-tRNA synthetase ORF U 
477779 − G -2.9536274 0.00727361 Spy_sRNA477984 ↔ Spy_sRNA477714 
 UTR U 
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285038 + G -5.3092415 0.00479199 sstT serine/threonine transporter SstT ORF U 
1683210 − G -4.0481137 0.0027707 sic inhibitor of complement-mediated lysis ORF S 
849024 + G -3.1773496 0.00528794 glmM phosphoglucosamine mutase ORF U 
319062 + G -4.5428746 0.00154055 trmL 23S rRNA methyltransferase ORF U 
932728 + G -4.6742514 0.00154055 pbuX purine permease ORF U 
278753 + C -3.6248272 0.00334461 SPy_0316 hypothetical protein ORF U 
1264364 − G -5.6432185 0.00074043 SPy_1536 ↔ lacI "hypothetical protein" ↔ "ribose transport operon repressor" UTR U 
1139348 − G -1.8191738 0.04036051 pstI phosphoenolpyruvate:sugar phosphotransferase system enzyme I ORF U 
1680618 − G -4.5139229 0.00321851 Spy_sRNA1680670  UTR U 
65047 + C -2.152743 0.03204506 rplD 50S ribosomal protein L4 ORF U 
784641 − G -2.4638029 0.01615945 SPy_0948 or SPy_0947 "hypothetical protein" or "hypothetical protein" ORF U 
1518318 + G -2.5784585 0.02063761 SPy_1828 hypothetical protein ORF U 
183554 − G -2.9797315 0.00278041 SPy_0201 hypothetical protein ORF U 
1535306 − G -3.500358 0.0074938 SPy_1850 esterase ORF U 
1792766 − G -4.2382581 0.01671002 SPy_2153 hypothetical protein ORF U 
115218 − G -2.9362253 0.04248731 rofA regulatory protein ORF U 
407561 − G -2.5414217 0.01328359 pcp pyrrolidone-carboxylate peptidase ORF U 
308001 − G -3.6760674 0.00956642 yidC2 OxaA-like protein ORF U 
1439397 + G -2.7989535 0.01109809 SPy_1737 hypothetical protein ORF U 
1404769 − G -2.3931691 0.01108144 Spy_sRNA1404921 glyQ leader UTR S 
705947 + G -4.2332012 0.00324595 fruB fructose-1-phosphate kinase ORF U 
18649 + G -3.3719277 0.00304669 SPy_r01 ↔ SPy_t01 "16S rRNA" UTR U 
14744 + G -2.1411051 0.04359308 ftsH cell division protein ORF U 
958809 + G -4.1543631 0.00154055 topA DNA topoisomerase I ORF U 
1792652 + G -5.1825736 0.00717095 SPy_2152 hypothetical protein ORF U 
1581533 − G -2.7451403 0.01102107 SPy_r12 ↔ SPy_t55 "16S rRNA" ↔ "tRNA-Ala (TGC)" UTR U 
78458 + G -3.5684251 0.00158438 rplQ 50S ribosomal protein L17 ORF U 
24650 + G -2.9598792 0.00753443 SPy_r03 ↔ SPy_t11 "16S rRNA" UTR U 
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640306 + C -2.8899624 0.00675131 dnaG DNA primase ORF S 
335393 + G -4.9382046 0.00117632 Spy_sRNA335396 UTR U 
265934 + G -2.7358625 0.00964512 SPy_r07 ↔ SPy_t35 "16S rRNA" ↔ "tRNA-Ala (TGC)" UTR U 
287634 − G -4.5329337 0.01118653 ntpJ V-type Na  -ATPase subunit J ORF U 
1611380 − G -3.679853 0.01378971 SPy_1936 hypothetical protein ORF U 
1387143 − G -4.1460129 0.00232382 SPy_1673 ABC transporter permease ORF U 
85408 + G -2.5395422 0.00831754 SPy_t34 tRNA-Leu (CAA) UTR U 
1698455 − C -5.5444909 0.00074043 SPy_2038  ORF U 
80868 + G -2.9256586 0.00954855 SPy_r05 ↔ SPy_t22 "16S rRNA" ↔ "tRNA-Ala (TGC)" UTR U 
1030602 − G -3.4153439 0.00517723 spxA transcriptional regulator Spx ORF U 
1683123 − G -4.1484974 0.00163858 sic inhibitor of complement-mediated lysis ORF S 
1455284 − G -4.4045308 0.00545934 phaB enoyl-CoA hydratase ORF U 
1053328 − A -3.5205225 0.02585314 phnA hypothetical protein ORF U 
1247216 − G -4.8773062 0.0038952 sepF hypothetical protein ORF U 
311860 + G -3.9528814 0.00562052 SPy_0358 hypothetical protein ORF U 
1762537 − G -4.6397886 0.00037248 SPy_2111 ↔ nrdD "hypothetical protein" ↔ "anaerobic ribonucleoside triphosphate reductase" UTR U 
1557813 + G -3.9401261 0.00402886 rnjA ↔ glnA "Zn-dependent hydrolase" ↔ "glutamine synthetase" UTR U 
110128 − G -3.7188665 0.00242634 SPy_0116 hypothetical protein ORF U 
1441577 + G -2.9233771 0.00964512 manM PTS system mannose-specific transporter subunit IIC ORF U 
122080 + G -2.3953095 0.02741635 SPy_0130 ↔ SPy_0131 "hypothetical protein" ↔ "hypothetical protein" UTR S 
897129 + G -3.9037623 0.00229742 folC.1 folyl-polyglutamate synthetase ORF U 
1844913 + G -2.5923234 0.01624666 SPy_2210 ABC transporter ATP-binding protein ORF U 
1540175 − G -4.0135435 0.00604315 norA antibiotic resistance protein NorA ORF S 
131575 − G -5.3159644 0.00522435 SPy_0144 hypothetical protein ORF U 
1454152 − G -3.7756169 0.02327768 fabH 3-oxoacyl-ACP synthase ORF U 
1713230 − G -3.1481282 0.00419439 secE ↔ pflA "preprotein translocase subunit SecE" ↔ "pyruvate formate-lyase activating protein" UTR U 
1764633 − G -3.2913278 0.01671002 SPy_2112 hypothetical protein ORF U 
1685503 − A -2.5441635 0.01722349 mga M protein trans-acting positive regulator ORF U 
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31422 + G -2.9299432 0.00493291 cdhA hypothetical protein ORF U 
29085 + A -4.1223532 0.00117632 SPy_t21 ↔ cdhA "tRNA-Ser (GCT)" ↔ "hypothetical protein" UTR S 
227166 + G -2.8702295 0.0104923 ksgA ↔ rsgA "dimethyladenosine transferase" ↔ "ribosome-associated GTPase" UTR U 
1390062 − G -2.9645959 0.02154857 tkt transketolase ORF U 
1345714 − G -2.6791934 0.00891298 stkP protein kinase ORF U 
307075 − G -3.8061917 0.01009089 yidC2 ↔ Spy_sRNA307010 "OxaA-like protein" UTR U 
370709 − G -3.5303362 0.03857277 mntR metal-dependent transcriptional regulator ORF U 
1329406 + G -2.7201455 0.03299831 SPy_1608 ↔ Spy_sRNA1329429 "hypothetical protein" UTR U 
93367 + G -3.0547674 0.00239447 Spy_sRNA93359  UTR U 
335380 + G -3.0857496 0.00451315 clpP ATP-dependent Clp protease proteolytic subunit ORF U 
1699202 − T -5.3650616 0.00503233 speB pyrogenic exotoxin B ORF U 
1698333 − T -6.1964279 0.00081057 SPy_2038 ↔ prsA2 "foldase PrsA" UTR U 
75005 + G -3.835325 0.00154055 secY preprotein translocase subunit SecY ORF U 
1055635 − G -3.1799145 0.00565414 sipC signal peptidase I ORF U 
1683190 − G -3.4714639 0.0141975 sic inhibitor of complement-mediated lysis ORF U 
1697886 − G -4.3049012 0.00688493 SPy_2038 ↔ prsA2 "foldase PrsA" UTR U 
69330 + A -2.7252457 0.0183345 rplN 50S ribosomal protein L14 ORF U 
117541 + G -3.2802471 0.00875631 cpa  ORF U 
1616523 − G -4.0750371 0.03226786 cysE ↔ SPy_1942 "serine acetyltransferase" ↔ "hypothetical protein" UTR U 
1698650 − T -5.2403324 0.00073023 SPy_2038  ORF U 
292611 + G -3.0832761 0.00344565 covS sensory transduction histidine kinase ORF U 
177858 + G -2.7200762 0.02015808 SPy_0190 or SPy_0191a "hypothetical protein" or "hypothetical protein" ORF U 
1141021 − G -2.7372841 0.00522435 ptsH phosphocarrier protein HPr ORF U 
1698505 − T -7.1420783 0.00352409 SPy_2038  ORF U 
 
Table A2. RNA 5′ ends more abundant in the WT strain than in ∆rny strain (5′ rny_ends). 
List of the RNA 5′ ends identified as more abundant in the WT strain than in the ∆rny strain and named as 5′ rny_ends (see Figure 11). The information is provided with 
regard the chromosome position, the directionality of the strand (positive (+) or negative (−)), the log 2 Fold Change (Log2FC), the False Discovery Rate (FDR), the 
gene ID (the symbol “↔”
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depicts the intergenic region between two genes), the description of the gene function based on NCBI, the location of the 5′ rny_end (open reading frame (ORF) and 




















Table A3. Simultaneous mapping of the speB sRNA 5′ and 3′ ends. 
List of the detected speB-sRNA 5′ (in purple) and 3′ (in green) ends obtained by circularization of RNA by 
self-ligation followed by Reverse Transcriptase-Polymerase Chain Reaction (Circ-RT-PCR; see Material & 
Methods and Figure 17). The DNA sequences amplified from the cDNA were cloned into the TOPO TA 
vector (Invitrogen) and analyzed by Sanger sequencing. The positions reported for the RNA 5′ and 3′ ends 
are relative to the speB start codon (see Figure 17). The n.d. (not determined) indicates the clones for which 
the transcript 5′ and 3′ could not be retrieved either because the DNA sequencing signal was undetectable 
or because the sequenced vector did not contain any inserts. For the clones 11, 15, 21 and 22 two Circ-RT- 
Clones Sequence Position 5′ end Position 3′ end 
1 TAGATTAACTTATTGTCTATTACC − 137 nt − 25 nt 
2 - n.d. n.d. 
3 - n.d. n.d. 
4 - n.d. n.d. 
5 - n.d. n.d. 
6 GTATAAAAAAAATGATTATTGTCTATTACC − 137 nt − 10 nt 
7 AAAGAAATTAGGTGTTCTATTACCATTCAT − 131 nt + 23 nt 
8 AAATGCAGTAGATTATTATTGTCTATTACC − 137 nt − 27 nt 
9 AAATGCAGTAGATTATTATTGTCTATTACC − 137 nt − 27 nt 
10 CAAATGCAGTAGATTTTATTGTCTATTACC − 137 nt − 28 nt 
11a GCAGTAGATTATTATTGTCTATT − 137 nt − 27 nt 
11b ATGCAGTAGATTAACTATTGTCTATTACCA − 136 nt − 25 nt 
12 AAATGCAGTAGATTATTATTGTCTATTACC − 137 nt − 27 nt 
13 - n.d n.d 
14 GTAGATTTTATTGTCTATTACC − 137 nt − 28 nt 
15a AATGCAGTAGATTAGTTATTGTCTATTACC − 137 nt − 28 nt 
15b AAATGCAGTAGATTAGTTATTGTCTATTAC − 138 nt − 27 nt 
16 AATTAGGTTATTGTCTATTACC − 137 nt + 20 nt 
17 - n.d. n.d. 
18 AAATGCAGTAGATTATCTATTACCATTCAT − 131 − 26 nt 
19 - n.d. n.d. 
20 AAATGCAGTAGATTATTATTGTCTATTACC − 137 nt − 27 nt 
21a CAAATGCAGTAGATTTTATTGTCTATTAC − 137 nt − 28 nt 
21b CAAATGCAGTAGATTTTATTGTCTATTACC − 137 nt − 28 nt 
22a AATGCAGTAGATTAATTATTGTCTATTACC − 137 nt − 26 nt 
22b CAAATGCAGTAGATTTCTATTACCATTCAT − 131 nt − 28 nt 
23 AATGCAGTAGATTAATATTGTCTATTACCA − 136 nt − 26 nt 
24 AAATGCAGTAGATTATTATTGTCTATTACC − 137 nt − 27 nt 
25 CAAATGCAGTAGATTTTATTGTCTATTACC − 137 nt − 28 nt 
26 ATGCAGTAGATTAACTTATTGTCTATTACC − 137 nt − 25 nt 
27 - n.d. n.d. 
28 CAAATGCAGTAGATTTTATTGTCTATTACCA − 137 nt − 28 nt 
29 AATGCAGTAGATTAATTATTGTCTATTACC − 137 nt − 26 nt 
30 AAATGCAGTAGATTATTATTGTCTATTACC − 137 nt − 27 nt 
31 CAAATGCAGTAGATTTCTATTACCATTCAT − 131 nt − 28 nt 
32 TAGATTAATTATTGTCTATTACC − 137 nt − 26 nt 
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PCR generated inserts were found in the vector (indicated as “a” and “b”) and both sequences were included 






Position Strand nt in 3′ Log 2 FC FDR Gene ID Description Location type 
1763385 − T -3.8568929 5.00E-05 SPy_2111 hypothetical protein ORF S 
477545 − T -3.7580326 3.36E-05 SPy_0593 (antisense) hypothetical protein UTR S 
861256 + T -3.072974 0.00852775 Spy_sRNA860730 ↔ lepA CRISPR RNA (crRNA) ↔ "GTP-binding protein LepA" UTR U 
1152709 − G -3.6611274 0.00040452 Spy_sRNA1153040 ↔ alaS "alanyl-tRNA synthetase" UTR U 
292690 + C -2.0623033 0.00809917 covS sensory transduction histidine kinase ORF S 
417307 + A -3.3282281 0.00768874 Spy_sRNA416968 ↔ thrS "threonyl-tRNA synthetase" UTR S 
377298 + C -3.0978246 0.0038518 ftsK hypothetical protein ORF S 
287540 − A -2.8618134 0.00863008 ntpJ V-type Na  -ATPase subunit J ORF S 
1633958 − T -4.1623222 0.0005108 proS prolyl-tRNA synthetase ORF U 
1152119 − A -3.1195535 0.00113354 alaS alanyl-tRNA synthetase ORF S 
656504 + T -4.1491298 0.01898369 SPy_0797 hypothetical protein ORF U 
1516070 − A -5.6467011 0.00073311 uvrA excinuclease ABC subunit A ORF U 
1405169 − G -4.7914094 0.00019191 SPy_1691 hypothetical protein ORF U 
524653 + T -2.4776189 0.02886727 aspC aspartate aminotransferase ORF U 
111312 + T -5.0038511 0.00409174 ytpR  ORF S 
1401103 − T -3.7757093 0.00254882 glyS ↔ SPy_1687 "glycyl-tRNA synthetase subunit beta" ↔ "hypothetical protein" UTR U 
350705 + A -3.7833051 0.00260679 Spy_sRNA350644  UTR U 
381252 + A -4.1598184 0.04574839 frr ↔ SPy_0464 "ribosome recycling factor" ↔ "hypothetical protein" UTR U 
323184 + G -4.1824682 0.00375107 hlyX hemolysin ORF U 
1023862 − T -3.1170428 0.01256691 pstB phosphate transporter ATP-binding protein ORF U 
1762451 − A -2.7001608 0.00059059 nrdD anaerobic ribonucleoside triphosphate reductase ORF S 
117634 + C -2.3210181 0.00863928 cpa  ORF S 
1811851 − C -2.9226296 0.00098742 Spy_sRNA1811977 ↔ rpsD "30S ribosomal protein S4" UTR U 
583794 + T -4.0273433 0.00316825 gyrB ↔ ezrA "DNA gyrase subunit B" ↔ "septation ring formation regulator EzrA" UTR U 
1276420 − T -3.4475931 0.00118597 SPy_1551 hypothetical protein ORF S 
473838 + C -2.6302029 0.04394521 SPy_0587 hypothetical protein ORF U 
302525 + C -2.4917831 0.01146702 murC UDP-N-acetylmuramate--L-alanine ligase ORF S 
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584148 + G -4.8362554 0.00265048 ezrA septation ring formation regulator EzrA ORF U 
278847 + T -3.3416019 0.00276394 SPy_0316 hypothetical protein ORF S 
1154281 − C -3.5500251 0.0038051 SPy_1391 O-methyltransferase ORF S 
1536397 − C -4.551466 0.0008995 SPy_1851 C3-degrading proteinase ORF U 
836743 + T -2.73752 0.02099924 acoB ↔ acoC 
"acetoin dehydrogenase (TPP-dependent) subunit 
beta" ↔ "branched-chain alpha-keto acid 
dehydrogenase E2 subunit" 
UTR U 
1366859 + C -2.9196368 0.00568763 recU Holliday junction-specific endonuclease ORF S 
91733 + T -3.1455631 0.00609803 pbp1b penicillin-binding protein 1b ORF S 
285126 + A -3.5989427 0.00369495 sstT serine/threonine transporter SstT ORF U 
1152853 − T -2.3907009 0.01903583 Spy_sRNA1153040  UTR U 
71242 + C -4.4743989 0.00260679 rpsH ↔ rplF "30S ribosomal protein S8" ↔ "50S ribosomal protein L6" UTR S 
120819 + T -2.8742207 0.02117838 SPy_0129 hypothetical protein ORF U 
1559098 − T -5.1115322 0.0002004 glnA glutamine synthetase ORF U 
849120 + A -3.6372278 0.00470206 glmM phosphoglucosamine mutase ORF S 
1556174 + T -3.8652108 0.00292 rnjA Zn-dependent hydrolase ORF S 
1432259 − T -4.0084674 0.00062484 ecsB ABC transporter permease ORF U 
706040 + A -3.7204913 0.00425789 fruB fructose-1-phosphate kinase ORF S 
115872 − G -3.865514 0.00120268 rofA regulatory protein ORF U 
502476 + C -3.0836874 0.00546513 pacL calcium-transporting ATPase ORF S 
1851196 + G -3.1728037 0.00901808 htrA serine protease ORF U 
409537 − T -2.7036679 0.00131067 SPy_0508 hypothetical protein ORF S 
415383 + T -3.2051353 0.02869468 dgs sugar transferase ORF U 
275363 + A -3.7163707 0.01676677 SPy_0309 hypothetical protein ORF U 
1558401 − G -3.4088237 0.00032401 glnA glutamine synthetase ORF S 
1454165 − T -2.6955879 0.00334994 fabH 3-oxoacyl-ACP synthase ORF U 
666036 + T -3.1112758 0.00751673 rlmI hypothetical protein ORF S 
744602 + T -3.4176019 0.01563308 Spy_sRNA744487 ↔ pyrF "orotidine 5'-phosphate decarboxylase" UTR U 
1840324 − A -4.5140052 9.00E-05 guaB inosine 5'-monophosphate dehydrogenase ORF U 
88538 + T -4.4644751 0.00396 adcB ABC transporter permease ORF U 
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1763860 − T -3.7898395 0.00268056 SPy_2111 hypothetical protein ORF U 
411744 − T -4.5263088 0.00046146 SPy_0512 NAD(P)H-dependent quinone reductase ORF U 
146883 + T -2.9185577 0.01567386 purA adenylosuccinate synthetase ORF U 
947611 + C -3.6198655 0.0137656 gyrA DNA gyrase subunit A ORF U 
931822 + T -3.0214728 0.02095553 pbuX purine permease ORF U 
640060 − G -4.2470927 0.00010443 mscL large conductance mechanosensitive channel ORF S 
1329559 + T -5.0813197 0.01418538 Spy_sRNA1329429 ↔ SPy_1610 "hypothetical protein" UTR U 
1124061 − C -3.2889381 0.00383466 murZ UDP-N-acetylglucosamine 1-carboxyvinyltransferase ORF U 
51860 + G -2.9651687 0.02304978 purB adenylosuccinate lyase ORF S 
585163 + G -4.4310869 0.00405894 ezrA septation ring formation regulator EzrA ORF U 
1459561 − G -3.6226876 0.00674955 grpE heat shock protein GrpE ORF U 
1105854 − T -5.2398441 0.00130121 obgE GTPase ObgE ORF U 
1517716 + C -3.1120511 0.02142733 corA divalent cation transport protein ORF U 
1761325 − T -3.9648187 0.00040452 nrdD anaerobic ribonucleoside triphosphate reductase ORF S 
1565753 − C -4.1878428 0.00290846 SPy_1885 hypothetical protein ORF U 
1266402 − G -3.2525311 0.00150099 rsmD hypothetical protein ORF U 
1057045 − A -3.4186853 0.01226775 pyk pyruvate kinase ORF U 
1109568 − T -3.4910506 0.00301534 SPy_1340 hypothetical protein ORF U 
1026696 − T -2.9695957 0.01743404 pstC2 phosphate ABC transporter permease ORF U 
758666 + T -2.6625223 0.0073664 SPy_t40 ↔ rpsA "tRNA-" ↔ "30S ribosomal protein S1" UTR U 
351331 + T -3.6931896 0.01249206 metS methionyl-tRNA synthetase ORF U 
902708 + T -3.4278645 0.01619415 potB spermidine / putrescine ABC transporter permease ORF U 
1451322 − A -3.372407 0.00464364 fabD ACP S-malonyltransferase ORF U 
1014156 − C -3.2694341 0.01760568 bmpA lipoprotein ORF U 
1026888 − T -3.6408174 0.00648616 pstC2 phosphate ABC transporter permease ORF U 
69496 + G -2.0300039 0.04394044 rplN ↔ rplX "50S ribosomal protein L14" ↔ "50S ribosomal protein L24" UTR U 
1453782 − T -5.6260181 0.00051279 fabH 3-oxoacyl-ACP synthase ORF U 
185345 + T -2.9675033 0.01106193 tgt queuine tRNA-ribosyltransferase ORF S 
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1611297 − G -4.0763607 0.00047754 SPy_1936 hypothetical protein ORF S 
714002 + T -3.2876809 0.01000566 Spy_sRNA713953 ↔ papS "tRNA CCA-pyrophosphorylase" UTR S 
73158 + A -3.7312026 0.00747594 Spy_sRNA73113 ↔ rplO "50S ribosomal protein L15" UTR U 
266186 + T -2.9692707 0.00417597 SPy_t35 ↔ SPy_r08 "tRNA-Ala (TGC)" ↔ "23S rRNA" UTR S 
1124008 − C -2.7016039 0.04687215 murZ UDP-N-acetylglucosamine 1-carboxyvinyltransferase ORF U 
1698393 − C -5.9396749 6.58E-05 SPy_2038  ORF U 
18901 + T -3.0663442 0.0040905 SPy_t01 ↔ SPy_r02 "23S rRNA" UTR S 
24902 + T -2.985014 0.00510673 SPy_t11 ↔ SPy_r04 "23S rRNA" UTR S 
1225917 − A -3.1458554 0.00713146 SPy_1494 hypothetical protein ORF U 
1581281 − T -2.7984486 0.00098071 SPy_t55 ↔ SPy_r11 "tRNA-Ala (TGC)" ↔ "23S rRNA" UTR S 
1334347 − T -3.1000049 0.00062425 SPy_t50 ↔ SPy_r09 "tRNA-Ala ("↔ "23S rRNA" UTR S 
81120 + T -2.8604307 0.00605576 SPy_t22 ↔ SPy_r06 "tRNA-Ala (TGC)" ↔ "23S RNA" UTR S 
319029 + A -4.1438573 0.00614776 trmL 23S rRNA methyltransferase ORF U 
1443367 + T -1.9016982 0.02351018 Spy_sRNA1443306  UTR S 
1404844 − A -4.2445705 1.28E-05 Spy_sRNA1404921 glyQ leader UTR S 
1053257 − C -5.3650373 0.00097458 phnA hypothetical protein ORF U 
1368291 + T -3.5666218 0.0096089 pbp1A penicillin-binding protein 1a ORF U 
72832 + A -3.6511853 0.00553136 rpsE 30S ribosomal protein S5 ORF S 
1698866 − C -4.8724699 0.00036038 speB pyrogenic exotoxin B ORF U 
185405 + G -3.4354811 0.02808139 tgt queuine tRNA-ribosyltransferase ORF U 
1455126 − G -3.1105306 0.01566637 phaB enoyl-CoA hydratase ORF U 
1441757 + T -2.5688785 0.0304393 manM PTS system mannose-specific transporter subunit IIC ORF U 
661518 + C -2.8453885 0.01791255 Spy_sRNA661400 ↔ infC "translation initiation factor IF-3" UTR S 
68255 + G -6.8473319 0.01594932 rplP 50S ribosomal protein L16 ORF U 
826106 + T -2.6039698 0.02021694 Spy_sRNA825970  UTR U 
1699898 − T -5.0563348 0.0027535 Spy_sRNA1699993 ↔ speB "pyrogenic exotoxin B" UTR U 
31491 + A -3.529689 0.00260679 cdhA hypothetical protein ORF S 
1295748 − T -3.2287988 0.0001929 Spy_sRNA1295825  UTR S 
  
167 Appendix 
1535220 − T -3.1389072 0.01831679 SPy_1850 ↔ pfl "esterase" ↔ "pyruvate formate-lyase" UTR U 
1441617 + T -3.2547213 0.02864112 manM PTS system mannose-specific transporter subunit IIC ORF U 
639502 + A -3.1424387 0.0255539 rpsU 30S ribosomal protein S21 ORF U 
1683342 − C -3.8742051 0.00779785 sic inhibitor of complement-mediated lysis ORF U 
116813 + A -3.1096906 0.00611928 Spy_sRNA116781 or cpa  ORF U 
661502 + C -2.604117 0.01453765 Spy_sRNA661400  UTR S 
1465711 − T -3.4642669 0.03002366 gatA aspartyl/glutamyl-tRNA amidotransferase subunit A ORF U 
946419 − T -3.7279895 0.01193934 ldh L-lactate dehydrogenase ORF U 
615125 + T -3.1894959 0.01188897 atpB ATP synthase F0F1 subunit A ORF U 
1518451 + C -3.9067601 0.00297359 SPy_1828 hypothetical protein ORF U 
1811863 − A -3.0695344 0.00783531 Spy_sRNA1811977 ↔ rpsD "30S ribosomal protein S4" UTR U 
1336230 − G -1.9729673 0.01159786 yhbH ↔ SPy_r10 "hypothetical protein" ↔ "16S rRNA" UTR U 
17018 + G -1.9785249 0.01773377 SPy_0016 ↔ SPy_r01 "amino acid permease" ↔ "16S rRNA" UTR U 
79237 + G -2.0956978 0.01429475 Spy_sRNA78598 ↔ SPy_r05 "16S rRNA" UTR U 
1137997 − T -3.6598094 0.00447574 gapN NADP-dependent glyceraldehyde-3-phosphate dehydrogenase ORF U 
1696694 + C -3.4968468 0.01259933 Spy_sRNA1696464 ↔ Spy_sRNA1696905 
 UTR U 
482849 − G -3.3230751 0.01063369 Spy_sRNA482963  UTR U 
31549 + T -2.4236401 0.02747926 cdhA hypothetical protein ORF U 
72163 + G -3.1657866 0.02850352 rplR 50S ribosomal protein L18 ORF U 
 
Table A4. RNA 3′ ends more abundant in the WT strain than in ∆rny strain (3′ rny_ends). 
List of the RNA 3′ ends identified as more abundant in the WT strain than in the ∆rny strain and named as 3′ rny_ends (see Figure 18). The information is provided with 
regard the chromosome position, the directionality of the strand (positive (+) or negative (−)), the log 2 Fold Change (Log2FC), the False Discovery Rate (FDR), the 
gene ID (the symbol “↔” depicts the intergenic region between two genes), the description of the gene function based on NCBI, the location of the 3′ rny_end (in open 
reading frame (ORF) and untranslated region (UTR)) and the type of 3′ rny_end (“unique” (U) or “stepped” (S)). R.A.-B. generated the raw list of 3′ rny_ends analysed by 
L.B., A.-L.L. and A.L.R. 
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31491 31491 + cdhA Hypothetical protein ORF 
31549 31553 + cdhA Hypothetical protein ORF 
71242 71241 + rpsH ↔ rplF 30S ribosomal protein S8 ↔ 50S ribosomal protein L6 UTR 
73158 73156 + Spy_sRNA73113 ↔ rplO 50S ribosomal protein L15 UTR 
111312 111312 + ytpR  ORF 
116813 116812 + Spy_sRNA116781 or cpa Collagen binding protein ORF 
117634 117634 + cpa Collagen binding protein ORF 
120819 120818 + SPy_0129 Hypothetical protein ORF 
185345 185344 + tgt Queuine tRNA-ribosyltransferase ORF 
278847 278847 + SPy_0316 Hypothetical protein ORF 
287540 287540 − ntpJ V-type Na  -ATPase subunit J ORF 
377298 377298 + ftsK Hypothetical protein ORF 
409537 409537 − SPy_0508 Hypothetical protein ORF 
477545 477545 − SPy_0593 (antisense) Hypothetical protein UTR 
502476 502476 + pacL Calcium-transporting ATPase ORF 
583794 583794 + gyrB ↔ ezrA DNA gyrase subunit B ↔ septation ring formation regulator EzrA UTR 
615125 615125 + atpB ATP synthase F0F1 subunit A ORF 
661502 661502 + Spy_sRNA661400  UTR 
666036 666036 + rlmI Hypothetical protein ORF 
706040 706040 + fruB Fructose-1-phosphate kinase ORF 
758666 758666 + SPy_t40 ↔ rpsA tRNA-Gln (TTG) ↔ 30S ribosomal protein S1 UTR 
836743 836743 + acoB ↔ acoC Acetoin dehydrogenase (TPP-dependent) subunit beta ↔ branched-chain alpha-keto acid dehydrogenase E2 subunit UTR 
849120 849120 + glmM Phosphoglucosamine mutase ORF 
861256 861256 + Spy_sRNA860730 ↔ lepA CRISPR RNA (crRNA) ↔ GTP-binding protein LepA UTR 
902708 902711 + potB Spermidine / putrescine ABC transporter permease ORF 
947611 947611 + gyrA DNA gyrase subunit A ORF 
1014156 1014153 − bmpA Lipoprotein ORF 
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1023862 1023862 − pstB Phosphate transporter ATP-binding protein ORF 
 
1057045 1057045 − pyk Pyruvate kinase ORF 
1105854 1105854 − obgE GTPase ObgE ORF 
1124061 1124061 − murZ UDP-N-acetylglucosamine 1-carboxyvinyltransferase ORF 
1152119 1152119 − alaS Alanyl-tRNA synthetase ORF 
1154281 1154280 − SPy_1391 O-methyltransferase ORF 
1225917 1225916 − SPy_1494 Hypothetical protein ORF 
1366859 1366859 + recU Holliday junction-specific endonuclease ORF 
1401103 1401100 − glyS ↔ SPy_1687 Glycyl-tRNA synthetase subunit beta ↔ hypothetical protein UTR 
1404844 1404844 − Spy_sRNA1404921 glyQ leader UTR 
1441617 1441618 + manM PTS system mannose-specific transporter subunit IIC ORF 
1454165 1454165 − fabH 3-oxoacyl-ACP synthase ORF 
1465711 1465711 − gatA Aspartyl/glutamyl-tRNA amidotransferase subunit A ORF 
1518451 1518451 + SPy_1828 Hypothetical protein ORF 
1536397 1536397 − SPy_1851 C3-degrading proteinase ORF 
1556174 1556174 + rnjA Zn-dependent hydrolase ORF 
1558401 1558401 − glnA Glutamine synthetase ORF 
1811851 1811851 − Spy_sRNA1811977 ↔ rpsD 30S ribosomal protein S4 UTR 




18901 18901 + SPy_t01 ↔ SPy_r02 23S rRNA UTR 
24902 24902 + SPy_t11 ↔ SPy_r04 23S rRNA UTR 
73158 73156 + Spy_sRNA73113 ↔ rplO 50S ribosomal protein L15 UTR 
81120 81120 + SPy_t22 ↔ SPy_r06 tRNA-Ala (TGC) ↔ 23S RNA UTR 
116813 116812 + Spy_sRNA116781 or cpa Collagen binding protein ORF 
266186 266186 + SPy_t35 ↔ SPy_r08 tRNA-Ala (TGC) ↔ 23S rRNA UTR 
278847 278847 + SPy_0316 Hypothetical protein ORF 
292690 292690 + covS Sensory transduction histidine kinase ORF 
302525 302522 + murC UDP-N-acetylmuramate--L-alanine ligase ORF 
411744 411741 − SPy_0512 NAD(P)H-dependent quinone reductase ORF 
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477545 477545 − SPy_0593 (antisense) Hypothetical protein UTR 
 
744602 744602 + Spy_sRNA744487 ↔ pyrF Orotidine 5'-phosphate decarboxylase UTR 
826106 826106 + Spy_sRNA825970  UTR 
861256 861256 + Spy_sRNA860730 ↔ lepA GTP-binding protein LepA UTR 
1026696 1026697 − pstC2 Phosphate ABC transporter permease ORF 
1137997 1137997 − gapN NADP-dependent glyceraldehyde-3-phosphate dehydrogenase ORF 
1152853 1152857 − Spy_sRNA1153040  UTR 
1276420 1276418 − SPy_1551 Hypothetical protein ORF 
1334347 1334347 − SPy_t50 ↔ SPy_r09 tRNA-Ala (TGC) ↔ 23S rRNA UTR 
1432259 1432259 − ecsB ABC transporter permease ORF 
1454165 1454169 − fabH 3-oxoacyl-ACP synthase ORF 
1559098 1559098 − glnA Glutamine synthetase ORF 
1581281 1581281 − SPy_t55 ↔ SPy_r11 tRNA-Ala (TGC) ↔ 23S rRNA UTR 
1633958 1633958 − proS Prolyl-tRNA synthetase ORF 
1761325 1761325 − nrdD Anaerobic ribonucleoside triphosphate reductase ORF 
1762451 1762455 − nrdD Anaerobic ribonucleoside triphosphate reductase ORF 







1152853 1152853 − Spy_sRNA1153040  UTR 
 
Table A5. List of 3'rny_ends that correspond to 3'-to-5' exoRNase trimming stop positions.  
The 3' rny_ends were compared to the trimming stop positions of PNPase, YhaM and RNase R (see Material & Methods and Figure 20A and B). The chromosome 
position of the matching 3' rny_ends and trimming stops is reported. Information is also provided with regard the directionality of strand positive (+) or negative (−), the 
gene ID (the symbol “↔” depicts an intergenic region between two genes), the gene description (based on NCBI) and the location of the processing site (in untranslated 
region (UTR) and open reading frame (ORF)). The list of the 3′ rny_ends ccorresponding to 3'-to-5' exoRNase trimming stop positions was generated by T.T.R. and 









31549 31714 + 165 cdhA ORF A G G T 
71242 71295 + 53 rpsH ↔ rplF UTR G T G A 
73158 73278 + 120 rplO ORF G A A T 
116813 116859 + 46 Spy_sRNA116781 or cpa ORF T C A A 
117634 117788 + 154 cpa ORF T G G A 
120819 121011 + 192 SPy_0129 ORF C G T A 
278847 278883 + 36 SPy_0316 ORF G G A T 
409537 409513 − 24 SPy_0508 ORF T C G A 
417307 417329 + 22 Spy_sRNA416968 ↔ thrS UTR T G A C 
477545 477426 − 119 SPy_0593 ↔ SPy_0591 UTR T C G A 
615125 615216 + 91 atpB ORF T G C T 
661502 661554 + 52 infC ORF G G A T 
758666 758684 + 18 rpsA ORF T T G A 
1014156 1014144 − 12 bmpA ORF G A T T 
1023862 1023727 − 135 phoU ORF G A A A 
1401103 1401097 − 6 SPy_1687 ORF G G A T 
1404844 1404774 − 70 Spy_sRNA1404921 UTR T G A A 
1441617 1441793 + 176 manN ORF G A A C 




278847 278849 + 2 SPy_0316 ORF A T G C 
292690 292696 + 6 covS ORF G T A A 
302525 302528 + 3 murC ORF G G A C 
1762451 1762450 − 1 nrdD ORF G A T A 
411744 411734 − 10 SPy_0512 ORF G G T T 
 
Table A6. List of the initial RNase Y processing sites identified as 3'-to-5' exoRNase trimming start positions. 
The initial RNase Y processing positions were identified by searching for 3'-to-5' exoRNase trimming start positions downstream of the 3' rny_ends corresponding to 
trimming stop positions (in Table A5), see Material & Methods and Figure 20B and C. The chromosome position of the 3' rny_ends and of the trimming start positions 
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(corresponding to the initial RNase Y processing site) is reported. Information is also provided with regard the directionality of the strand (positive (+) or negative (−)), 
the processivity (i.e. distance between the two positions), the gene ID (the symbol “↔” depicts an intergenic region between two genes), the gene description (based on 
NCBI) and the location of the processing site (in untranslated region (UTR) and open reading frame (ORF)) and the nucleotide (nt) at the 3'-to-5' exoRNase trimming 
start position and also the nt at the 3 following positions. The list of the 3'-to-5' exoRNase trimming start positions located downstream of the 3' rny_ends corresponding 









115872 115872 − 0 rofA ORF G 
482849 482849 − 0 Spy_sRNA482963 UTR G 
585163 585163 + 0 ezrA ORF G 
639502 639506 + 4 rpsU ORF G 
1696694 1696695 + 1 Spy_sRNA1696464 ↔ Spy_sRNA1696905 UTR G 




1455126 1455125 − 1 phaB ORF A 
1405169 1405167 − 2 SPy_1691 ORF A 
 
Table A7. List of 3'rny_ends that correspond to 3'-to-5' exoRNase trimming start positions.  
The 3' rny_ends were compared to the trimming start positions of PNPase, YhaM and RNase R (see Material & Methods and Figure 20A and D). The chromosome 
position of the matching 3' rny_ends and trimming starts is reported. Information is also provided with regard the directionality of strand (positive (+) or negative (−)), 
the distance between the 3' rny_end and the trimming start positions, the gene ID (the symbol “↔” depicts an intergenic region between two genes), the gene description 
(based on NCBI) and the location of the processing site (in untranslated region (UTR) and open reading frame (ORF)) and the nucleotide (nt) at the 3'-to-5' exoRNase 




        
Appendix 174 
174 Appendix 
5′ rny_end 3′ rny_end Distance Strand Gene ID Location Trimming stop position Trimming start position 
Fragments trimmed by PNPase 
31422 31491 69 + cdhA ORF 31491  
71149 71242 93 + rpsH ↔ rplF UTR 71241 71295 
111220 111312 92 + ytpR ORF 111312  
117541 117634 93 + cpa ORF 117634  
120684 120819 135 + SPy_0129 ORF 120818  
287634 287540 94 − ntpJ ORF 287540  
409647 409537 110 − SPy_0508 ORF 409537 409513 
614992 615125 133 + atpB ORF 615125 615216 
665855 666036 181 + rlmI ORF 666036  
705947 706040 93 + fruB ORF 706040  
849024 849120 96 + glmM ORF 849120  
947461 947611 150 + gyrA ORF 947611  
1023988 1023862 126 − pstB ORF 1023862  
1152301 1152119 182 − alaS ORF 1152119  
1366777 1366859 82 + recU ORF 1366859  
1401255 1401103 152 − glyS ORF 1401100 1401097 
1518318 1518451 133 + SPy_1828 ORF 1518451  
1558584 1558401 183 − glnA ORF 1558401  
1840448 1840324 124 − guaB ORF 1840322  
Fragments trimmed by PNPase and YhaM 
 PNPase YhaM PNPase YhaM 
73054 73158 104 + rpmD ↔ Spy_sRNA73113 UTR 73156 73156 73278 73158 
278753 278847 94 + SPy_0316 ORF 278847 278847 278883 278849 
1454339 1454165 174 − fabH ORF 1454165 1454169   
Fragments trimmed by YhaM 
302413 302525 112 + murC ORF 302522 302528 
744449 744602 153 + SPy_0899 ↔ SpRNA744487 UTR 744602  
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1152937 1152853 84 − Spy_sRNA1153040 UTR 1152857 1152854 
1276533 1276420 113 − SPy_1551 ORF 1276418  
1634045 1633958 87 − proS ORF 1633958  
1761437 1761325 112 − nrdD ORF 1761325  
1762537 1762451 86 − SPy_2111 ↔ nrdD UTR 1762455 1762450 
1763486 1763385 101 − SPy_2111 ORF 1763385  
292611 292690 79 + covS ORF 292690 292696 
Fragments not identified as trimmed  
88476 88538 62 + adcB ORF 
1698455 1698393 62 − SPy_2038 ORF 
69330 69496 166 + rplN ORF 
115985 115872 113 − rofA ORF 
146735 146883 148 + purA ORF 
275237 275363 126 + SPy_0309 ORF 
285038 285126 88 + sstT ORF 
318951 319029 78 + trmL ORF 
323093 323184 91 + hlyX ORF 
381172 381252 80 + frr ↔ SPy_0464 UTR 
473749 473838 89 + SPy_0587 ORF 
713911 714002 91 + SPy_0865 ↔ Spy_sRNA713953 UTR 
1053328 1053257 71 − phnA ORF 
1152840 1152709 131 − Spy_sRNA1153040 UTR 
1329406 1329559 153 + SPy_1608 ↔ Spy_sRNA1329429 UTR 
1453867 1453782 85 − fabH ORF 
1455284 1455126 158 − phaB ORF 
1517566 1517716 150 + corA ORF 
1535306 1535220 86 − SPy_1850 ORF 
1611380 1611297 83 − SPy_1936 ORF 
1764034 1763860 174 − SPy_2111 ORF 
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Table A8. List of short RNA fragments generated by RNase Y processing. 
The chromosome positions of the 3' rny_ends and 5' rny_ends that were found from 50 to 200 nt of distance from each other are reported (see Figure 24). The information 
is provided with regard the distance in nt between the 3' rny_ends and 5' rny_ends, the directionality of the strand (positive (+) or negative (−)), the gene ID (the symbol 
“↔” depicts an intergenic region between two genes), the gene description (based on NCBI) and the location of the processing site (in untranslated region (UTR) and 









14744 14743 + 1 ftsH cell division protein ORF 
662728 662727 + 1 rplT ↔ ltaS "50S ribosomal protein L20" ↔ "hypothetical protein" UTR 
1625568 1625569 − 1 rpsO 30S ribosomal protein S15 ORF 
1844913 1844912 + 1 SPy_2210 ABC transporter ATP-binding protein ORF 
897129 897127 + 2 folC.1 folyl-polyglutamate synthetase ORF 
1057924 1057926 − 2 pfkA ↔ pyk "6-phosphofructokinase" ↔ "pyruvate kinase" UTR 
1353157 1353159 − 2 rpoZ DNA-directed RNA polymerase subunit omega ORF 
1400285 1400287 − 2 SPy_1686 ↔ Spy_sRNA1400292 "hypothetical protein" UTR 
1518318 1518316 + 2 SPy_1828 hypothetical protein ORF 
1530955 1530953 + 2 SPy_1845 hypothetical protein ORF 
1764034 1764036 − 2 SPy_2111 hypothetical protein ORF 
73054 73051 + 3 rpmD 50S ribosomal protein L30 UTR 
1014753 1014756 − 3 cdd ↔ bmpA "cytidine deaminase" ↔ "lipoprotein" UTR 
1455284 1455287 − 3 phaB enoyl-CoA hydratase ORF 
1387143 1387147 − 4 SPy_1673 ABC transporter permease ORF 
1430377 1430381 − 4 trmB ↔ SPy_t51 "tRNA (guanine-N(7)-)-methyltransferase" ↔ "tRNA-Ser (GGA)" UTR 
849003 848998 + 5 glmM phosphoglucosamine mutase ORF 
1404769 1404774 − 5 Spy_sRNA1404921  UTR 
71140 71134 + 6 rpsH 30S ribosomal protein S8 ORF 
1764633 1764640 − 7 SPy_2112 hypothetical protein ORF 
78458 78450 + 8 rplQ 50S ribosomal protein L17 ORF 
1761437 1761446 − 9 nrdD anaerobic ribonucleoside triphosphate reductase ORF 
287642 287652 − 10 ntpJ V-type Na-ATPase subunit J ORF 
 
Table A9. List of 5'rny_ends paired to PNPase trimming start positions.  
The 5' rny_ends were associated to the trimming start positions of PNPase, YhaM and RNase R (see Material & Methods and Figure 26C). The chromosome position of 
the paired 5' rny_ends and trimming starts is reported. The 5' rny_ends were paired only to PNPase trimming start positions. Information is also provided with the regard 
the directionality of strand (positive (+) or negative (−)), the distance between the 5' rny_end and the PNPase trimming start positions, the gene ID (the symbol “↔” 
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depicts an intergenic region between two genes), the gene description (based on NCBI) and the location of the processing site (in untranslated region (UTR) and open 





Position Strand End nt in 3′ Log 2 FC FDR Gene ID Description Location Type 
1412318 − 5 A 3.244795993 0.00261103 SPy_1700 hypothetical protein ORF U 
31777 + 3 T 4.864234462 0.001395021 cdhA ↔ prsA "hypothetical protein" ↔ "ribose-phosphate pyrophosphokinase" UTR U 
1186492 + 5 A 4.450264832 0.001176324 pyrD dihydroorotate dehydrogenase 1A ORF U 
1547173 − 5 G 3.162110058 0.007856842 SPy_1865 hypothetical protein ORF U 
1130742 + 5 G 3.893188339 0.001540553 SPy_1363 (antisense) hypothetical protein UTR S 
727437 + 5 A 3.219844174 0.002063885 idi ↔ mvaS_1 "isopentenyl pyrophosphate isomerase" ↔ "3-hydroxy-3-methylglutaryl-coenzyme A" UTR S 
279077 + 5 A 4.722613683 0.001176324 SPy_0316 hypothetical protein ORF U 
75054 + 3 T 2.844357304 0.006147763 secY ↔ adk "preprotein translocase subunit SecY" ↔ "adenylate kinase" UTR U 
148549 + 3 T 2.993031075 0.004034073 SPy_0163 ↔ nusG "ABC transporter lipoprotein" ↔ "transcription antitermination protein NusG" UTR U 
929283 + 5 G 3.384308457 0.003315777 opuC ABC transporter binding protein ORF U 
1528152 + 5 G 3.931316635 0.001540553 spi signal peptidase I ORF S 
1609322 − 5 G 4.006491275 0.001684618 rpsI 30S ribosomal protein S9 ORF U 
279187 + 3 A 3.440779327 0.013503824 SPy_0316 ↔ SPy_0317 
"hypothetical protein" ↔ "ABC transporter substrate-
binding protein" UTR S 
1330497 − 5 A 3.483996284 0.000597033 SPy_t43 tRNA-Glu (TTC) UTR U 
713953 + 5 A 5.210396624 0.001487154 Spy_sRNA713953  UTR S 
115179 − 5 A 3.339084724 0.003709849 rofA regulatory protein ORF U 
292739 + 3 T 4.122776922 0.00091425 covS sensory transduction histidine kinase ORF S 
319134 + 3 A 3.134577129 0.005191423 trmL ↔ Spy_sRNA319190 "23S rRNA methyltransferase" UTR U 
320688 + 3 T 3.637082831 0.004208683 Spy_sRNA320648  UTR U 
1108344 − 5 A 5.191850828 0.010839866 rsuA 16S pseudouridylate synthase ORF U 
292628 + 5 A 3.110889408 0.002229995 covS sensory transduction histidine kinase ORF U 
579705 + 5 G 5.890580428 0.001176324 Spy_sRNA579683  UTR U 
338836 + 3 T 3.825351226 0.007366398 SPy_0405 DNA replication intiation control protein YabA ORF U 
419327 + 3 T 3.760282357 0.004034073 thrS ↔ SPy_0518 "threonyl-tRNA synthetase" ↔ "ABC transporter ATP-binding protein" UTR S 
477312 + 3 T 4.190742522 0.001972553 SPy_0591 ↔ SPy_0593 "protease" ↔ "hypothetical protein" UTR U 
580158 + 3 A 4.848729018 9.47E-05 rplS ↔ SPy_t38 "50S ribosomal protein L19" ↔ "tRNA-Arg (CCT)" UTR S 
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1746369 + 5 C 3.761395227 0.001176324 SPy_2091 ↔ rpsB "regulatory protein" ↔ "30S ribosomal protein S2" UTR U 
588004 + 3 T 3.269186155 0.002288374 eno ↔ SPy_0732 "phosphopyruvate hydratase" ↔ "hypothetical protein" UTR S 
714055 + 3 T 4.437644172 0.001188554 papS tRNA CCA-pyrophosphorylase ORF S 
1144148 + 5 A 3.786668655 0.001540553 nrdE.2 ↔ nrdF2 "ribonucleotide-diphosphate reductase subunit alpha" ↔ "ribonucleotide-diphosphate reductase subunit beta" UTR S 
1838938 − 5 A 4.932955795 0.003446201 Spy_sRNA1839037 ↔ glcU "hypothetical protein" UTR U 
639523 + 5 A 2.863512655 0.005361114 rpsU 30S ribosomal protein S21 ORF S 
727562 + 3 T 7.562067715 0.002606791 idi ↔ mvaS_1 "isopentenyl pyrophosphate isomerase" ↔ "3-hydroxy-3-methylglutaryl-coenzyme A" UTR S 
826149 + 3 T 3.294671728 0.004090498 Spy_sRNA825970 ↔ SPy_1016 "hypothetical protein" UTR U 
1821630 − 5 A 2.999134765 0.027237832 mnmA tRNA-specific 2-thiouridylase MnmA ORF U 
834702 + 3 C 3.000933933 0.035924422 acoA acetoin dehydrogenase (TPP-dependent) subunit alpha ORF U 





319526 + 5 T 3.342980327 0.028051389 ribU hypothetical protein ORF U 
1108243 − 5 G 2.864832125 0.005191277 rsuA 16S pseudouridylate synthase ORF U 
864784 + 5 A 3.227903282 0.00367721 sciB hypothetical protein ORF U 
1065236 + 3 C 2.146581975 0.027637579 SPy_s01 or Spy_sRNA1065030 "tmRNA" ORF U 
799582 + 5 C 3.442340784 0.006937556 SPy_0976 hypothetical protein ORF S 
1633069 − 5 A 4.141392793 0.002021061 proS prolyl-tRNA synthetase ORF U 
1115389 − 3 T 3.851533941 0.005745952 psr ↔ rumA "PBP 5 synthesis repressor" ↔ "RNA methyltransferase" UTR S 
1053815 − 5 G 2.826755011 0.033393607 glmS glucosamine--fructose-6-phosphate aminotransferase ORF U 
279091 + 5 A 4.814114689 0.001540553 SPy_0316 hypothetical protein ORF U 
1122830 − 3 T 4.807025719 3.53E-05 grab ↔ rimJ "protein G-like alpha 2M-binding protein" ↔ "acetyl transferase" UTR S 
917331 − 5 A 2.440070502 0.016897091 SPy_1119 hypothetical protein ORF U 
1696503 + 5 T 4.729383544 0.001176324 BILSSTRPYOSF370V1_01732T 
 ORF U 
1130843 + 3 G 4.237316485 0.001972553 SPy_1363 ↔ dnaX "hypothetical protein" ↔ "DNA polymerase III subunits gamma and tau" UTR S 
759365 + 5 G 3.507232645 0.007214717 rpsA 30S ribosomal protein S1 ORF U 
985204 − 5 A 3.221124257 0.018937515 SPy_1202 GntR family transcriptional regulator ORF U 
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1108207 − 5 C 2.577212306 0.00688493 rsuA 16S pseudouridylate synthase ORF U 
1144343 + 3 T 3.175542327 0.002972542 nrdE.2 ↔ nrdF2 "ribonucleotide-diphosphate reductase subunit alpha" ↔ "ribonucleotide-diphosphate reductase subunit beta" UTR U 
1839292 − 5 G 3.876062579 0.002426336 guaB inosine 5'-monophosphate dehydrogenase ORF U 
1152858 − 3 T 3.921362055 2.26E-05 Spy_sRNA1153040  UTR S 
866502 + 5 C 2.951959969 0.00902615 SPy_1056 hypothetical protein ORF U 
759781 + 5 C 2.653863581 0.004502182 rpsA 30S ribosomal protein S1 ORF U 
1722836 − 5 T 3.429178026 0.009340337 groEL molecular chaperone GroEL ORF U 
1186671 + 3 T 3.494584094 0.002200297 pyrD ↔ Spy_sRNA1186876 "dihydroorotate dehydrogenase 1A" UTR S 
764039 − 5 G 2.947438158 0.020263336 SPy_0919 hypothetical protein ORF U 
1144105 + 5 A 3.891549698 0.002491144 nrdE.2 ↔ nrdF2 "ribonucleotide-diphosphate reductase subunit alpha" ↔ "ribonucleotide-diphosphate reductase subunit beta" UTR U 
1747099 + 5 A 4.664244977 0.002159742 rpsB 30S ribosomal protein S2 ORF U 
1747552 + 5 C 4.444347355 0.001540553 tsf elongation factor Ts ORF S 
1330352 − 3 T 1.998032027 0.018905098 Spy_sRNA1330456 ↔ SPy_1610 "hypothetical protein" UTR U 
1362429 − 3 T 3.46021708 0.000334488 mapZ ↔ luxS "hypothetical protein" ↔ "S-ribosylhomocysteinase" UTR S 
1747452 + 5 C 6.070343159 0.001176324 tsf elongation factor Ts ORF U 
1412225 − 3 A 3.601123157 0.002254547 SPy_1699 (antisense) transcriptional regulator UTR S 
1746402 + 5 C 4.570385015 0.001176324 SPy_2091 ↔ rpsB "regulatory protein" ↔ "30S ribosomal protein S2" UTR U 
1547061 − 3 T 5.39976177 0.000155917 dnaQ DNA polymerase III subunit epsilon ORF U 
1564217 − 3 T 4.157821937 0.001494411 SPy_1885 ↔ SPy_1884 
"hypothetical protein" ↔ "several hypersensitive-induced 
response proteins" UTR U 
1746359 + 5 C 3.708363188 0.001540553 SPy_2091 ↔ rpsB "regulatory protein" ↔ "30S ribosomal protein S2" UTR U 
1632984 − 3 T 4.417898184 0.000290432 proS ↔ polC "prolyl-tRNA synthetase" ↔ "DNA polymerase III PolC" UTR U 
1820651 − 5 T 4.551197459 0.011935722 mnmA ↔ Spy_sRNA1820593 "tRNA-specific 2-thiouridylase MnmA" UTR U 
587903 + 5 G 3.669307524 0.001540553 eno ↔ SPy_0732 "phosphopyruvate hydratase" ↔ "hypothetical protein" UTR S 
1611214 − 5 C 2.673843167 0.007081647 SPy_1936 hypothetical protein ORF U 
1365697 − 5 C 4.812691898 0.004926863 gpsB hypothetical protein ORF U 




 UTR U 
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1115544 − 5 G 4.674251651 0.005409722 psr PBP 5 synthesis repressor ORF U 
579750 + 5 A 4.150242413 0.001540553 Spy_sRNA579683 ↔ rplS "50S ribosomal protein L19" UTR U 
1701760 − 3 T 4.194774524 0.000467351 mf ↔ ropB "mitogenic factor" ↔ "transcriptional regulator" UTR S 
1747070 + 3 A 5.557468515 0.002066464 rpsB 30S ribosomal protein S2 ORF U 
1747315 + 3 T 4.597213274 0.000149841 rpsB ↔ tsf "30S ribosomal protein S2" ↔ "elongation factor Ts" UTR S 
1365865 − 5 T 3.588992733 0.004830991 gpsB hypothetical protein ORF U 
1747475 + 5 T 6.677236028 0.001176324 tsf elongation factor Ts ORF S 
1747474 + 3 T 4.283558874 0.001045368 tsf elongation factor Ts ORF S 
1747596 + 3 T 5.59603246 0.002650485 tsf elongation factor Ts ORF U 
1365841 − 5 C 4.423587162 0.003390621 gpsB hypothetical protein ORF U 
378719 + 5 G 3.035908755 0.00462229 rplK ↔ rplA "50S ribosomal protein L11" ↔ "50S ribosomal protein L1" UTR U 
1747690 + 3 C 5.444698369 0.002650485 tsf elongation factor Ts ORF U 
1053640 − 5 G 2.888051895 0.005968461 glmS glucosamine--fructose-6-phosphate aminotransferase ORF U 
1341253 + 5 T 3.954196474 0.011653679 cysM O-acetylserine lyase ORF U 
1519103 − 5 T 4.042479513 0.00908257 ssb single-stranded DNA-binding protein ORF U 
1748450 + 3 T 4.706143711 0.000149841 tsf ↔ pepO "elongation factor Ts" ↔ "endopeptidase O" UTR S 
1774730 + 3 T 3.448833775 0.00522187 int4 ↔ Spy_sRNA1774740 "integrase" UTR U 
1774768 + 3 T 3.262800682 0.002200297 Spy_sRNA1774740  UTR S 
577834 + 5 C 3.09750458 0.036116287 SPy_0721 flavodoxin ORF U 
1747337 + 5 T 4.540070372 0.002472901 rpsB ↔ tsf "30S ribosomal protein S2" ↔ "elongation factor Ts" UTR S 
1824525 − 3 T 3.060858593 0.023350155 SPy_2191 ↔ sdhA "hypothetical protein" ↔ "L-serine dehydratase subunit alpha" UTR U 
1404830 − 5 T 4.122351516 0.000597033 Spy_sRNA1404921 glyQ leader UTR S 
1747787 + 5 T 6.275497155 0.001455677 tsf elongation factor Ts ORF U 
 
Table A10: Transcript ends (5′ or 3′) more abundant in the ∆rny strain than in the WT strain. 
List of the RNA ends identified as more abundant in the ∆rny strain than in the WT strain, named as 5′ or 3′ ∆rny_ends. The information is provided with regard the 
chromosome position, the nature of the end (5′ or 3′), the directionality of the strand (positive (+) or negative (−)), the log 2 Fold Change (Log2FC), the False Discovery 
Rate (FDR), the gene ID (the arrow “↔”depicts the intergenic region between two genes), description of the gene function based on NCBI, the location of the ∆rny_end 
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(in open reading frame (ORF) and untranslated region (UTR)) and the type of end (“unique” (U) or “stepped” (S)).  R.A.-B. generated the raw list of ∆rny_ends analysed 
by L.B, A.-L.L. and A.L.R. 
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